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Chairman’s Letter
5 October 2011
Senator the Hon Kim Carr 
Minister for Innovation, Industry, Science and Research
Parliament House
CANBERRA ACT 2601
Dear Minister
In accordance with Section 9 of the Commonwealth Authorities and Companies Act 
1997 (CAC Act), I am pleased to present the Annual Report of the Australian Nuclear 
Science and Technology Organisation (ANSTO) for the period 1 July 2010 to 30 June 
2011. This Annual Report includes a Report of Research and Operations, the content and 
preparation of which the Board is responsible for under Section 9 of the CAC Act.
Yours sincerely
Professor Paul Greenfield AO 
Chairman
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About ANSTO
ANSTO – the Australian Nuclear Science 
and Technology Organisation – is home 
to Australia’s nuclear expertise. ANSTO 
employs over 1,100 people in southwest 
Sydney, and supplies Australia with 
outstanding nuclear research, medicine 
and technology capabilities.
The organisation provides policy advice 
to Government on all matters relating 
to nuclear science, technology and 
engineering. It supports Government in 
undertaking its international roles and 
obligations.
It also undertakes research and pursues 
innovation in areas aligned with the 
national research priorities and those that 
have the potential to deliver key outcomes 
to support Australians and Australian 
industry.
ANSTO strives to achieve key outcomes 
in publishing scientific research, securing 
intellectual property, training research 
students, developing software, providing 
engineering design and services, and 
consulting for industry.
Innovation is critical to increasing 
Australia’s productivity and 
competitiveness. The Australian 
Government invested over $9 billion 
in science research and innovation in 
the 2010-2011 financial year and this 
investment is evident through the 
landmark science infrastructure Australian 
scientists can now access at ANSTO.
What we do
ANSTO is the custodian of nuclear 
knowledge and expertise in Australia and 
operates OPAL, Australia’s only research 
reactor. OPAL is used for scientific 
research, the production of medical 
radioisotopes, the activation of targets 
and the irradiation of silicon used for 
microelectronics.
OPAL facilitates specialised research 
using a growing suite of neutron beam 
instruments at ANSTO’s Bragg Institute. 
ANSTO also operates two particle 
accelerators, which are fundamental to 
addressing the national research priorities 
and advancing knowledge in areas as 
important as climate change.
Each week ANSTO delivers 10,000 patient 
doses of potentially lifesaving nuclear 
medicines to over 250 partner hospitals 
and medical practices across Australia. 
The mining industry relies on ANSTO to 
provide advice and technology to handle 
naturally occurring radioactive materials in 
mineral processing. ANSTO also provides 
expert advice on the safe treatment 
and disposition of nuclear waste and 
specialised irradiation services.
Our networks
ANSTO is connected with all Australian 
and New Zealand universities through the 
Australian Institute of Nuclear Science and 
Engineering (AINSE), providing researchers 
access to Australia’s nuclear science, 
technology and engineering expertise 
and landmark infrastructure which in 
turn, facilitates greater national science 
collaboration.
ANSTO’s strategic international 
collaborations ensure Australian scientists 
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are connected with important global 
research projects. In 2010-2011 ANSTO 
broadened its relationship with Japan’s 
High Energy Accelerator Research 
Organisation including exchanges 
between ANSTO’s neutron beam facilities 
and the Japan Proton Accelerator 
Research Complex (J-PARC) neutron 
spallation source. These techniques 
are complementary in nature and the 
relationship between the organisations 
capitalises on the scientific infrastructure 
available to each country.
Other international collaborations initiated 
during the reporting period were with 
the French Atomic Energy Commission 
(CEA), including a staff exchange in 
reactor operations, and with the European 
Organisation for Nuclear Research (CERN), 
focusing on nuclear, accelerator and 
materials science.
Our Corporate Plan 2010-2015
In 2010, the ANSTO Corporate Plan for 
2010-2015 was developed and approved 
by the ANSTO Board and accepted by  
the Minister for Innovation, Industry, 
Science and Research, Senator the  
Hon. Kim Carr. Our 2010-2015 Corporate 
Plan is a public document, available via 
the ANSTO website, and sets out the 
organisation’s key goals and strategic 
direction for this period.
Our Vision
To deliver excellence in innovation, 
insight and discovery through our people, 
partnerships, nuclear expertise and 
landmark infrastructure.
Our strategic directions for 2010-2015
• Deliver world-class research and 
innovation in nuclear science and 
technology
• Expand ANSTO’s reach and contribution, 
exploiting landmark technologies
• Serve the nuclear needs of government, 
industry, community and the people of 
Australia
• Drive organisational renewal.
Responsible Minister
Minister for Innovation, Industry, Science 
and Research, Senator the Hon. Kim Carr.
Statement of Compliance
This report is written with reference 
to the Commonwealth Authorities and 
Companies (Report of Operations)  
Orders 2008.
Senator the Hon. Kim Carr.
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Members of the Board
Professor Paul Greenfield AO (Chair)
BE (Hons), B.Econ, PhD, FTSE, FIEAust, 
FIChE, FAICD, CPEng, CEng, CSci
Vice-Chancellor University of Queensland; 
academic, engineer.
Chairman from 24 February 2011
Appointed 25 July 2007
Reappointed 25 July 2010
Term concludes 24 July 2014
Dr Zygmunt (Ziggy) Switkowski  
(former Chair)
BSc (Hons), PhD, FAICD
Company director, former chief executive,
scientist
Chair 1 March 2007 - 31 December 2010
Appointed 1 January 2006
Term concluded 31 December 2010
Professor Andrew Scott
MBBS (Hons), MD, FRACP, DDU, FAICD
Director, Ludwig Institute for Cancer 
Research; nuclear medicine
physician, scientist and academic.
Appointed 26 September 2007
Term concludes 25 September 2011
Professor David Copolov OAM
MBBS, PhD, FRACP, FRANZCP, MPM, 
DPM
Pro Vice-Chancellor, Office of the  
Vice-Chancellor and Professor of 
Psychiatry, Monash University.
Appointed 1 May 2008
Term concludes 30 April 2012
Professor John Hearn
BSc, MSc, PhD
Deputy Vice-Chancellor (International)  
and Professor of Physiology
University of Sydney.
Appointed 1 May 2008
Term concludes 30 April 2012
 
Ms Erica Smyth
MSc, FAICD
Scientist and businesswoman.
Appointed 12 December 2008
Term concludes 11 December 2012
Ms Christine McLoughlin
BA, LLB (Hons)
Company Director; former financial 
services executive,
lawyer and businesswoman.
Appointed 13 March 2009
Term concludes 12 March 2013
Dr Susan Pond AM
MBBS (Hons), MD, DSc, FTSE, FRACP
Adjunct Professor, University of Sydney; 
medicine, science, business.
Appointed 1 July 2010
Term concludes 30 June 2014
 
Mr John Ryan PSM
BEc, MEc
Executive Director, Cloon Economics
Appointed 24 February 2011
Term concludes 23 February 2016   
Dr Adrian (Adi) Paterson
BSc, PhD
Chief Executive Officer.
Appointed 1 March 2009
Term concludes 28 February 2014
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Pictured from left to right (back row) Erica Smyth, Adi Paterson, Christine McLoughlin, Andrew Scott,  
(front row) Susan Pond, David Copolov, Paul Greenfield, John Ryan.
Not present: John Hearn
5  l  Australian Nuclear Science and Technology Organisation
ANSTO Executive Team
Dr Adrian (Adi) Paterson 
Chief Executive Officer
Dr Greg Storr 
General Manager, Nuclear Operations
Mr Peter Arambatzis 
Chief Financial Officer
Mr Geoff Askew 
Chief Security Officer (to 28 February 2011)
Mr Paul Jones 
General Manager, Security and Safeguards 
(from 17 January 2011)
Mr Douglas (Doug) Cubbin 
Executive General Manager for Business 
Development and Commercialisation
Professor John Dodson 
Head, Institute for Environmental Research
Professor Lyndon Edwards 
Head, Institute of Materials Engineering
Dr Ron Hutchings 
Head, International Relations 
(to 1 December 2010)
Mr Shaun Jenkinson 
General Manager, ANSTO Health
Mr Con Lyras 
General Manager, Engineering & Capital 
Programs
Ms Amelia McArdle 
General Manager, Human Resources  
(to 18 May 2011)
Mr Robert (Rob) Blissett 
General Manager, Human Resources  
(from 28 April 2011)
Dr Robert (Bob) Ring 
General Manager, ANSTO Minerals
Dr Robert (Rob) Robinson 
Head, Bragg Institute
Dr Ron Weiner  
Head, ANSTO LifeSciences  
(to 28 February 2011)
Dr Marie-Claude Gregoire 
Head, ANSTO LifeSciences  
(from 1 March 2011)
By invitation:
Professor Richard Banati 
Distinguished Research Fellow and  
ANSTO LifeSciences
Mr Michael Beckett 
General Manager, Support Services & 
Chief Information Officer
Ms Stephanie Cole 
Legal Counsel
Mr Hefin Griffiths 
Manager, Safety, Environmental & 
Radiological Assurance
Ms Nadia Levin 
Head, Strategic Communications and 
Government Affairs
Mr Kobus Naude 
Senior Manager, Strategy & Planning 
(from 8 November 2010)
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Pictured from left to right (back row) Kobus Naude, Rob Blissett, Hefin Griffiths, Michael Beckett,  
Stephanie Cole, John Dodson, Lyndon Edwards, Rob Robinson, Paul Jones, Richard Banati  
(front row) Peter Arambatzis, Nadia Levin, Adi Paterson, Greg Storr, Marie-Claude Gregoire.
Not present: Shaun Jenkinson, Con Lyras, Doug Cubbin, Bob Ring, Ron Hutchings, Geoff Askew,  
Amelia McArdle, Ron Weiner.
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Chairman’s Report
ANSTO continues to fulfil its mission as 
an international centre of excellence in 
nuclear science and technology. Through 
the operation of the OPAL research reactor 
and its complementary suite of neutron 
beam instruments, ANSTO maintains its 
role as the home of nuclear and accelerator 
science expertise in Australia and attracts 
interest and collaboration from researchers 
around Australia and the world.
The development of strategic research 
collaborations and landmark infrastructure 
is ensuring Australian researchers have a 
part to play in the global nuclear science 
landscape and share the benefits with 
Australia.
We can look back on 2010-2011 as being a 
year when ANSTO demonstrated just how 
important this organisation is to Australia.
Of course, one of the major events 
during this period was the earthquake 
and tsunami in Japan and the subsequent 
accident at the nuclear power plant at 
Fukushima Daiichi. 
ANSTO supported the Australian 
Government by providing timely technical 
advice during the crisis and our radiation 
protection experts helped keep Australia’s 
emergency response teams in Japan safe 
by providing portable radiation monitoring 
equipment. 
We are also proud that ANSTO has been 
able to offer Japanese scientists access 
to our neutron-beam instruments here in 
Australia while their own research reactors 
are out of operation. These offers have 
been gratefully accepted by our Japanese 
colleagues and we continue to offer 
assistance in their scientific endeavours.
In other areas, reliable operation of 
the OPAL reactor and ANSTO Health 
production facilities have continued 
to offer assistance in overcoming 
international shortfalls in the supply of 
radiopharmaceuticals due to scheduled and 
unscheduled shutdowns.
ANSTO Health has continued to deliver 
in excess of 10,000 patient doses of 
vital radiopharmaceuticals, used for the 
diagnosis and treatment of diseases 
including cancer, to the Australian health 
industry each week, and has commenced 
exports of radioisotopes to the United 
States (US). This is a major milestone for 
the Organisation and it is a testament 
to ANSTO Health’s capabilities. ANSTO 
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is playing an important role in ensuring 
nuclear medicine reaches two million 
patients across the globe each year.
Notably, ANSTO was praised by the US 
Department of Energy for helping meet 
their need for nuclear medicine produced 
using low enriched uranium fuel and  
targets – which helps international efforts 
in nuclear non-proliferation.
While radiopharmaceuticals produced by 
ANSTO Health are experiencing record 
demand, ANSTO’s commercial expertise 
in other areas is also proving to be a great 
national asset. 
ANSTO Minerals is experiencing 
unprecedented demand for its consulting 
services from the mining industry and 
the Institute for Environmental Research 
is providing important information for 
scientists trying to better understand 
climate change. Meanwhile, researchers 
from LifeSciences are delivering exciting 
new insights into diseases such as 
Parkinson’s disease and melanoma 
– breakthrough research that has the 
potential to significantly improve the health 
outcomes of millions of Australians.
The ANSTO Corporate Plan 2010-2015 
provides clear direction for the organisation. 
Over the past twelve months, ANSTO  
has made commendable progress  
through its journey of organisational 
change and renewal and is emerging  
as a more sophisticated and outward  
looking organisation.  
I am proud to present my first Annual 
Report, and hope you will share my sense 
of excitement about our achievements and 
the future prospects for ANSTO.
Professor Paul Greenfield AO
Chairman
9  l  Australian Nuclear Science and Technology Organisation
Chief Executive Officer’s Report
As a nuclear organisation, safety is 
fundamental to everything we do. The 
2010-2011 financial year had a great focus 
on safety, both locally and across the 
international nuclear industry. I am proud 
that throughout the year, improving our 
safety record was a priority embraced by 
our entire organisation. Events previously 
considered insignificant are now being 
recorded, and importantly lost time injuries 
fell by more than half. 
ANSTO is appreciative of the continued 
support from the Minister for Innovation, 
Industry, Science and Research, the Hon. 
Kim Carr and we welcomed the review of 
Current Health and Safety Arrangements 
at ANSTO Health. ANSTO’s safety 
improvement journey is a continuing one 
but I would like to thank staff who have 
embraced a more robust safety culture 
during this period.
Every aspect of the global nuclear industry 
has been effected by the aftermath of 
the Japanese earthquake and tsunami 
that compromised the Fukushima Daiichi 
Nuclear Power station in March 2011. 
Nuclear organisations around the world 
now find themselves operating in a very 
different landscape. 
Despite the new challenges, there have 
been important learnings from the events 
that took place at Fukushima Daiichi, which 
were discussed at the IAEA Ministerial 
Conference on Nuclear Safety that I 
attended in June 2011. ANSTO’s presence 
at events such as this ensures Australia 
benefits from the shared safety lessons 
and importantly, that we have a seat at the 
global nuclear table. 
Locally, ANSTO has continued to thrive 
under a strong leadership team. We are 
seeing the fruits of good leadership, 
planning and hard work by all parts of the 
organisation.  
During the past financial year we have 
seen the ANSTO Corporate Plan 2010-2015 
come to life, and the organisation is tracking 
towards achieving its prescribed goals. 
Collaboration is the framework for 
modern science, and in the past year 
ANSTO has worked to ensure we develop 
strategic collaborations both locally and 
internationally that will facilitate research  
to benefit all Australians. 
We believe that the best way for us to 
continue to deliver world-class research 
outcomes is to engage with world-class 
researchers – and that is precisely what we 
are doing. In the past year we welcomed in 
excess of 243 researchers from other parts 
of Australia and around the world, who 
used our landmark facilities for multiple 
research projects.
In recent times, we have signed important 
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agreements with the likes of the Chinese 
Academy of Sciences, CEA, CERN, J-PARC 
and the Korea Atomic Energy Research 
Institute (KAERI). These collaborations 
open many doorways for our researchers.
OPAL is a fantastic example of the fact 
that investments in science can pay off 
in many different ways – but we are not 
resting on our laurels. ANSTO continues 
to invest in infrastructure, with numerous 
new instruments coming online or under 
construction in the Bragg Institute to 
maximise the advantages brought to us  
by OPAL.
The announcement of new investments 
in accelerators as part of the Australian 
Collaboration for Accelerator Science 
(ACAS) will complement our work with 
neutrons, and unite some of Australia’s 
brightest research talents in physics.
Research outcomes at ANSTO continue to 
offer excellent prospects. Many of the big 
scientific questions are within the sights 
of our researchers, whether it is how to 
create more efficient batteries, better 
ways to manage scarce water resources, 
or new imaging techniques for melanoma 
or Parkinson’s disease. 
Our researchers not only find new 
solutions, they provide the insights we 
need for informed decision making.
In the environmental field, nuclear 
techniques have been used to gain a better 
understanding of the water cycle in the 
Murray-Darling Basin. ANSTO researchers 
have also discovered light responsive 
molecules with potential applications in 
detecting the presence of toxic levels 
of carbon dioxide; exciting new ways 
of creating magnetic interfaces at the 
atomic level; and new understandings of 
the properties of crystals that can benefit 
industry. 
As an organisation ANSTO is committed 
to the innovative application of nuclear 
technologies. We are pleased to encourage 
other scientific organisations to apply 
technology in innovative ways through the 
support of the inaugural ANSTO Eureka 
Prize for Innovative Use of Technology.
Importantly, ANSTO is engaging with 
the community and enjoying clear public 
support. This is evident in the record 
number of 11,114 visitors participating 
in tours of ANSTO facilities this year–
an improvement of 16 per cent on the 
previous year and more than doubling 
since 2005-2006. One of the key 
messages conveyed by respondents in 
a 2010 public survey was that Australia 
should have a national nuclear science 
centre and that the organisation should 
provide advice on nuclear issues. 
This Annual Report demonstrates how 
ANSTO is playing an important role and 
achieving outcomes that are benefiting 
the lives of many Australians. I would 
like to recognise the Board for their part 
as custodians of our vision and mission 
and for continuing to support the good 
governance and promotion of ANSTO.
Dr Adrian (Adi) Paterson 
Chief Executive Officer
2010-2011 highlights
New leadership for ANSTO Board 
ANSTO’s continual delivery of excellence in 
the field of nuclear science and technology 
has been assured with the appointment 
of Professor Paul Greenfield AO as the 
Organisation’s Chairman in February 2011.
Professor Greenfield takes over from the 
tremendous contribution of Dr Zygmunt 
(Ziggy) Switkowski. Professor Greenfield 
has been a member of the ANSTO Board 
since 2007 and his skills in science and 
senior management will ensure ANSTO’s 
continued success. 
ANSTO welcomed Dr Susan Pond as a 
member of the Board from 1 July 2010.  
Dr Pond has a distinguished record 
within the medical, science and business 
arenas including serving as the Chairman 
of Johnson & Johnson Research Pty 
Limited from 2003-2009, as Chairman of 
AusBiotech Limited from 2007-2008 and 
more recently as a non-Executive Director 
of Commercialisation Australia from 2010.
Mr John Ryan was also appointed as a 
member of the Board in February 2011.  
Mr Ryan has had several public sector 
roles, including Deputy Secretary of the 
Department of Resources, Energy and 
Tourism, and was head of the secretariat 
for the panel that delivered the Prime 
Minister’s Uranium Mining, Processing  
and Nuclear Energy Review (UMPNER)  
in 2006.
ANSTO Board member, Professor David 
Copolov, was awarded the Order of 
Australia in the General Division (OAM) for 
service to medical research, to professional 
organisations and to higher education. 
International radioisotope 
production groups 
ANSTO is a participant in the IAEA 
International Working Group on Conversion 
Planning for Mo-99 Production Facilities 
from highly enriched uranium (HEU) to low 
enriched uranium (LEU) and in the OECD 
Nuclear Energy Agency’s (NEA) High-level 
Group on the Security of Supply of Medical 
Radioisotopes. 
The IAEA working group aims to identify 
areas of potential multilateral collaboration 
in support of the conversion from HEU to 
proliferation-resistant LEU by current major 
producers of molybdenum-99 (Mo-99). 
ANSTO, as one of the few LEU producers 
of Mo-99 in the world, is in a position to 
provide a significant contribution to this 
working group. The NEA Working Group 
is examining ways in which future global 
supply shortages of Mo-99 can be avoided 
or ameliorated. OPAL’s production capacity 
could make a significant contribution in  
this regard.
Award winning Moata 
decommissioning
ANSTO was honoured with two 
prestigious awards for project managing 
the decommissioning of the Moata 
research reactor, the first ever project of its 
kind on a nuclear reactor in Australia.
The national ‘Best Small Project Award’ 
was received from the Australian Institute 
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of Project Management, and the State 
Project Management Achievement  
Award was received from the NSW 
division of the Australian Institute of 
Project Management. 
Both awards recognised the complexities 
of the project, which had to be delivered 
safely while complying with a complex 
range of state, national and international 
requirements. It was also delivered on 
time and within budget.
Moata operated successfully for 34 years 
until 1995. It was initially used for research 
and training and later included activation 
analysis and neutron radiography. Moata 
also played an important role in aircraft 
safety. Commercially, Moata was used for 
approximately 15 per cent of all procedures 
world-wide involving radiography to check 
the structural soundness of jet engine 
turbine blades. The reactor was also an 
important tool for Australia’s uranium 
mining industry, providing rapid and 
accurate measurements of ore. 
External revenue outcomes 
ANSTO delivered an external revenue 
outcome of $69.68 million. This exceeded 
the budget estimate of $65 million.
Of this total revenue, earnings by 
ANSTO business and commercial groups 
amounted to $59.13 million in 2010-2011.  
This was up $5.2 million, being a 9.6 per 
cent increase on the previous year.
Within this business and commercial 
revenue, ANSTO Health’s earnings were 
$27.18 million in 2010-2011, up $4.56 
million from the previous year. ANSTO 
Minerals revenue earning was again 
outstanding, with total earnings of $12.22 
million, a solid increase of 16 per cent 
against the 2009-2010 result.
The core members of the Moata Reactor Decommissioning project team pictured from left to right, 
Gary Simms, John Macleod, Paul Gambell, Glen Felstead, Geoff Malone and Alec Kimber.
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2010-2011 highlights
Increase in local processing 
ability for Mo-99
ANSTO began exporting supplies of the 
critical diagnostic agent Mo-99 to the US 
with the first shipments for clinical use 
made on 22 May 2011. Radioisotopes 
produced using LEU targets are favoured 
by customers such as the US because 
they ensure that the uranium targets can 
only be used for peaceful applications. 
ANSTO’s reactor is one of the few 
research reactors in the world that both 
runs on LEU and can produce commercial 
quantities of medical isotopes using LEU 
targets. OPAL’s fuel and targets consist 
of around 20 per cent uranium-235, which 
compares to older research reactors 
requiring as much as 95 per cent  
enriched uranium.  
Mo-99 is the raw isotope used to produce 
technetium-99m (Tc-99m), a product that 
is used in the diagnosis of illnesses like 
cancer and heart disease. ANSTO is the 
only producer of this nuclear medicine in 
Australia, and supplies hospitals across the 
country with around 10,000 patient doses 
each week.
Globally, the majority of Mo-99 is supplied 
by Canada, The Netherlands, Belgium 
and South Africa but scheduled and 
unscheduled shutdowns have caused 
supply problems in recent years. With  
Tc-99m used in over 80 per cent of  
nuclear medicine procedures worldwide,  
ANSTO’s production increase has bolstered 
international supplies as required.
New software aids reliable  
power supply 
Australia’s demand for electricity is 
skyrocketing while the country’s power 
infrastructure ages. But a new software 
program developed by ANSTO’s materials 
engineering specialists is helping coal-fired 
power stations improve their efficiency 
and sustain a reliable output. The software, 
‘RemLife’, is already in use by several 
power companies across Australia 
to gauge the wear and tear of plant 
infrastructure. 
ANSTO’s software means power stations 
can generate electricity more reliably. The 
software calculates the damage a power 
plant sustains during its operating cycle, 
which allows predictions of how much 
longer the plant can operate safely. 
If plant operators better manage their 
operating profiles and more accurately 
identify areas that need pro-active 
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maintenance, then they have the capacity 
to increase the life of the station and boost 
the efficiency of the unit. 
RemLife is quick and cost-effective, rather 
than spending a week to assess a single 
component within the power plant, the 
assessment can be carried out in minutes.
Professor John Dodson book 
release
Head of ANSTO’s Institute for 
Environmental Research (IER), Professor 
John Dodson, edited a new book on the 
effects of climate change - Changing 
Climates, Earth Systems and Society. 
The book offers insights into the climate 
change phenomenon, with a particular 
focus on the impacts on human society.  
It brings together authors from around  
the world to take an in-depth look at 
climate change and its impact including 
melting ice caps, spread of disease and 
food insecurity.
Taipan unleashed
The operating licence for ANSTO’s 
seventh neutron beam instrument, Taipan, 
was issued on Friday 15 October 2010 by 
the Australian Radiation Protection and 
Nuclear Safety Agency (ARPANSA).
Taipan is a thermal neutron 3-axis 
spectrometer. As one of the most 
advanced of its kind, the $7 million 
instrument’s precise measurements will 
provide insight into how materials like 
superconductors and high-performance 
magnets change structure. These 
studies will be used to advance magnetic 
information storage, shape memory 
materials and thermo-electric materials.
John Dodson’s book – Changing Climates, Earth 
Systems and Society
Mohana Yethiraj (left) and Sergey Danilkin 
(right) working on ANSTO’s triple-axis 
spectrometer, Taipan.
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Top honours for Materials 
Engineering
ANSTO’s Institute of Materials 
Engineering (IME) won the prestigious 
Welding Technology Institute of Australia 
(WTIA) Company of the Year award in 
acknowledgment of their work in the 
science and technology of welding and 
welded structures, which has contributed 
to Australia’s high international profile and 
competitiveness in these fields.
ANSTO has been involved with welding 
and welded structure research and 
development for over 50 years, providing 
materials selection advice, inspections, 
fabrication advice, design review and 
material investigations for the power 
generation, petrochemical, defence and 
transportation industries.
IME also contributes to WTIA Panels and 
Australian Standards committees, and 
undertakes remaining life and structural 
integrity research and consultation.
ANSTO Eureka Prize for 
Innovative Use of Technology
In 2011, ANSTO was proud to establish a 
new category in the Australian Museum 
Eureka Prizes. The Eureka Prizes 
showcase the best of Australian science, 
research and innovation every year, and 
the ANSTO Eureka Prize for Innovative 
Use of Technology aims to put outstanding 
Australian research and technological 
innovation under the spotlight.
2010-2011 highlights
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The IME team pictured from left to right, Bob Harrison, David Carr, Michael Drew, Paul Di Pietro, Ondrej 
Muransky, Phil Bendeich and Lyndon Edwards.
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Australia’s nuclear expertise
Advice to Government on 
Fukushima 
Following the March 2011 earthquake and 
tsunami in Japan and associated disaster 
at the Fukushima Daiichi nuclear power 
plant, ANSTO supported government by 
providing technical information and advice 
to the Interdepartmental Emergency 
Task Force chaired by the Department of 
Foreign Affairs and Trade. ANSTO provided 
advice on issues such as the effects of the 
presence of mixed oxide (MOX) fuel in Unit 
3 and the likely impact of a hypothetical 
melt of spent fuel in the Unit 4 spent fuel 
pond (which did not eventuate). 
IAEA Ministerial Conference on 
Nuclear Safety
ANSTO CEO, Dr Adi Paterson attended the 
IAEA Ministerial Conference on Nuclear 
Safety in Vienna from 20-24 June 2011. 
The conference was aimed at ensuring 
the worldwide safety and emergency 
preparedness of nuclear facilities, and  
the radiation protection of people and  
the environment.
IAEA member states from across the 
globe were present at the conference 
which identified and discussed lessons 
learned from the March nuclear accident 
at the Fukushima Daiichi Nuclear Power 
Station in Japan.
Indonesian radiation safety
The Indonesian emergency preparedness 
and response (EPR) Project is conducted 
under the ANSTO BATAN Memorandum of 
Cooperation and funded by the Australian 
Government through the Indonesian 
Counter Terrorism Cooperation. ANSTO 
has conducted EPR workshops with 
the National Nuclear Energy Agency of 
Indonesia (BATAN) both at ANSTO and  
in Indonesia.
These workshops focused on potential 
terrorist incidents involving radiological 
or nuclear materials. They enabled 
participants to assess and advise on 
nuclear and radiological hazards during 
emergencies; make contaminated areas 
safe; and recommend protective measures 
for response personnel and others involved 
in the incident.
A radiological worker from Indonesia’s national 
nuclear agency, BATAN, participates in an emergency 
preparedness and response workshop at ANSTO.  
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Health and life sciences 
Promising new melanoma diagnostic
An ANSTO LifeSciences research team, 
led by Ivan Greguric, has played a key 
role in the development of a promising 
new radiopharmaceutical to characterise 
melanoma tumours.
A key feature of many primary melanoma 
tumours is the increased level of melanin, 
characterised by the high level of 
pigmentation. The new radiopharmaceutical, 
[18F]N-(2- (diethylamino)-ethyl)-6-
fluoronicotinamide, known as Mel050,  
has been designed to specifically target 
melanin, which is often present in high 
concentrations in the cancer cells, offering 
opportunities for better disease localisation. 
More importantly related compounds 
labelled with I-131 may offer potential 
radiotherapeutic applications for this  
deadly disease.
Mel050 is being developed as part of 
the Cooperative Research Centre for 
Biomedical Imaging Development’s 
(CRCBID) research program. Collaborators 
in this project are the Peter MacCallum 
Cancer Centre and Cyclotek (Aust) Pty Ltd.
Next generation 
radiopharmaceuticals
ANSTO is undertaking research to optimise 
the specific radioactivity of radionuclides 
obtained from OPAL irradiations. This, in 
turn, should improve the effectiveness 
of radiopharmaceuticals that are taken up 
by receptors and/or antigens on tumour 
cells. Enhancing the specific activity allows 
ANSTO LifeSciences’ Mel050 research team, pictured from left to right, Andrew Katsifis, Naomi Wyatt,  
Cathy Jiang, Tien Pham and Ivan Greguric.
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more radioactive atoms to be delivered to 
the tumour, either enhancing the image 
quality in biomedical imaging or improving 
the effectiveness of internally deposited 
radionuclides for radiotherapeutic 
treatments. This research should improve 
the formulation of radiopharmaceuticals 
that treat tumours in several different 
cancers including neuroendocrine tumours, 
breast and colon cancer, and lymphomas.
Neutrons and Food Workshop
ANSTO hosted the Neutrons and Food 
Workshop in Sydney in late 2010, which 
looked at the future of smart food and  
food packaging including the potential  
for producing foods that reduce weight  
and prevent disease, and packaging that 
tells you how fresh and nutritious the  
contents are.
ANSTO’s Jaroslav Blazek and Elliot Gilbert 
presented a paper on their research 
looking at how bowel cancer, the second 
most deadly cancer, could be prevented 
by better understanding the molecular 
structure of starch and how it is digested 
in the human body. 
This type of research may be the key to 
reducing the incidence of diet-related 
disease such as colorectal cancer and type 
2 diabetes. The paper showed that the tiny 
pores and channels in starch play a key 
role in processes of digestion. 
Blazek and Gilbert have also published 
their findings in the international journal, 
Biomacromolecules. 
Two steps better than one 
A two or dual step reactor radiolabelling 
module which is known as FlexLAB, being 
tested by ANSTO, is a key goal in the 
research program of the CRCBID, which is 
developing novel radiopharmaceuticals for 
use in diagnosis.
Neutrons and Food Workshop attendees, 31 October - 3 November 2010
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Making a radiopharmaceutical that 
will be injected into the human body 
is a complex procedure. Each step 
in the production process is carefully 
designed and measured to make sure the 
radiopharmaceutical - or tracer as they 
are more commonly known - can do the 
important job it is made to do.
To ensure the manufacturing process is as 
easy, safe and efficient as possible, a new 
production system has been developed 
that reduces the level of manual handling 
of radioactive materials that scientists 
need to do when making a tracer.
The new two step reactor provides the 
scientists with two ‘pots’ or reactors in 
which the synthesis of more complex, 
novel tracers can be carried out in an 
automated process. This also means that 
the cost of supply of the tracer is kept as 
low as possible, due to the efficiencies of 
automated manufacture, which is good for 
patients and doctors alike.
The FlexLAB is the result of a cooperative 
effort of the commercial and research 
partners of CRCBID, which includes 
ANSTO LifeSciences, the Peter MacCallum 
Cancer Centre and Cyclotek (Aust.) Pty Ltd.
Environment and climate change
Darling River evaporation and 
groundwater inputs during drought
The Darling River faces environmental 
pressures from both direct human 
influence and climate change. Irrigation 
demands have dramatically altered the 
riverine ecosystem over the last century, 
but during drought it is evaporation and 
saline groundwater that impact the river’s 
water quality through the formation of algal 
blooms, salinisation and acidification.
Dryland rivers are particularly challenging 
to monitor because they experience 
variable rainfall, low flow and evaporation. 
This is why more sophisticated tools  
such as isotopic tracers are being used  
to establish baseline signatures of these 
river systems.
Since mid-2002 ANSTO has been 
monitoring the changes along the 
Darling River using stable isotopes and 
subsequently modelled evaporative losses 
and saline groundwater input to the river 
during the long drought of the last decade. 
Research such as this is being used to 
help inform decision makers in charge of 
managing the river system.
Unravelling farming and metallurgy 
in ancient China with nuclear science
Nuclear techniques are being used 
increasingly to tell us who we are and 
where we have come from. ANSTO 
research is shedding new light on early 
cultural connectivity across Eurasia by 
investigating sites in northwest China. 
Separate systems of agriculture emerged 
independently in eastern and western Asia 
around 8000 -10,000 years ago. 
In the east, incipient agriculture centred on 
cultivating millet and rice, while in the west 
it centred on wheat and barley.
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ANSTO is applying isotopic methods 
and atomic mass-spectrometry with 
radiocarbon dating to archaeological 
remains from Bronze Age sites in northern 
China in order to better understand cereal 
cultivation, animal husbandry and bronze 
metal-work technology.
Using cosmic rays and radionuclides 
to measure the contribution of the 
East Antarctic Ice Sheet to changes 
in global sea-level
Current global climate models do not fully 
incorporate the contribution of Antarctic 
ice sheets to changes in sea level despite 
dramatic changes in the past. 
Projected sea-level rise by the end of 
the 21st century ranges from 20 to 60 
centimetres, mainly attributed to the 
Antarctic Peninsula, Greenland and ocean 
thermal expansion.
During the last ice age, about 20,000-
25,000 years ago, the sea-level was 120 
metres lower and Antarctic ice volume 
three times larger than today. Hence, 
documenting the size and retreat rate of 
the East Antarctic Ice Sheet since the last 
ice age (called the Last Glacial Maximum) 
will allow a better understanding of 
ice sheet dynamics and sensitivity 
to increasing warming, and validate 
predictions of future sea-level change.
Using the new innovative technique 
of in situ cosmogenic radionuclide 
surface exposure dating, ANSTO has 
for the first time provided quantitative 
geochronological constraints on the 
variability and sensitivity of East Antarctic 
Scientists with view of the Prince Charles Mountain flanking the Lambert Glacier near Loewe Massif, Antarctica.
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ice volume, suggesting that parts of 
the Ice Sheet respond more rapidly to 
global climate change than previously 
assumed and that East Antarctica was not 
responsible for a controversial dramatic 
pulse in sea-level rise of 20 metres 14,500 
years ago.
Understanding and managing 
wetland health
ANSTO is conducting research on 
Australia’s fragile wetlands. These 
wetlands undergo frequent stresses 
from droughts and floods, which in turn 
impact a diverse range of aquatic, avian, 
and terrestrial biota. During these periods 
of change in water levels, the food 
webs of the wetland shift, increasing 
the competition between native and 
introduced species.
ANSTO measures these impacts using 
isotopes of carbon and nitrogen -  
the fundamental building blocks of  
wetland animals and plants. ANSTO’s 
study is adding to the understanding of 
how wetland health fluctuates as a result 
of natural and human-caused changes,  
and provides information about what 
actions are needed to sustain  
functioning wetlands.
Wading into sediment studies 
ANSTO research being conducted in 
conjunction with Queensland’s James 
Cook University is using accelerator mass 
spectrometry (AMS) dating techniques at 
ANSTO’s accelerator facilities to analyse 
sediment of low-lying reef islands.
The research centres on the study of 
skeletal components in sediment like coral, 
coralline algae, molluscs, and the naturally-
occurring carbon-14 (C-14) radioisotope 
in each layer. Analysis of the specimens 
is undertaken using ANSTO’s Australian 
National Tandem Accelerator for Applied 
Jordan Iles (left) and Debashish Mazumder (right) taking samples from Australian wetlands.
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Research (ANTARES) and Small Tandem 
for Applied Research (STAR) accelerators.
By studying the sediment, scientists are 
able to find out the age of the particular 
layer, examine patterns of sediment 
production and more accurately  
determine the growth rates of reef  
islands. This research will enable 
an improved understanding of the 
environmental change in tropical marine 
ecosystems and will help marine 
authorities in implementing a sustainable 
management framework for the Great 
Barrier Reef.
A cleaner future for Darwin Harbour 
ANSTO’s expertise is providing a scientific 
basis for good environmental management 
in the Northern Territory’s Darwin Harbour. 
ANSTO’s Dr Cath Hughes, Stuart Hankin 
and Robert Chisari recently travelled to 
Darwin at the invitation of the Northern 
Territory’s Power and Water Corporation to 
collect data to help model currents and the 
dispersion of pollutants in Darwin Harbour.
Power and Water, which is responsible for 
sewerage services in Darwin, has been 
working with Charles Darwin University 
to develop a hydrodynamic water quality 
modeling tool to help predict the dispersion 
of treated wastewater discharged into 
Darwin Harbour.
The model can also provide an important 
environmental management tool to assist 
environmental regulators to investigate 
spills and contaminated runoff from the 
catchment. The model will also be used to 
optimise the location for an extension of 
the existing outfall at Darwin’s East Point.
Materials
Waste – a resource when using 
selective separation
Selective separation of aqueous elements 
is a vitally important and industrially 
significant process not only with regards 
to reducing the volumes of nuclear waste 
materials, but also for extracting industrially 
important elements: all rely upon the 
ability to remove a specific element from a 
complex mixture of elements.
ANSTO research is creating new 
functionally designed materials for 
selective separation, in particular, for the 
nuclear industry.
An aerial image of a tracer plume in Darwin Harbour and study team. Photos courtesy Simon Hobbs.
ANSTO Annual Report 2010-2011  l  24
Making better Li-ion batteries using 
neutron diffraction
Lithium ion (Li-ion) batteries are  
ubiquitous in Australian households. They 
can be found in mobile phones, media 
players, laptop computers and many other 
portable devices. ANSTO research uses 
neutron diffraction to learn what happens 
to the molecular-scale structure of 
components within Li-ion batteries  
during use and re-charge.
ANSTO researchers are exploring 
electrochemical properties and the 
mechanism of charge-transfer in order 
to improve our understanding of the 
performance of Li-ion batteries. Both the 
Wombat and Echidna neutron diffraction 
instruments are used in undertaking this 
research.
Developing radiation-tolerant 
materials
ANSTO is conducting research on 
materials that will be used in future nuclear 
energy production that need to perform 
under extreme levels of irradiation and 
elevated temperature. These materials 
need to perform without significant 
degradation of properties for a specified 
service life. 
ANSTO’s research investigates radiation 
damage in complex perovskite systems, 
by testing the theory that a coupling exists 
between the radiation damage recovery 
mechanism and a phase transition system.
Neeraj Sharma preparing samples for Li-ion battery 
research.
Tamim Darwish pictured is developing chemical 
sensors that can visually detect CO2 in the air.
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Visual probes for carbon dioxide and 
new molecular logic-systems
Excessive exposure to high levels of 
carbon dioxide (CO2) can endanger human 
health and even be fatal. As CO2 is invisible 
to the naked eye, it can only be monitored 
using electronic equipment. ANSTO is 
developing chemical sensors that are 
highly sensitive to the presence of CO2 and 
more importantly can be used to visually 
detect toxic levels of CO2 in the air. 
A spectrum of colours, from purple to 
yellow, can be obtained depending on the 
concentration of CO2 being introduced. 
Just like photochromic (light-responsive) 
molecules darken UV sensitive sunglasses 
when exposed to the sun, this research 
has the potential to develop products that 
will change colour when exposed to high 
levels of CO2.
Interfaces of ionic liquids to improve 
industrial electrochemical processes
Ionic liquids are simply salts with a melting 
point below 100°C. Their rather varied 
physical and chemical properties are 
interesting because they can be employed 
in improving various chemical processes, 
such as the electrodeposition of metals.
They have attracted particular interest 
because they may allow aluminium to be 
smelted at room temperature. ANSTO has 
used modelling combined with neutron 
and X-ray reflectometry to examine the 
structure of ionic liquids at the air-liquid and 
electrode-liquid interfaces to understand 
the electrochemical processes.
Engineering/technology
Research to improve nuclear safety 
ANSTO’s research into the flow 
characteristics of oddly shaped, or 
‘deformed’, bubbles at high gas velocities 
in nuclear power reactors aims to improve 
the safety of nuclear reactors around the 
world.
Although the behaviour and impact of 
spherical bubbles is quite well understood, 
there has been little research into the 
behaviour of ‘deformed’ bubbles which 
behave quite differently.
ANSTO’s research will create computer 
models that will identify reactor design and 
operational factors that cause or encourage 
the presence of ‘deformed’ bubbles. 
The modelling data can then be used to 
inform regulators, reactor designers and 
operators on more efficient reactor designs 
and operating procedures. 
Operation of OPAL and other 
facilities
OPAL
In the 2010-2011 financial year, the OPAL 
research reactor operated for 276 days 
at high power, which translates to a 
total availability of 76 per cent. This was 
4 per cent less than the target, mainly 
attributable to some extra maintenance 
activities that were required as operation 
proceeded. OPAL reliability, which is 
defined as adherence to the published 
schedule, was greater than 90 per cent. 
This result compares favourably with  
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other highly utilised research reactors 
around the world.
Production increased significantly during 
the year. The irradiation of uranium plates 
for the production of Mo-99 was increased 
from two runs to four runs per week in 
the second half of 2010, and has been 
maintained at that level. More than 27 
tonnes of silicon ingots were irradiated in 
OPAL during the year, generating revenue 
for ANSTO. On time delivery of irradiated 
products has met the internal client 
demand. 
The Cold Neutron Source, which supplies 
important low energy neutrons for research, 
was unavailable for about 30 per cent of 
the year due to several equipment failures. 
While this affected research for ANSTO 
and university scientists, remedial work has 
been undertaken to improve its reliability.
Construction of a Heavy Water Isotopic 
Purification System plant was completed. 
The plant should be fully operational by 
late 2011. It will be used to purify the 
heavy water that surrounds the reactor 
core, leading to improved efficiency and 
production.
ANSTO plans to operate the reactor for 
300 days in 2011-2012. 
Neutron-beam instruments 
OPAL’s neutron research facilities contain 
neutron-beam instruments which use 
OPAL’s neutrons for solving complex 
research and industrial problems in many 
important fields.
Neutron scattering allows scientists to 
see what X-rays cannot. Neutrons are 
used to see the internal structure of 
many classes of materials, thus helping 
scientists understand why materials 
have the properties that they do, and 
helping tailor new materials that suit 
specific technological needs in computing, 
refrigeration, mobile batteries, solar cells, 
renewable plastic packaging and medicine.
ANSTO’s operating neutron-beam 
instruments are:
Echidna – high-resolution powder 
diffractometer
Koala – single-crystal Laue diffractometer
Kowari – residual-stress diffractometer
Platypus – neutron reflectometer
Quokka – small-angle neutron scattering 
instrument (SANS)
Taipan – thermal triple-axis spectrometer
Wombat – high-intensity powder 
diffractometer
In October 2010, ARPANSA approval to 
operate Taipan was obtained, completing 
the initial suite of neutron-scattering 
instruments at OPAL. 
Six additional neutron-scattering 
instruments were under procurement or 
construction, four of which were funded 
under a national Education Investment 
Fund (EIF) project: 
•  The time-of-flight spectrometer (Pelican) 
and a cold triple-axis spectrometer (SIKA) 
were nearing completion, with first 
neutrons expected in early 2012. 
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• The high-resolution backscattering 
spectrometer (Emu), an ultra small-angle 
scattering instrument (Kookaburra), a 
neutron radiography, tomography and 
imaging station (Dingo) and a time-of-
flight SANS instrument (Bilby) were in 
the procurement phase and scheduled 
for completion in 2013.
Radiopharmaceutical production 
facilities
ANSTO supplies radiopharmaceuticals to 
over 220 nuclear medicine centres across 
Australia and exports to New Zealand, 
Southeast Asia, the US and South Africa.
ANSTO produces large quantities of 
different isotopes used in the diagnosis 
and treatment of serious illnesses such  
as cancer.
ANSTO’s processing facility manufactures 
Mo-99 to meet the demand for this 
important radiopharmaceutical which is 
used in 80 per cent of nuclear medicine 
procedures performed around the world. 
The other main radiopharmaceuticals 
distributed are iodine-131 (I-131) for the 
diagnosis and treatment of thyroid cancer 
and hyperthyroidism; gallium-67 (Ga-67) to 
determine the extent of Hodgkin’s disease, 
lymphomas and bronchogenic carcinoma; 
iodine-123 mIBG (I-123) for detection, 
staging and follow-up to therapy for 
neuroblastomas; and thallium-201(Tl-201) 
used in myocardial perfusion imaging for 
the diagnosis and localisation of  
myocardial infarction. 
National Deuteration Facility
ANSTO’s National Deuteration Facility 
offers the capability to produce molecules 
where all or part of the molecular hydrogen 
is in the form of the stable non-radioactive 
isotope of hydrogen called deuterium.
This important technique enables 
scientists to more effectively investigate 
the relationship between the structure 
and function of proteins, DNA, synthetic 
polymers and other materials known as 
‘soft matter’.
Deuteration of parts of a molecule creates 
contrast between those parts containing 
deuterium and those with normal 
hydrogen, thus providing more information 
about the molecular structure. 
Molecular deuteration assists in making 
it possible to observe the arrangement 
of sub-units of an enzyme, or changes in 
shape when molecules interact or become 
active or inactive. This can be done with 
molecules in solution under relevant real 
life conditions. Hydrogen and deuterium 
atoms scatter neutrons quite differently 
when placed in front of a neutron beam.
Accelerators
Accelerators are used to analyse materials 
- often using extremely small samples – to 
determine their elemental composition 
and age. ANSTO currently has two 
accelerators, ANTARES and STAR, both of 
which are used in ion beam analysis and 
accelerator mass spectrometry. 
ANSTO is also in the planning stages of 
the Federal Government funded Centre 
for Accelerator Science (CAS) at ANSTO. 
ANSTO will develop the Centre over the 
next few years. 
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The new accelerators are a low-energy 
multi-isotope accelerator mass 
spectrometer and a new medium-energy 
tandem accelerator. 
The Centre will act as a strong drawcard 
for Australian and overseas scientists 
from nearly every scientific field, working 
in areas such as radiocarbon dating and 
environmental studies.
Irradiation facility
ANSTO’s irradiation facility, known as 
GATRI (Gamma Technology Research 
Irradiator), is used to irradiate items for 
medical health, industry, agriculture and 
research. 
GATRI is the only Australian provider of 
high precision irradiation services including:
• ANSTO underpins the sterility of donated 
human bone and tendons for transplants 
and grafting in surgery, leading to 
improved outcomes for patients.
• Irradiation of the Queensland fruit fly to 
help control infestations
• Irradiation of quarantined goods
• Plant mutation studies
• Sterilisation of medical products
• Accelerating long term storage effects 
on products such as plastics and 
electronics.
Decommissioning – HIFAR and the 
National Medical Cyclotron
Following the successful decommissioning 
of the Moata reactor, ANSTO has 
commenced decommissioning of the 
National Medical Cyclotron (NMC) at 
Camperdown NSW, and continued 
preparation for the decommissioning of  
the HIFAR reactor at Lucas Heights.
The 2010-2011 Federal Government 
budget allocated $9.7 million towards 
the continued safe decommissioning 
of ANSTO’s disused nuclear facilities. 
The decommissioning is undertaken in 
accordance with highly regulated national 
and international safety requirements.
Community and education
Record number of visitors 
In the 2010-2011 financial year a record 
11,114 visitors took tours of ANSTO’s 
facilities, up 16 per cent on the previous 
record of 9,543 visitors in 2009-2010, with 
the number of visitors more than doubling 
since 2005-2006. 
Visitors enjoying a tour of ANSTO facilities.
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The community and school tours are 
designed to introduce more visitors, 
including potential scientists of the  
future, to the world of nuclear science  
and technology.
Year 9 and 10 students benefit greatly 
from a visit to ANSTO as these students 
are in the process of choosing their 
Higher School Certificate subjects, and are 
formulating opinions of science in general. 
The tours have been adapted to be more 
age appropriate, and to reflect the broad 
sweep of ANSTO research, with Biology 
and Earth and Environment Science 
excursions recently added to the traditional 
Physics, Chemistry and General Science 
tours.
The tours differ slightly but typically 
involve a presentation in the Visitor Centre, 
followed by visits to ANSTO’s state-of-
the-art research reactor, OPAL, and one of 
ANSTO’s accelerators, where guests are 
encouraged to try the hands-on exhibits.
Likewise, visits to ANSTO’s website were 
at an all-time high, with 30,080 visits to the 
website in June 2011, up 67 per cent on 
June 2010.
Sponsorships
In 2010-2011, ANSTO sponsored a 
range of research and community 
events. Sponsorship highlights included 
the inaugural ANSTO Eureka Prize for 
Innovative Use of Technology, significant 
involvement in the National Youth Science 
Forum (NYSF), and the continuation of the 
Fulbright Professional or Senior Scholarship 
in Nuclear Science and Technology for 
Australians undertaking research in the 
US. NYSF is a forum bringing together 
Australia’s brightest year 11 students to 
engage with researchers and discover 
exciting and fascinating career options  
in science.
ANSTO has continued to focus on 
education, supporting the Australian 
2011 ANSTO Australia Day stand at Cronulla Beach.
ANSTO Annual Report 2010-2011  l  30
Museum’s Science in the Bush/Suburbs/
City program which brings hands-on 
science to primary and secondary school 
students across New South Wales.  
ANSTO also sponsored two high school 
students attending the International 
Science Olympiads.
ANSTO also supported key international 
conferences and workshops to increase  
its profile and awareness of the user 
access program that allows researchers 
access to landmark infrastructure on a 
merit-based system.
ANSTO participated in a number of 
conferences, including:
• the International Conference on 
Coordination Chemistry (ICCC 39) in 
Adelaide
• the 11th South Pacific Environmental 
Radioactivity Association Conference 
(SPERA 2010) in Surfers Paradise
• the 2010 Chemeca chemistry conference 
in Sydney
• the 19th Australian Institute of Physics 
Congress in Melbourne
• the 35th Annual Condensed Matter and 
Materials Meeting in Wagga Wagga
• the Accelerator Mass Spectrometry 
Conference (AMS 12) in Wellington,  
New Zealand.
An important part of ANSTO’s  
sponsorship work is community support 
and engagement, which increases 
awareness of the outstanding science and 
innovation being performed in Australia. 
Examples of this include sponsorship 
and participation in the Sutherland Shire 
Australia Day events, and the Women 
in Science and Engineering Summit and 
Science meets Parliament events at 
Parliament House in Canberra.
Pictured from left to right, Richard Banati, Neeraj Sharma, Michael Zettinig, Jasmin Craufurd-Hill, Michael 
Weir, Debashish Mazumder, Alexander Szabo and Justin Davies at the Science meets Parliament event at 
Parliament House.
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Distinguished Lecture Series
In 2010-2011 ANSTO continued to run 
the popular Distinguished Lecture Series 
which is open to the general public. The 
world-class scientists speaking this year 
included:
• Dr Michael Doser, Senior Physicist from 
CERN in Switzerland, who spoke on 
antimatter
• Professor David Wehe from the 
University of Michigan, who presented 
on radiation detection
• Associate Professor Robyn Sloggett, 
Director and Chief Conservator at 
the Centre for Cultural Materials 
Conservation in the University of 
Melbourne, who discussed the latest 
methods used to conserve priceless 
cultural materials
• Dr Stephen Myers, Director of 
Accelerators and Technology also from 
CERN, who spoke about the world 
famous Large Hadron Collider (LHC)
• Dr William Thomlinson from Monash 
University, who spoke on the increasing 
use of synchrotrons
• Professor (Emeritus) Martin Suter from 
the Laboratory of Ion Beam Physics, ETH 
Zürich, Switzerland, who talked on AMS
• Mr John Carlson, former Director 
General of the Australian Safeguards and 
Non-Proliferation Office (ASNO), who 
discussed nuclear governance for the 
21st century.
Outstanding staff achievements
Institute of Materials Engineering
The IME has won the prestigious 
WTIA Company of the Year award in 
acknowledgment of their work in the 
science and technology of welding and 
welded structures.
ANSTO has been involved with welding 
and welded structure research and 
development for over 50 years. IME 
provides materials selection advice, 
inspections, fabrication advice, design 
review and investigations for the power 
generation, petrochemical, defence and 
transportation industries.
Professor John Dodson
Professor John Dodson, Head of ANSTO’s 
Institute for Environmental Research, 
released Changing Climates, Earth 
Systems and Society. The book provides 
insights into the phenomenon of climate 
change and its impact on society.
Dr David Cohen 
Three decades of scientific research 
by ANSTO’s Senior Principal Research 
Scientist, Dr David Cohen, was recognised 
by the Australian Nuclear Association 
(ANA) who awarded Dr Cohen the 2010 
Annual Award. Dr Cohen received the 
award for his outstanding contributions to 
research and applications of accelerator 
science and technology.
Dr Cohen’s current research is helping 
identify the sources of fine particle 
pollution across Asia.
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Businesses
External Earnings by ANSTO business and 
commercial groups amounted to $59.13 
million in 2010-2011. This was up $5.2 
million, being a 9.6 per cent increase on 
the previous year.
ANSTO Health 
ANSTO Health is the commercial 
division of ANSTO that produces 
radiopharmaceuticals in Australia and 
operates a production facility from 
ANSTO’s southern Sydney campus. 
ANSTO Health plays an important role in 
the nuclear medicine and health industries 
in Australia, supplying around 550,000 
patient doses of radiopharmaceuticals 
each year. The ANSTO Health business 
continues to grow and as mentioned 
previously, now exports Mo-99 to the US.
ANSTO Health’s revenue earning was 
$27.18 million in 2010-2011. This was up 
$4.56 million from the previous year.
Lutetium-177
Lutetium-177 (Lu-177) is a radioisotope 
used for therapeutic applications. 
In March 2011 ANSTO signed an 
agreement with Isotope Technologies 
Garching (ITG) to enable local production 
to support growing demand for this 
radioisotope.
ANSTO Minerals
ANSTO Minerals is a commercial 
consultancy group focussed on the 
uranium and rare earths mining sector. 
ANSTO has over 30 years experience 
and expertise that includes chemical 
engineering, metallurgy, mineralogy, 
chemistry, geology and radiation safety. 
ANSTO Minerals offer solutions and 
innovative technology including flow sheet 
design, bench testing and scale up pilot 
plant. These services delivered by ANSTO 
Minerals generate substantial financial 
and environmental benefits to mining and 
mineral processing customers.
ANSTO Minerals’ revenue earnings for 
2010-2011 was $12.22 million. This was 
up $1.7 million from the previous year. This 
is due to continual commercial activities in 
uranium and rare earths.
Partnerships and associated 
organisations
CERN
ANSTO signed an agreement with CERN 
which will allow scientists affiliated with 
each organisation to collaborate and 
receive reciprocal use of equipment. This 
David Cohen
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means scientists from CERN benefit from 
access to ANSTO’s facilities, including the 
OPAL reactor.
The agreement is expected to lay a 
pathway for collaborative research by 
Australia’s best and brightest scientists in 
areas such as accelerator science, health 
and life sciences, information technology 
and radiation detection.
Australia is among a number of countries 
outside of the European Union to sign  
an agreement allowing access to the 
famous facilities.
By engaging with CERN, ANSTO and 
Australia will benefit from cutting-edge 
research and develop expertise in areas 
such as particle-therapy platforms and 
large-scale accelerator facilities.
The collaboration may also involve the joint 
supervision of research students, staff 
exchanges and negotiated arrangements 
for the exploitation of intellectual property.
Australian Synchrotron
Synchrotron radiation-based techniques 
are vital to a wide range of research fields 
including physics, chemistry, materials 
science, structural biology, polymer 
research, environmental science and 
geophysics. 
Synchrotron radiation techniques are 
similar to neutron scattering techniques 
that require a reactor such as OPAL, 
Adi Paterson and Kim Carr in front of the Large Hadron Collider in Geneva, Switzerland.
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and the results from each are often 
complementary. While there are things a 
reactor can do that a synchrotron cannot, 
there is significant overlap in the user 
communities. 
ANSTO is one of ten foundation investors 
in the Australian Synchrotron and has 
special access to it, averaging six days per 
year on each beamline. Proposals for this 
special access are internally reviewed by 
ANSTO. 
ANSTO has used this beamtime to 
perform strategic experiments; to initiate 
new projects; to conduct preliminary and 
pilot studies; for training and familiarisation 
of staff on new techniques; for a small 
molecule crystallography service; and to 
give increased time allocations to ANSTO 
proposals which have been submitted via 
the regular scientific merit system.
This year, ANSTO researchers were 
awarded 30 days of beamtime at the 
Australian Synchrotron. While all eight 
operating beamlines were used, a clear 
trend of increasing demand for the small 
angle X-ray scattering (SAXS) beamline 
has emerged, reflecting the close 
complimentarity of this technique with 
SANS at the Quokka instrument at OPAL. 
In addition, the synchrotron’s online 
proposal and user administration system 
was developed and continues to be 
maintained by the Bragg Institute under a 
contract from the Australian Synchrotron.
This is a significant benefit to users of the 
synchrotron and the neutron scattering 
instruments at OPAL as both facilities run 
the same online user system.
ANSTO, the Australian Synchrotron, 
Monash University and other partners 
organised the ‘Synchrotron and Neutron 
New Users Symposium’ to educate 
potential new users about the landmark 
infrastructure available and the user-access 
programs at ANSTO’s Bragg Institute and 
the Australian Synchrotron.  
AINSE
Located on ANSTO’s southern Sydney 
campus, AINSE provides universities and 
other tertiary institutions with access to 
ANSTO’s nuclear facilities, facilitating 
a culture of cooperation in the nuclear 
science and engineering fields. AINSE 
arranges for the training of scientific 
research workers and the award of 
scientific research studentships in 
matters associated with nuclear science 
and engineering. AINSE’s membership 
comprises 39 Australian and New Zealand 
universities plus GNS Science, New 
Zealand, and ANSTO.
IMSS - KEK
ANSTO signed a memorandum of 
understanding (MOU) with the Institute of 
Materials Structure Science (IMSS), High 
Energy Accelerator Research Organisation 
(KEK) in Tsukuba, Japan. 
The agreement is aimed at promoting 
collaborative research and science using 
neutron and synchrotron research facilities 
at ANSTO’s OPAL research reactor and 
the J-PARC Materials and Life Science 
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Experimental Facility spallation source and 
Photon Factory synchrotron in Japan.
SINAP
ANSTO began negotiations for a general 
MOU with the Shanghai Institute of 
Applied Physics (SINAP) that covers a 
range of potential collaborative research 
projects in areas of mutual interest 
such as nuclear materials engineering, 
air pollution studies, ground water 
and water sustainability research, 
radiopharmaceutical research and 
development, and detector development 
projects.
The agreement will cover many of 
Australia’s National Research Priorities and 
aims to enhance Australian engagement 
with China, which is a Federal Government 
priority area for international research and 
innovation engagement.
Details of the agreements were developed 
during a two-day workshop in Shanghai, 
hosted by SINAP and attended by 
nine of ANSTO’s top scientists. The 
workshop was supported by the Federal 
Government’s International Science 
Linkages program.
Austin Health
ANSTO announced it will be investing 
$1.5 million to construct a state-of-the-art 
laboratory at the Austin Hospital in Victoria.
The laboratory will be used to develop new 
treatments and imaging tools to advance 
medical research into cancer detection  
and treatment. 
This investment is in addition to the 
Victorian Government’s $4.3 million 
investment in a new cyclotron at Austin 
Health’s Centre for Positron Emission 
Tomography.
Turning of the sod on the new Environmental Radioactivity Measurement Centre. Pictured from left to right, 
John Dodson, Con Lyras, Steve Vikatos and Henk Heijnis.
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Austin Health’s Centre for Positron 
Emission Technology (PET) is the largest 
academic PET centre in Australia and has 
an international reputation as a leader 
in research into cancer and neurological 
disorders.
Workshops
ANSTO/AINSE Neutron School 
The Bragg Institute, in conjunction with 
AINSE, hosted over 30 domestic and 
international tertiary students for the 
six-day ANSTO/AINSE Neutron School on 
Dynamics and Kinetics 2010.
Drawing participants from universities in 
Australia, New Zealand, Singapore, Taiwan, 
China and South Africa, the program was 
aimed at PhD students, postdoctorate and 
novice users, new to neutron scattering 
techniques.
Italian and Australian Archaeology 
and Cultural Heritage Workshop 
Organised by the Embassy of Italy 
and ANSTO, the Italian and Australian 
Archaeology and Cultural Heritage 
Workshop looked at how research 
facilities, such as ANSTO, are used 
in archaeological and cultural heritage 
research and discussed potential new 
fields of collaboration.
ANSTO speakers highlighted the work 
already done here in the field of cultural 
heritage and archaeology using neutron 
scattering, X-ray techniques, accelerators 
and neutron activation analysis. Australian 
Synchrotron speakers discussed 
techniques available at the synchrotron 
that are complementary to those provided 
by ANSTO.
Access to Major Research Facilities 
Program
ANSTO operated the Access to Major 
Research Facilities Program. 
This program included large facilities not 
available in Australia, such as high flux 
neutron beam sources and high energy 
physics and astronomical facilities.
During the 2010-2011 financial year, the 
program funded 81 teams to perform 
experiments using facilities in the US, 
South America, Europe and Asia. ANSTO 
led 14 of these teams.
Capital investment 
Numerous major construction projects 
are underway at ANSTO that will deliver 
highly improved scientific facilities and 
infrastructure. 
Some of the key constructions include:
•  The Environmental Radioactivity 
Measurement Centre, which will provide 
new laboratories and office space to be 
used for the reconstruction of human 
impacts on ecosystems over the past 
8000 years, and to monitor ANSTO’s 
local environment. It will be built from 
materials with low background radiation 
levels to ensure interference does 
not occur during tests of low levels of 
radioactivity
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• the Integrated Waste Management 
Facility which will improve efficiency 
through the consolidation of a number 
of operations currently carried out at 
different locations across site 
• the ANSTO Minerals Precinct Facilities,  
which will allow the amount and scope 
of work undertaken by this successful 
ANSTO business to be expanded. It 
includes bays, offices, laboratories and 
associated services infrastructure
• the OPAL building project, which will 
include a two storey office building, 
laboratories and workshops to 
accommodate 100 nuclear operations 
staff currently located in other areas 
across site
• the Centre for Accelerator Science (CAS), 
which will reinforce ANSTO’s place 
at the forefront of AMS and ion beam 
analysis research. The new facilities 
will feature two new accelerators for 
radiocarbon dating, analysis of long-
lived radioisotopes and materials 
microanalysis, and laboratory facilities for 
sample preparation.
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Performance against 
strategic objectives
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Key Performance Indicators 2009-2010 2010-2011   
Facility availability  
-  Neutron Beam instruments - % days 85% 83% 
operated per days beamline availability 
-  Total availability of OPAL: % of days at power 73% 76% 
-  Planned availability of OPAL: % of  93% 90% 
actual operating to scheduled operating time   
-  Accelerators: average % of days 78% 78% 
operated per planned operation  
Nuclear Science Facilities project  
-  percentage of capital funding completed 32% 48.4%1 
Radiopharmaceutical doses  
- Potential Doses 2,113,396 2,276,764
1  Actual expenditure was less than estimated. The draw-down of funds from the Department was decreased 
accordingly.
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Australian Nuclear Science and Technology Organisation
Financial Statements 2010-2011
ANSTO Annual Report 2010-2011  l  44
Consolidated statement of comprehensive income 
for the year ended 30 June 2011
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
for the year ended 30 June 2011
Notes 2011 2010
$'000 $'000
EXPENSES
A6stifeneb eeyolpmE 103,062 90,164
B6sesnepxe sreilppuS 61,255 73,867
C6noitasitroma dna noitaicerpeD 80,174 54,422
D6stessa fo tnemriapmi dna nwod etirW 5,241 17
Grants 6E 6,225 4,330
Finance costs 6F 15,192 14,060
G6sessol egnahcxe ngieroF 696 353
H6selas tessa morf sessoL 3,151 1,748
TOTAL EXPENSES 274,996 238,961
LESS:
OWN-SOURCE INCOME
Own-source revenue
B5secivres fo gniredner dna sdoog fo elaS 56,582 47,660
Interest 5D 7,357 6,268
Grants 5C 2,084 4,222
Total own-source revenue 66,023 58,150
Gains
E5stessa fo elas morf sniaG 270 634
Foreign exchange gains - non speculative 5F 832 949
Other income 5G 2,550 108
Total gains 3,652 1,691
Total own-source income 69,675 59,841
Net cost of services 205,321 179,120
Revenue from Government 5A 165,592 155,240
)927,93(snoitarepo gniunitnoc no xat emocni erofeb )ticifeD( (23,880)
Income tax (expense) benefit 23 (345) 138
)470,04(snoitarepo gniunitnoc no xat emocni retfa )ticifeD( (23,742)
(Deficit) after income tax (40,074) (23,742)
)470,04(tnemnrevoG nailartsuA eht ot elbatubirtta )ticifeD( (23,742)
OTHER COMPREHENSIVE INCOME
Changes in asset revaluation reserves 10 10,652 34,185
)224,92(xat emocni retfa )ticifed( emocni evisneherpmoc rehto latoT 10,443
Total comprehensive income (deficit) attributable to the Australian Government (29,422) 10,443
The above statement should be read in conjunction with the accompanying notes
Consolidated
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Consolidated balance sheet 
as at 30 June 2011
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
CONSOLIDATED BALANCE SHEET
as at 30 June 2011
Consolidated
2011 2010                   2009
Notes $'000 $'000 $'000
ASSETS
Financial assets
12 ,A7stnelaviuqe hsac dna hsaC 3,278 5,023                  3,752
12 ,B7selbaviecer rehto dna edarT 11,727 9,045                  9,557
Investments 7C, 21 115,268 134,000              142,661
Total financial assets 130,273 148,068              155,970
Non-financial assets
A8sgnidliub dna dnaL 209,164 196,510              157,645
B8seitilicaf rojam dna tnempiuqe dna tnalp ,erutcurtsarfnI 696,513 688,655              612,299
Inventories 8C 15,629 13,784                8,711
Intangibles 8D 18,948 15,417                5,241
Tax assets 8E - 433                     318
Other 8E 7,255 6,226                  4,086
Total non-financial assets 947,509 921,025              788,300
Total assets 1,077,782 1,069,093 072,449           
LIABILITIES
Payables
Suppliers 9E, 21 11,383 12,578                8,263
Employees 9F, 21 3,836 2,815                  1,609
Grants 9G, 21 687 562                     575
Other 9H, 21 1,433 1,557                  1,171
Total payables 17,339 17,512                11,618
Interest bearing liabilities
Other 9A, 21 2,484 3,497                  3,308
484,2seitilibail gniraeb tseretni latoT 3,497                  3,308
Provisions
B9snoisivorp eeyolpmE 28,528 25,487                23,213
C9noisivorp gninoissimmoceD 291,465 269,517              181,762
Other 9D 286 270                     2,007
Total provisions 320,279 295,274              206,982
Total liabilities 340,102 316,283              221,908
Net Assets 737,680 752,810              722,362
EQUITY 10
Contributed equity 481,956 467,856              447,856
Reserves 350,809 343,358              307,679
Retained (deficit) (95,085) (58,404)               (33,173)
Total equity 737,680 752,810              722,362
The above statement should be read in conjunction with the accompanying notes
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Consolidated statement of cash flows
for the year ended 30 June 2011
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
CONSOLIDATED STATEMENT OF CASH FLOWS 
for the year ended 30 June 2011
2011 2010
$'000 $'000
Inflows Inflows
Note (Outflows) (Outflows)
OPERATING ACTIVITIES
Cash received
Sales of goods and rendering of services 56,640 53,738
Interest 8,377 5,984
Receipts from Government 165,592 155,240
Total cash received 230,609 214,962
Cash used
Employees (99,000) (86,684)
Suppliers (81,201) (85,956)
Total cash used (180,201) (172,640)
NET CASH FLOWS FROM OPERATING ACTIVITIES 11 50,408 42,322
INVESTING ACTIVITIES
Cash received
Proceeds from sale of property, plant and equipment 1,526 1,707
Proceeds from investment sales 173,525 274,626
Total cash received 175,051 276,333
Cash used
Purchase of property, plant and equipment (81,511) (70,737)
Purchase of investments (159,793) (266,647)
Total cash used (241,304) (337,384)
)352,66(SEITIVITCA GNITSEVNI YB DESU HSAC TEN (61,051)
FINANCING ACTIVITIES
Cash received
Appropriation - contributed equity 14,100 20,000
001,41SEITIVITCA GNICNANIF MORF SWOLF HSAC TEN 20,000
)547,1(DLEH HSAC NI )ESAERCED(/ESAERCNI TEN 1,271
Cash and cash equivalents at the beginning of the reporting period 5,023 3,752
872,3doirep gnitroper eht fo dne eht ta stnelaviuqe hsac dna hsaC 5,023
The above statement should be read in conjunction with the accompanying notes
Consolidated
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Consolidated statement of changes in equity 
for the year ended 30 June 2011
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
CONSOLIDATED STATEMENT of CHANGES in EQUITY
for the year ended 30 June 2011
Retained Surpluses
2011         2010       2011           2010         2011          2010        
2011           2010         2010           2010        
$'000 $'000 $'000 $'000 $'000 $'000
$'000 $'000 $'000 $'000
)404,85(ecnalaB gninepO (33,173) 328,456 294,271 14,902       13,408
467,856 447,856 752,810 722,362
Foreign currency translation -                -              -                 -               201 16            
-                 -                201             16            
Revaluation increment -                -              10,652        34,185 -                 -               
-                 -                10,652        34,185
Other -                -              -                 -               (139)           (11)           
-                 -                (139)           (11)           
Surplus (deficit) for the period (a) (40,074) (23,742) -                 -               -                 -               
-                 -                (40,074) (23,742)
)470,04(emocni evisneherpmoc latoT (23,742) 10,652        34,185 62              5              
-                 -                (29,360) 10,448
Contributions by Owners
Appropriation (equity injection) (a) -                -              -                 -               -                 -               
14,100        20,000 14,100        20,000
-srenwO htiw snoitcasnarT latot-buS                 -              -                 -               -                 -
               14,100        20,000 14,100        20,000
393,3stnenopmoc ytiuqe neewteb srefsnarT         (1,489) -                 -               (3,263)        1,489       
-                 -                130             -               
)580,59(enuJ 03 ta sa ecnalab gnisolC (58,404) 339,108 328,456 11,701       14,902
481,956 467,856 737,680 752,810
Closing balance attributable to Australian Government (95,085)
ecnalaB gninepO
Foreign currency translation
Revaluation increment
Other
Surplus (deficit) for the period (a)
emocni evisneherpmoc latoT
Contributions by Owners
Appropriation (equity injection) (a)
srenwO htiw snoitcasnarT latot-buS
stnenopmoc ytiuqe neewteb srefsnarT
enuJ 03 ta sa ecnalab gnisolC
Closing balance attributable to Australian Government
(58,404) 339,108 328,456 11,701       14,902
481,956 467,856 737,680 752,810
Note
(a) Changes to 2010 comparatives are covered in note 26.
The above statement should be read in conjunction with the accompanying notes
detubirtnoC
tessA
Consolidated
Consolidated
Revaluation Reserve
Total EquityEquity/Capital
Other Reserves
Financial Statements 2010-2011
ANSTO Annual Report 2010-2011  l  48
Consolidated schedule of commitments not recognised as liabilities 
as at 30 June 2011
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
CONSOLIDATED SCHEDULE OF COMMITMENTS NOT RECOGNISED AS LIABILITIES 
as at 30 June 2011
Notes 2011               2010            
$'000 $'000
BY TYPE
Commitments receivable
Other commitments receivable
GST recoverable from Australian Taxation Office on Commitments 6,290              1,293           
Total other commitments receivable 6,290              1,293           
Commitments payables
CAPITAL COMMITMENTS
Infrastructure, plant and equipment 67,944            6,563           
Total capital commitments 67,944            6,563           
OTHER COMMITMENTS
)a()LAPO( tcejorP rotcaeR hcraeseR tnemecalpeR 6,786              6,819           
Operating lease (b) 1,862              1,999           
Fuel elements purchase 1,242              5,527           
Mo-99 plates purchase 901                 2,135           
Total other commitments 10,791            16,480         
Net commitments by type 72,445            21,750         
By maturity
Capital commitments payable
One year or less 22,693            3,318           
From one to five years 45,251            3,245           
67,944            6,563           
OTHER COMMITMENTS
One year or less 9,066              14,738         
From one to five years (a) 685                 1,682           
Over five years 1,040              60                
Total other commitments 10,791            16,480         
Other commitments receivable
One year or less 2,176              1,293           
From one to five years 4,114              -                  
6,290              1,293           
Net commitments by maturity 72,445            21,750         
(a) A contract was executed on 13 July 2000 between ANSTO and INVAP SE for the design, construction and commissioning of a
replacement research reactor at Lucas Heights. The remaining amount of $6.786 million (2010: $6.819 million) is included 
in commitments
.
(b) ANSTO has a twenty five year lease contract with Central Sydney Area Health Services that will expire on 29 Jan 2025 with an 
annual rental payable of $137,000 (2010: $137,000).The annual rental is subject to review every three years.
The amounts reported as commitments payable includes GST where relevant. Recoveries due from the Australian Taxation Office in 
relation to commitments payable are disclosed as commitments receivable.
The above schedule should be read in conjunction with the accompanying notes.
Consolidated
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Schedule of contingencies 
as at 30 June 2011
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
SCHEDULE OF CONTINGENCIES
as at 30 June 2011
Unquantifiable Contingencies
At 30 June 2011, ANSTO still has the likelihood of claims in relation to asbestos related diseases. It is not possible to estimate the 
amounts of any eventual payments that may be required in relation to these claims. Such claims are however covered by the 
Department of Finance and Deregulation provision dealing with asbestos related claims against any Commonwealth Authorities
including ANSTO in the event of any litigation or claim for compensation.
The above schedule should be read in conjunction with the accompanying notes. 
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Schedule of asset additions 
for the year ended 30 June 2011AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
SCHEDULE OF ASSET ADDITIONS
for the year ended 30 June 2011
SCHEDULE OF ASSET ADDITIONS 
The following non-financial non-current assets were added in 2010-11: (Consolidated)
Other
Investment Heritage & property, plant
Additions funded in the current year Land Buildings Properties cultural & equipment Intangibles Other Total
$'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000
- gnidnuf tnemnrevoG - esahcrup yB          16,733        -                -               54,071                 10,196         -         81,000          
-sdnuf detanod - esahcrup yB          24               -                -               487                      -               -         511               
-rehto - esahcrup yB          -              -                -               -                       -               -         -                
-snoitanod/stfig sa deviecer stessA          -              -                -               -                       -               -         -                
From acquisition of entities or operations -         -              -                -               -                       -               -         -                
-)gnirutcurtser gnidulcni(          -              -                -               -                       -               -         -                
Total additions funded in the current year -         16,757       -              -             54,558               10,196       -         81,511
Additions recognised in 2010-11 - to be funded in future years
Decommissioning costs -         1,553          -                -               25,942                 -               -         27,495          
by finance lease - future years -         -              -                -               -                       -               -         -                
Other -         -              -                -               -                       -               -         -                
Total additions funded in the future year -         1,553         -              -             25,942               -             -         27,495
-snoitidda tessa latoT          18,310       -              -             80,500               10,196       -         109,006
The following non-financial non-assets were added in 2009-10 (Consolidated)
Other
Investment Heritage & property, plant
Additions funded in the current year Land Buildings Properties cultural & equipment Intangibles Other Total
$'000 $'000 $'000 $'000 $'000 $'000 $'000 $'000
- gnidnuf tnemnrevoG - esahcrup yB          18,266        -                -               41,198                 10,286         -         69,750          
-sdnuf detanod - esahcrup yB          -              -                -               987                      -               -         987               
-rehto - esahcrup yB          -              -                -               -                       -               -         -                
-snoitanod/stfig sa deviecer stessA          -              -                -               -                       -               -         -                
From acquisition of entities or operations -         -              -                -               -                       -               -         -                
-)gnirutcurtser gnidulcni(          -              -                -               -                       -               -         -                
Total additions funded in the current year -         18,266       -              -             42,185               10,286       -         70,737
Additions recognised in 2009-10 - to be funded in future years
Decommissioning costs -         10,869        -                -               104,213               -               -         115,082        
by finance lease - future years -         -              -                -               -                       -               -         -                
Other -         -              -                -               -                       -               -         -                
Total additions funded in the future year -         10,869       -              -             104,213             -             -         115,082
-snoitidda tessa latoT          29,135       -              -             146,398             10,286       -         185,819
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AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS 
for the year ended 30 June 2011
Note Description
1 Objectives of the entity
2 Summary of significant accounting policies
3 Events subsequent to reporting date
4 Reporting of outcomes
5 Income
6 Expenses
7 Financial assets
8 Non-financial assets
9 Liabilities
10 Equity
11 Cash flow reconciliation
12 Government funding
13 Board membership
14 Remuneration of members of the Board
15 Remuneration of senior executives
16 OPAL Nuclear Research Reactor 
17 Insurances
18 Remuneration of auditors
19 Related party disclosures
20 Trust money
21 Financial instruments
22 Operating lease arrangements
23 Income tax expense
24 Other comprehensive income
25 Information relating to ANSTO ('the parent entity")
26 Prior year adjustments
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1 Objectives of Australian Nuclear Science and Technology Organisation
Australian Nuclear Science  and Technology Organisation (ANSTO) is an Australian Government controlled entity. The objectives of ANSTO 
are detailed in the body of this Annual Report. 
ANSTO has only one outcome as reflected in the 2010-11 Portfolio Budget Statement as indicated below:
Outcome 1: Improved knowledge, innovative capacity and healthcare through nuclear -based facilities, research, training, products,
services and advice to Government, industry, the education sector and the Australian population.
ANSTO's activities contributing towards the outcome are classified as departmental. Departmental activities involve the use of assets,
liabilities, revenues and expenses controlled or incurred by ANSTO in its own right. Administered activities involve the management
or oversight by ANSTO, on behalf of the Government, of items controlled by the Government. ANSTO does not have any administered activities.
The continued existence and operations of the Australian Nuclear Science and Technology Organisation (ANSTO) and its present programs
is dependent on Government policy and on continuing funding by the Commonwealth Government for ANSTO's administration 
and programs.
Where it refers to ANSTO, this means ANSTO Consolidated except for under taxation note 2(s).
2 Summary of significant accounting policies
(a) Basis of preparation of the Financial Statements
The financial statements and notes are required by clause 1(b) of Schedule 1 to the Commonwealth Authorities and 
Companies Act 1997 (CAC Act) and are general purpose financial statements.
They have been prepared:
i. having regard to the provisions of the Australian Nuclear Science and Technology Organisation ( ANSTO)  Act 1987 (as
amended)
ii. in accordance with: 
. Finance Minister's Orders (FMOs) for reporting periods ending on or after 1 July 2010; and
. Australian Accounting Standards and Interpretations issued by the Australian Accounting Standards 
 Board (AASB) that apply for the reporting period.
The financial statements have been prepared on an accruals basis and in accordance with the historical cost convention, except for
certain assets which are stated at fair value. Except where stated, no allowance is made for the effect of changing prices on the results
or the financial position.
The financial report is presented in Australian dollars and values are rounded to the nearest thousand dollars unless 
otherwise specified.
Unless an alternative treatment is specifically required by an Accounting Standard or the FMOs, assets and liabilities are
recognised in the Balance Sheet when and only when it is probable that future economic benefits will flow to ANSTO or a future sacrifice
of economic benefits will be required and the amounts of the assets or liabilities can be reliably measured. However, assets and liabilities
arising under executor contracts are not recognised unless required by an Accounting Standard. Liabilities and assets that are
unrecognised are reported in the Schedule of Commitments or the Schedule of Contingencies.
Unless alternative treatment is specifically required by an Accounting Standard, income and expenses are recognised in the 
Statement of Comprehensive Income when and only when the flow, consumption or loss of economic benefits has occurred and 
can be reliably measured.
(b) Significant Accounting Judgements and Estimates
In the process of applying the accounting policies listed in this note, ANSTO has made the following judgements that
have the most significant impact on the amounts recorded in the financial statements. 
• The fair value of land and buildings has been taken by the Directors to be the market value of similar properties .
• The fair value of OPAL and other plant and equipment and their useful life.
• Decommissioning costs provision.
Apart from these assumptions and estimates no other accounting assumptions or estimates have been identified that have a significant
risk of causing a material adjustment to carrying amounts of assets and liabilities within  the next accounting period.
(c) Statement of Compliance
Australian Accounting Standards require a statement of compliance with International Financial Reporting Standards (IFRSs) to
be made where the financial report complies with these standards. Some Australian equivalents to IFRSs and other Australian
Accounting Standards contain requirements specific to not-for-profit entities that are inconsistent with IFRS requirements. 
ANSTO is a not-for-profit entity and has applied these requirements, so while this financial report complies with Australian
Accounting Standards including Australian Equivalents to International Financial Reporting Standards (AEIFRSs) it does 
not comply with IFRS in all respects.
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(d) Adoption of new Australian Accounting Standard requirements
No accounting standard has been adopted earlier than the application date as stated in the standard. 
No new standards/revised standards/Interpretations or amending standards were issued prior to the signing of the statement 
by the chief executive and chief financial officer, which were applicable to the current reporting period and had a financial impact on ANSTO.
Other new standards/revised standards/Interpretations or amending standards that were issued prior to the signing of the 
statement by the chief executive and chief financial officer and are applicable to the current reporting period did not have a financial
impact, and are not expected to have a future financial impact on ANSTO.
Future Australian Accounting Standard Requirements
No new standards/revised standards/Interpretations or amending standards were issued by the Australian Accounting Standards Board prior 
to the signing of the statement by the chief executive and chief financial officer, which are expected to have a financial impact on ANSTO 
for future reporting periods.
Other new standards/revised standards/Interpretations or amending standards that were issued prior to the signing of the 
statement by the chief executive and chief financial officer and are applicable to the future reporting period are not expected
to have a future financial impact on ANSTO.
(e) Reporting by outcomes
A comparison of current and prior years' figures by outcome as specified in the Portfolio Budget Statements relevant to 
ANSTO, is presented in Note 4.
(f) Revenue recognition
Revenue from Government 
Funding received or receivable from Department of Innovation, Industry, Science and Research (DIISR) (appropriated to ANSTO as a CAC Act
body) is recognised as Revenue from Government unless it is in the nature of an equity injection.
Equity injections
Amounts that are designated as equity injections for a year are recognised directly in contributed equity in that year.
Operating revenue from goods and services
Revenue from the sale of goods is recognised when:
• The risks and rewards of ownership have been transferred to the buyer;
• ANSTO Consolidated retains no managerial involvement nor effective control over the goods;
• The revenue and transaction costs incurred can be reliably measured; and
• It is probable that the economic benefits associated with the transaction will flow to ANSTO.
Receivables for goods and services are recognised at the nominal amounts due less any impairment allowance.
Collectability of debts is reviewed at balance date. Allowance is made when collectability of the debt is no longer probable.
Revenue received in advance
Revenue received in advance is initially brought to account as "unearned revenue" and subsequently recognised as revenue when
earned.
Contract revenue
Revenue from the rendering of a service is recognised by reference to the stage of completion of each contract. The stage of
completion is determined by reference to the proportion that the completed physical contract work bears to the estimated total
physical contract work.
Interest revenue
Interest revenue is recognised using the effective interest method as set out in AASB 139 Financial Instruments: 
Recognition and Measurement.
Gains from sale of assets
Revenue is recognised when control of the asset has passed to the buyer.
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Core operations
All material revenues described in this note are revenues relating to the core operating activities of ANSTO. 
Details of revenue amounts are given in Note 5.
Resources Received Free of Charge
Resources received free of charge are recognised as revenue when and only when a fair value can be reliably determined and the
services would have been purchased if they had not been donated. Use of those resources is recognised as an expense.
Resources received free of charge are recorded as either revenue or gains depending on their nature i.e. whether they have been
generated in the course of the ordinary activities of ANSTO.
Parental Leave Payments Scheme
Amounts received under the Parental Leave Payments Scheme not yet paid to employees would be presented gross 
as cash and a liability (payable). No amount has been received under this scheme as this will start on 1 July 2011. 
(g) Employee benefits
Benefits
Liabilities for services rendered by employees are recognised at the reporting date to the extent that they have not been settled.
Liabilities for wages and salaries and annual leave are measured at their nominal amounts. Other employees benefits expected to
be settled within 12 months of their reporting date are also measured at their nominal amounts.
The provision for employee entitlements encompasses annual leave and long service leave that ANSTO has a present
obligation to pay resulting from employee services provided up to balance date. The leave liabilities are calculated on the basis of
employees' remuneration, including employer superannuation contribution rates to the extent that the leave is likely to be taken
during service rather than paid out on termination. 
The liability for long service leave has been determined by reference to an actuary review as of 30 June 2011. However, ANSTO has used 
the Finance shorthand method in valuation of the liability. The estimate of the present value of the liability takes into account attrition rates 
and pay increases through promotion and inflation.
The nominal amount is calculated with regard to the rates expected to be paid on settlement of the liability. 
General leave
The Enterprise Agreement provides under the heading General Leave for an employee entitlement which combines sick leave,
carer's leave and leave for other prescribed purposes. No provision has been made for general leave as all such leave is
non-vesting and the average general leave taken by employees is less than the annual entitlement.
Separation and redundancy
Provision is made for separation and redundancy benefits payments. ANSTO recognises a provision for termination
when it has developed a detailed formal plan for the termination and has informed those employees affected that it
will carry out the termination. The total provision in the financial statements for 5 staff (2010: 3) amounted to $ 436,000 (2010: $327,000). 
(h) Superannuation
ANSTO contributes to the Commonwealth Superannuation (CSS) and the Public Sector (PSS) superannuation schemes
or PSS accumulation plan (PSSap) which provide retirement, death and disability benefits to employees. 
The CSS and PSS are defined benefit schemes for the Commonwealth while the PSSap is a defined contribution scheme. 
Contributions to the schemes are at rates calculated to cover existing and emerging obligations. Applicable contribution rates in 2011
were 14.4% (2010 13.9%) of salary (PSS), 17.0% (2010 19.1%) of salary (CSS), and 15.4% (2010 15.4%) of salary (PSSap).
An additional 3% is contributed to PSS and CSS for employer productivity benefits. The Enterprise Agreement signed in April 2009 provided 
that all ANSTO employees under the agreement who contributed to non Commonwealth superannuation schemes, are to receive a contribution
equivalent to 15.4% of salary. For those staff who do not contribute to any of these schemes and are not covered by Enterprise Agreement,
ANSTO contributes an amount equivalent to 9% of salary to the Australian Government Employees Superannuation Trust fund or to the complying 
fund nominated by the employee. 
ANSTO makes employer contributions to the employees' superannuation scheme at rates determined by actuary to be 
sufficient to meet the current cost to the Government. ANSTO accounts for contributions as if they are contributions 
to defined contribution plans.
The liability for superannuation recognised as at 30 June represents outstanding contributions for the final fortnight of the year.
Contributions during the year are detailed in Note 6A.
(i) Leases
Operating leases payments are expensed on a straight-line  basis which is representative of the pattern of benefits derived
from the leased assets.
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(j) Cash
Cash is recognised at its nominal amount. Cash and cash equivalents includes:
• cash on hand;
• demand deposits in bank accounts with an original maturity of 3 months or less that are readily convertible 
   to known amounts of cash and subject to insignificant risk of changes in value.
(k) Financial instruments
ANSTO classifies its financial assets in the following categories:
• 'financial assets as 'at fair value through profit or loss'
• 'held-to-maturity investments',
• 'loans and receivables'.
The classification depends on the nature and purpose of the financial assets and is determined at the time of initial recognition.
Financial assets are recognised and derecognised upon ‘trade date’.
Effective interest method
The effective interest method is a method of calculating the amortised cost of a financial asset and of allocating interest income
over the relevant period.  The effective interest rate is the rate that discounts estimated future cash receipts through 
the expected life of the financial asset, or, where appropriate, a shorter period.
Income is recognised on an effective interest rate basis except for financial assets ‘at fair value through profit or loss’.
Financial assets at fair value through profit or loss
Financial assets are classified as financial assets at fair value through profit or loss where the financial assets have been acquired
principally for the purpose of selling in the near future. Assets in this category are classified as current assets.
Financial assets at fair value through profit or loss are stated at fair value, with any resultant gain or loss recognised in the profit or
loss.  The net gain or loss recognised in the profit or loss incorporates any interest earned on the financial assets.
Where a reliable fair value cannot be established for unlisted investments in equity instruments, cost is used less impairment if applicable.
Held-to-maturity investments
Non-derivative financial assets with fixed or determinable payments and fixed maturity dates that the group has the positive 
intent and ability to hold to maturity are classified as held-to-maturity investments.  Held-to-maturity investments are recorded
at amortised cost using the effective interest method less impairment, with revenue recognised on an effective yield basis.
Loans and receivables
Trade receivables, loans and other receivables that have fixed or determinable payments that are not quoted in an active market
are classified as ‘loans and receivables’. Loans and receivables are measured at amortised cost using the effective interest
method less impairment.  Interest is recognised by applying the effective interest rate.
Impairment of financial assets
Financial assets are assessed for impairment at each balance date.
• Financial assets held at amortised cost - If there is objective evidence that an impairment loss has been incurred for loans and
receivables or held to maturity investments held at amortised cost, the amount of the loss is measured as the difference between
the asset’s carrying amount and the present value of estimated future cash flows discounted at the asset’s original effective
interest rate.  The carrying amount is reduced by way of an allowance account.  The loss is recognised in the statement of 
comprehensive income.
• Available for sale financial assets (held at cost)  - If there is objective evidence that an impairment loss has been incurred the
amount of the impairment loss is the difference between the carrying amount of the asset and the present value of the estimated
future cash flows discounted at the current market rate for similar assets.
Financial Liabilities
Financial liabilities are classified as either financial liabilities ‘at fair value through profit or loss’ or other financial liabilities.
Financial liabilities are recognised and derecognised upon ‘trade date’.
Other financial liabilities
Other financial liabilities, including borrowings, are initially measured at fair value, net of transaction costs. These liabilities are 
subsequently measured at amortised cost using the effective interest method, with interest expense recognised on an effective 
yield basis.
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The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating interest expense 
over the relevant period.  The effective interest rate is the rate that exactly discounts estimated future cash payments through
the expected life of the financial liability, or, where appropriate, a shorter period.
Supplier and other payables
Supplier and other payables are recognised at amortised cost.  Liabilities are recognised to the extent that the goods or services
have been received (and irrespective of having been invoiced).
(l) Contingent Liabilities and Contingent Assets
Contingent liabilities and contingent assets are not recognised in the balance sheet but are reported in the relevant schedules
and notes.  They may arise from uncertainty as to the existence of a liability or asset or represent an asset or liability in respect
of which the amount cannot be reliably measured. Contingent assets are disclosed when settlement is probable but not virtually 
certain and contingent liabilities are disclosed when settlement is greater than remote.
(m) Acquisition of Assets
Assets are recorded at cost on acquisition except as stated below.  The cost of acquisition includes the fair value of assets 
transferred in exchange and liabilities undertaken.  Financial assets are initially measured at their fair value plus transaction costs 
where appropriate.
Assets acquired at no cost, or for nominal consideration, are initially recognised as assets and revenues at their fair value at the date 
of acquisition, unless acquired as a consequence of restructuring of administrative arrangements.  In the latter case, assets are
initially recognised as contributions by owners at the amounts at which they were recognised in the transferor's accounts immediately
prior to the restructuring.
(n) Buildings, infrastructure, plant and equipment and major facilities
Asset recognition threshold
Items of buildings, infrastructure, plant and equipment and major facilities are recorded at cost of acquisition and depreciated as
outlined below. Items of plant and equipment with a cost of less than $3,000 are expensed in the year of acquisition.
The initial cost of an asset includes an estimate of the cost of dismantling and removing the item and restoring the site on which
it is located at the end of its useful life. This is particularly relevant to ‘make good’ or decommissioning provisions on buildings, infrastructure,
plant and equipment and major facilities,  taken up by ANSTO where there exists an obligation to restore the property to its original condition.
These costs are included in the value of the asset it relates to with a corresponding provision for the ‘make good’ or decommissioning taken up.
Any changes to the initial decommissioning cost attributable to adjustments to the consumer price index (cpi) and discount rate at 
30 June each year will be reflected as an adjustment to the Provision for Decommissioning cost and Asset Revaluation Reserve in
accordance to the Department of Finance and Deregulation Accounting Guidance Note.
The cost of assets constructed by the entity includes the cost of materials, direct labour and an appropriate proportion of fixed
and variable overheads.
Revaluations
Fair values for each class of asset are determined as shown below:
Following initial recognition at cost, buildings, infrastructure, plant and equipment and major facilities are carried at fair value less 
accumulated depreciation and accumulated impairment losses. Valuations are conducted with sufficient frequency to ensure that the
carrying amounts of assets do not differ materially from the assets’ fair values as at the reporting date.  The regularity of independent
valuations depends upon the volatility of movements in market values for the relevant assets. 
Revaluation adjustments are made on a class basis. Any revaluation increment is credited to equity under the heading of asset
revaluation reserve except to the extent that it reverses a previous revaluation decrement of the same asset class that was
previously recognised through profit and loss. Revaluation decrements for a class of assets are recognised directly through
profit and loss except to the extent that they reverse a previous revaluation increment for that class.
Any accumulated depreciation as at the revaluation date is eliminated against the gross carrying amount of the asset and the asset
restated to the revalued amount.
Market Value
Market Value
Market Value
Market Value
Site infrastructure
Electrical infrastructure
Plant and equipment
National and major facilities
ta derusaem eulav riaFssalC tessA
Land
Buildings
Market Value
Market Value
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The valuations of land, buildings, infrastructure, plant and equipment including national and other major facilities were performed
by independent valuers of the Australian Valuation Office (AVO), Mr. Frank Andreatta and Mr. Simon O'Leary (registered
Valuer Nos. 2388 and 1128 respectively) at 30 June 2007, based on the asset list at 28 February 2007. 
The OPAL and NBI valuations were performed by Mr. Simon O'Leary (registered Valuer No. 1128) of AVO based on the asset 
list at 31 May 2009. 
The Australian Valuation Office (AVO) has reviewed the current book values for land, building and site improvements (LB&I) for ANSTO
Lucas Height’s site for 2010/11 financial reporting purposes. The Australian Valuation Office is of the opinion  that the overall asset value
of the LB&I appears to be at the upper limit that may warrant a revaluation at this time. However, after taking into consideration
the components of materiality, AVO do not believe that a full revaluation is warranted at this time. This is also the view of the Directors. 
AVO have recommended that a full valuation be carried out during the 2011/12 financial year.
Depreciation and amortisation
Items of  buildings, infrastructure, plant and equipment and major facilities, but excluding freehold land, are depreciated 
over their estimated useful lives to ANSTO using the straight line method. 
Depreciation and amortisation rates applying to each class of depreciable asset are based on the following useful lives:
2011 2010
Buildings on freehold land 5 to 50 years 5 to 50 years
Plant and equipment 2 to 30 years 2 to 30 years
Infrastructure 20 years 20 years
National and major facilities 5 to 40 years 5 to 40 years
The depreciation rates (useful lives) of ANSTO's buildings, infrastructure, plant and equipment and major facilities have been 
reviewed during the year and found to be appropriate.
The aggregate amount of depreciation allocated for each class of asset during the reporting period is disclosed in Note 6C.
Impairment
All assets were assessed for impairment at 30 June 2011. Where indications of impairment exist, the asset’s recoverable amount
is estimated and an impairment adjustment made if the asset’s recoverable amount is less than its carrying amount.
The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. Value in use is the present value 
of the future cashflows expected to be derived from the asset. Where the future economic benefit of an asset is not primarily dependent
on the asset's ability to generate future cash flows, and the asset would be replaced if the entity were deprived of the asset, its value 
in use is taken to be its depreciated replacement cost.
(o) Inventories
Stores are valued at purchase cost on a first-in-first-out basis. Provision is made for obsolete inventory and diminution in value.
Inventories of Cobalt-60 and enriched uranium are valued on the basis of lower of cost and net realisable value.
Stocks of reactor fuel are valued at average purchase price.
Heavy water is valued at lower of cost and net realisable value.
Finished goods and work in progress are valued at cost of direct materials and labour plus attributable costs that are capable of
being allocated on a reasonable basis.
(p) Intangibles
Software
Items of software are recorded at cost and amortised as outlined below. Items with a cost of less than $3,000 are expensed in
the year of acquisition. 
There is no material internal software development.
Software and licences are reported at cost.
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Amortisation
Intangibles are amortised over their estimated useful lives to ANSTO using the straight line method. 
Amortisation rates applying to intangibles are as follows:
2011 2010
Purchased software 2 - 7 years 2 - 7 years
Licences 3 years 3 years
The amortisation rates (useful lives) of ANSTO's software and licences have been reviewed during the year and found to be
appropriate.
The aggregate amount of amortisation allocated for each class of asset during the reporting period is disclosed in Note 6C.
Impairment
All assets were assessed for impairment at 30 June 2011. Where indications of impairment exist, the asset’s recoverable amount
is estimated and an impairment adjustment made if the asset’s recoverable amount is less than its carrying amount
(q) Patents
Due to the uncertain commercial value of patents, trademarks, designs and applications, and because benefits extending beyond
one accounting period cannot be assured, the costs associated with the development and registration of patents are expensed in
the year in which they are incurred, unless recoverability is assured beyond any reasonable doubt. At 30 June 2011 there were
212 patents, trademarks, design and applications (98 at 30 June 2010) registered to ANSTO and no associated costs are
recognised as an asset (nil at 30 June 2010).
(r) Foreign currency
Transactions denominated in a foreign currency are converted to Australian currency at the rate of exchange prevailing at the date
of the transaction. At balance date, amounts receivable and payable in foreign currency are translated to Australian currency at
the exchange rate prevailing at that date and any exchange differences are brought to account in the Statement of Comprehensive Income. 
ANSTO did not enter into speculative forward exchange contracts during the reporting period.
(s) Taxation
ANSTO is exempt from all forms of taxation in Australia except fringe benefits tax (FBT) and the goods and services tax (GST).
ANSTO is not subject to exemption from any foreign taxation laws relative to its overseas operations.
ANSTO's subsidiaries are subject to normal taxation.
ANSTO Inc, a USA company, is subject to US tax laws. The Deferred Tax Asset of USD 369,000 or AUD 433,000 recognised as an asset at 
30 June 2010 has been derecognised at 30 June 2011 as the directors do not believe it is probable that sufficient profits will be generated to utilise 
the tax losses.
Revenues, expenses and assets are recognised net of GST except:
• where the amount of GST incurred is not recoverable from the Australian Taxation Office; and
• for receivable and payables.
Subsidiaries
Unbooked deferred tax assets in relation to unrecouped tax losses in the subsidiaries is $1,047 thousand (2010: $320 thousand).
In respect of the subsidiaries, current tax assets and liabilities for the current and prior periods are measured at the amount expected 
to be recovered from or paid to the taxation authorities based on the current period's taxable income. The tax rates and tax laws used 
to compute the amount are those that are enacted or substantively enacted by the balance sheet date.
Deferred income tax is provided on all temporary differences at the balance sheet date between the tax bases of assets and 
liabilities and their carrying amounts for financial reporting purposes.
Deferred income tax liabilities are recognised for all taxable temporary differences except:
• when the deferred income tax liability arises from the initial recognition of goodwill or of an asset or liability in a transaction that 
   is not a business combination and that, at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; or
• when the taxable temporary difference is associated with investments in subsidiaries, associates or interests in joint ventures, and 
   the timing of the reversal of the temporary difference can be controlled and it is probable that the temporary difference will not 
   reverse in the foreseeable future.
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Deferred income tax assets are recognised for all deductible temporary differences, carry forward of unused tax credits and 
unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary
differences and the carry forward of unused tax credits and unused tax losses can be utilised, except:
• when the deferred income tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or 
   liability in a transaction that is not a business combination and, at the time of the transaction, affects neither the accounting profit 
   nor taxable profit or loss; or
• when the deductible temporary difference is associated with investments in subsidiaries, associates or interests in joint ventures,
   in which case a deferred tax asset is only recognised to the extent that it is probable that the temporary difference will reverse in 
   the foreseeable future and taxable profit will be available against which the temporary difference can be utilised.
Unrecognised deferred income tax assets are reassessed at each balance sheet date and are recognised to the extent that it 
has become probable that future taxable profit will allow the deferred tax asset to be recovered.
Deferred income tax assets and liabilities are measured at the tax rates that are expected to apply to the year when the asset is realised 
or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the balance sheet date.
Deferred tax assets and deferred tax liabilities are offset only if a legally enforceable right exists to set off current tax assets against 
current tax liabilities and the deferred tax assets and liabilities relate to the same taxable entity and the same taxation authority.
(t) Principles of consolidation
ANSTO has investments in a number of companies (refer Note 7D) over which it has control. These companies have been 
established for the purpose of (i) commercialisation of ANSTO's intellectual property or (ii) a requirement for ANSTO to operate in
the industry as in the case of ANSTO Inc., an operation in the U.S.A..
(u) Interest in joint venture
A joint venture is a contractual arrangement whereby ANSTO and the other parties undertake an economic activity that is subject to
joint control ( i.e when the strategic financial and operating policy decisions relating to the activities of the joint venture require the 
unanimous consent of the  parties sharing control).
ANSTO has an investment in Element 42 LLC (refer Note 7E) over which it has shared control.
(v) Change in accounting policies
During 2009-10, ANSTO  received funding of $20,000,000 from the Education Investment Fund (EIF).  This funding was recorded as revenue
in the prior year’s Financial Statements.  Under the program conditions, the funds are used for capital projects and the Department of Innovation, 
Industry, Science and Research (DIISR) has recognised these payments as capital in 2010-11.  To ensure a consistent application with DIISR the 
EIF payments to ANSTO have been recognised as capital in 2010-11. The prior year adjustment has been reflected in the 2009-10 comparative
information with a decrease in revenue (note 5c)  of $20,000,000 and an increase in equity of $20,000,000 (note 10).
(w) Comparatives
Where necessary, comparative information for the preceding financial year has been reclassified to achieve consistency
in disclosure with current financial year amounts and other disclosures.
Comparatives for 2009/10 have been adjusted to reflect the current year accounting treatment of EIF contributions from the Department of 
Finance and Deregulation and prior year errors. Refer note 26.
(x) Rounding 
Amounts are rounded to the nearest one thousand dollars except in relation to:
- remuneration of members of the Board
- remuneration of executives
- audit fees
3 Events subsequent to reporting date
No events have arisen since the end of the financial year which require disclosure or the financial statements 
to be adjusted.
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4 Reporting of Outcomes
ANSTO operates mainly within Australia, and mainly in the nuclear scientific research industry.
Reporting by outcomes:
Major Classes of Departmental Revenues and Expenses by Outcome - Consolidated
2011 2010
$'000 $'000
Operating revenues
   Revenue from Government 165,592 155,240
   Sale of goods and services 56,582 47,660
   Interest 7,357 6,268
   Net gain from sale of assets 270 634
   Other 5,466 5,417
Total operating revenues 235,267 215,219
Operating expenses
   Employees 103,062 90,164
   Suppliers 61,255 73,867
   Depreciation and amortisation 80,174 54,422
   Finance costs 15,192 14,060
   Write-down and impairment of assets 5,241 17
   Other 10,417 6,431
Total operating expenses 275,341 238,961
Major Classes of Departmental Assets and Liabilities by Outcome - Consolidated
2011 2010
$'000 $'000
Assets
   Cash and cash equivalents 3,278 5,023
   Trade and other receivables 11,727 9,045
    Investments 115,268 134,000
    Land and buildings 209,164 196,510
    Infrastructure, plant and equipment 696,513 688,655
    Inventories 15,629 13,784
    Intangibles 18,948 15,417
    Tax assets -               433
    Other 7,255 6,226
287,770,1stessa latoT 1,069,093
    Suppliers 11,383 12,578
    Employees payables 3,836 2,815
    Grants 687 562
    Other payables 1,433 1,557
    Interest bearing liabilities 2,484 3,497
    Employee provisions 28,528 25,487
    Decommissioning provision 291,465 269,517
    Other provisions 286 270
201,043seitilibail latoT 316,283
Notes:
The net costs include intra - government costs that would be eliminated in calculating the actual Budget outcome.
ANSTO has only one outcome.
Consolidated
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NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2011
2011 2010        
Notes $'000 $'000
5 Income
5A. Revenue from Government 
CAC Act payments from DIISR 165,592 155,240
5B. Goods and services
Radioisotope sales 27,176 22,623
Services and contract research 18,699 17,027
Silicon irradiation 4,310 2,883       
CSIRO site support 1,218 1,080       
Training courses 303 207          
Land management 3,420 3,039       
Australian Synchrotron Research Project 15 85            
AINSE interactions 1,441 716          
285,65secivres dna sdoog fo selas latoT 47,660
5C. Grants 2,084 4,222       
753,7knaB - tseretnI.D5 6,268       
5E. Gain from sale of assets
Proceeds from sale of assets 813 1,287       
Carrying value of assets sold (543) (653)         
Gain from disposal of infrastructure, plant and
equipment 270               634          
238 evitaluceps non - sniag egnahcxe ngieroF.F5 949          
5G. Other income:
Gain from Revaluation - 61            
Other 2,550 47            
Total other income 2,550 108          
576,96emocni ecruos-nwO latoT 59,841
762,532  seitivitca yranidro morf seunever latoT 215,081
5H. Sales of goods and services
Goods 27,176 22,623
Services 29,406 25,037
Total sales of goods and services 5B 56,582 47,660
Provision of goods to:
External entities 27,176 22,623
671,72 sdoog fo selas latoT 22,623
Rendering of services to:
Related entities 1,324 1,686       
External entities 28,082 23,351
604,92secivres fo gniredner latoT 25,037
Consolidated
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2011             2010        
000'$setoNsesnepxE6 $'000
The breakdown of operating expenses is: 
6A. Employee expenses: 
Wages and salaries 76,671          67,473     
Superannuation 14,776          12,827     
Leave and other entitlements 10,578          8,950       
Separation and redundancy 1,037            914          
260,301 sesnepxe eeyolpme latoT         90,164     
6B. Supplier expenses: 
Goods from external entities 28,491          28,480     
Services from related entities 22,332          19,755     
Workers compensation premiums - related 1,042            1,078       
Services from external entities 9,187            24,545     
Operating lease rentals - external 203               9              
552,16 sesnepxe reilppus latoT           73,867     
6C. Depreciation and amortisation 
B8 )a(    tnempiuqe dna tnalp ,ytreporp fo noitaicerpeD 74,447          51,387     
D8   ecnecil - stessa elbignatni fo noitasitromA 30                 -           
D8   erawtfos - stessa elbignatni fo noitasitromA 5,697            3,035       
471,08 noitasitroma dna noitaicerped latoT           54,422     
6D. Write-down and impairment of assets  
Financial assets:
Receivables for goods and services 3                   15            
C7 tnemtsevni fo nwod-etirW 5,000            -           
Non financial assets: 
Materials - write off obsolete stock 238               2              
142,5stessa fo nwod-etirw latoT             17            
6E. Grants
Public sector
Australian Government entities (related entities) 2,210            2,262       
State Government 1,400            -           
Local Government 1              
Private sector
Profit Organisation 1,183            582          
Non Profit Organisation 1,309            1,439       
Overseas 123               46            
6,225            4,330       
6F. Finance costs  
Unwinding of discount on decommissioning costs 15,087          13,862     
Interest 105               198          
15,192          14,060     
6G. Foreign exchange losses
Foreign exchange loss - non speculative -                    -           
-realised 347               451          
-unrealised 349               (98)           
696               353          
6H. Losses from asset sales
Proceeds from sale of assets 1,095            419          
Carrying values of assets sold (4,246)           (1,297)      
Loss from sale of assets 3,151            878          
Loss on sale of subsidiary -                    870          
151,3selas tessa morf sessol latoT             1,748       
699,472 sesnepxe gnitarepo latoT         238,961
(a) Depreciation of property, plant and equipment:
The aggregate amounts of depreciation expensed during the reporting 
period for each depreciable class of property, plant and equipment 
are as follows: 
Buildings on freehold land 4,565            7,405       
Plant and equipment 38,622          15,286     
Infrastructure 2,815            2,535       
National and major facilities 28,445          26,161     
Total allocated 74,447          51,387     
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2011           2010                
$'000 $'000
7 Financial assets
7A. Cash and cash equivalents
Cash on hand or on deposit 3,278          5,023               
Total cash 3,278 5,023               
7B. Trade and other receivables
Goods and services (a)
Goods and services - related entities 297 334                  
Goods and services - external parties 9,250 6,097               
745,9secivres dna sdoog rof selbaviecer latoT           6,431               
Other receivables
Interest accrued 628 1,648               
Reimbursable foreign exchange loss - -                      
Other 768             471                  
Loans to related parties -              -                  
GST receivable from the Australian Taxation Office 787             510                  
Total other receivables (a) 2,183          2,629               
Less impairment allowance account:
Goods and services 3                 15                    
Total impairment allowance (b) 3                 15                    
Total receivables (net) 11,727 9,045               
(a) Total receivables are aged as follows:
Age analysis of trade debtors
Current 7,182          6,392               
Overdue:
Less than 30 days 1,991          1,849               
30 to 60 days; and 721             277                  
60 to 90 days 763             354                  
More than 90 days 1,070          173                  
11,727        9,045               
(b) The provision for doubtful debts represents certain debts aged more than 90 days (2010: aged more than 90 days).
The Impairment allowance is aged as follows:
Age analysis of trade debtors
More than 90 days 3                 15                    
3                 15                    
Reconciliation of the Impairment Allowance Account:
Opening Balance 15               36                    
Amount provided 3                 15                    
Amount recovered and reversed (15)              (36)                  
Closing Balance 3                 15                    
7C. Investments
Bank bills 108,000      129,000           
Term deposit 7,268 -                      
Investment in Australian Synchrotron (c) - 5,000               
Total investments 115,268 134,000           
(c) The investment in Australian Synchrotron Holding Company (ASHCo) of $5 million was assessed as requiring impairment testing. Due to significant 
uncertainty regarding future funding, the decision was taken that the investment be impaired.
Interest rates (weighted average) 2011           2010                
Bank deposits 3.421% 2.617%
Term deposits 5.330% 6.830%
7D. Investment in subsidiaries
The details of the subsidiaries of ANSTO are:
denwO %noitaroprocnI fo ecalPemaN
2011 2010 2011 2010
 $  $  $  $
ACN 120 875 498 Pty Limited
(formerly Australian Membrane 
%001ailartsuA)detimiL ytP seigolonhceT 1                   1 -                  -
%001ailartsuAdtL ytP ailartsuA  TENTEP 13,627,588   5,000,000   -                  10,000,000
%001.A.S.U erawaleD.cnI OTSNA -                -              -                  1,255,566
13,627,589   5,000,001   - 11,255,566
ANSTO Inc. was incorporated in Delaware, USA on 27 October 1999.  At 30 June 2011: US$100 (2010: US$100).
of capital has been invested in this wholly owned subsidiary. This investment has been written off in prior periods.
In November 2004, the Board decided to utilise ANSTO Inc to promote the commercialisation of ANSTO Technology in the USA
The loan to ANSTO Inc., $US1,470,118 (2010: $US1,070,118) was considered impaired and hence fully provided as at 30 June 2011 in the parent entity due.
to ANSTO Inc.'s net assets deficiency and unlikely ability to repay the loan.
On 24 June 2011, PETNET Australia Pty Ltd Board resolved to issue shares to ANSTO equivalent to the amount of the convertible notes which were converted 
from the loans and outstanding interest as at 31 May 2011.
ANSTO assessed the carrying value of the ANSTO investment in PETNET, including a review of the cash flow projections. The resulting PETNET 
valuation based on a discount rate of 13.81% and 15 years cash flow plus the value of cash on hand (surplus asset) was $13,628 thousand compared 
to a carrying value of the investment of $17,228 thousand, giving an impairment of $3,600 thousand.
For the financial year ended 30 June 2011, the financial statements of ANSTO Inc. were audited by Galusha, Higgings & Galusha, P.C. and there 
were no requirements for  financial statements to be prepared or audited for ACN 120 875 498 Pty Limited (previously Australian Membrane 
Technolgies Pty Limited) as it is a dormant company.
7E. Investment in joint venture
denwO %noitaroprocnI fo ecalPemaN
Element 42 LLC Delaware U.S.A. 50%
Element 42 LLC. was incorporated in Delaware, USA on 1 June 2010.  At 30 June 2011 ANSTO's investment was carrying value of investment:
US$200 (2010: US$200). Element 42 LLC has not traded.
7F. Investment - other
denwO %noitaroprocnI fo ecalPemaN
2011 2010
 $  $
%5ailartsuAdtL ytP slacituecamrahP ytiralC -                -              
%4ailartsuAkirtemyloP ecnavdA -                -              
-                -
Clarity Pharmaceuticals Pty Ltd. was incorporated in New South Wales, Australia on 17 Sept 2010.
Advance Polymetrik Pty Ltd. was incorporated in Victoria, Australia on 20 Dec 2001. 
Investment
Investment
Consolidated
Loan/Convertible Notes
21
Financial Statements 2010-2011
Notes to and forming part of the Financial Statements 
for the year ended 30 June 2011
ANSTO Annual Report 2010-2011  l  64
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
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2011           2010                
$'000 $'000
7 Financial assets
7A. Cash and cash equivalents
Cash on hand or on deposit 3,278          5,023               
Total cash 3,278 5,023               
7B. Trade and other receivables
Goods and services (a)
Goods and services - related entities 297 334                  
Goods and services - external parties 9,250 6,097               
745,9secivres dna sdoog rof selbaviecer latoT           6,431               
Other receivables
Interest accrued 628 1,648               
Reimbursable foreign exchange loss - -                      
Other 768             471                  
Loans to related parties -              -                  
GST receivable from the Australian Taxation Office 787             510                  
Total other receivables (a) 2,183          2,629               
Less impairment allowance account:
Goods and services 3                 15                    
Total impairment allowance (b) 3                 15                    
Total receivables (net) 11,727 9,045               
(a) Total receivables are aged as follows:
Age analysis of trade debtors
Current 7,182          6,392               
Overdue:
Less than 30 days 1,991          1,849               
30 to 60 days; and 721             277                  
60 to 90 days 763             354                  
More than 90 days 1,070          173                  
11,727        9,045               
(b) The provision for doubtful debts represents certain debts aged more than 90 days (2010: aged more than 90 days).
The Impairment allowance is aged as follows:
Age analysis of trade debtors
More than 90 days 3                 15                    
3                 15                    
Reconciliation of the Impairment Allowance Account:
Opening Balance 15               36                    
Amount provided 3                 15                    
Amount recovered and reversed (15)              (36)                  
Closing Balance 3                 15                    
7C. Investments
Bank bills 108,000      129,000           
Term deposit 7,268 -                      
Investment in Australian Synchrotron (c) - 5,000               
Total investments 115,268 134,000           
(c) The investment in Australian Synchrotron Holding Company (ASHCo) of $5 million was assessed as requiring impairment testing. Due to significant 
uncertainty regarding future funding, the decision wa  taken that the investment be impaired.
Interest rates (weighted average) 2011           2010                
Bank deposits 3.421% 2.617%
Term deposits 5.330% 6.830%
7D. Investment in subsidiaries
The details of the subsidiaries of ANSTO are:
denwO %noitaroprocnI fo ecalPemaN
2011 2010 2011 2010
 $  $  $  $
ACN 120 875 498 Pty Limited
(formerly Australian Membrane 
%001ailartsuA)detimiL ytP seigolonhceT 1                   1 -                  -
%001ailartsuAdtL ytP ailartsuA  TENTEP 13,627,588   5,000,000   -                  10,000,000
%001.A.S.U erawaleD.cnI OTSNA -                -              -                  1,255,566
13,627,589   5,000,001   - 11,255,566
ANSTO Inc. was incorporated in Delaware, USA on 27 October 1999.  At 30 June 2011: US$100 (2010: US$100).
of capital has been invested in this wholly owned subsidiary. This investment has been written off in prior periods.
In November 2004, the Board decided to utilise ANSTO Inc to promote the commercialisation of ANSTO Technology in the USA
The loan to ANSTO Inc., $US1,470,118 (2010: $US1,070,118) was considered impaired and hence fully provided as at 30 June 2011 in the parent entity due.
to ANSTO Inc.'s net assets deficiency and unlikely ability to repay the loan.
On 24 June 2011, PETNET Australia Pty Ltd Board resolved to issue shares to ANSTO equivalent to the amount of the convertible notes which were converted 
from the loans and outstanding interest as at 31 May 2011.
ANSTO assessed the carrying value of the ANSTO investment in PETNET, including a review of the cash flow projections. The resulting PETNET 
valuation based on a discount rate of 13.81% and 15 years cash flow plus the value of cash on hand (surplus asset) was $13,628 thousand compared 
to a carrying value of the investment of $17,228 thousand, giving an impairment of $3,600 thousand.
For the financial year ended 30 June 2011, the financial statements of ANSTO Inc. were audited by Galusha, Higgings & Galusha, P.C. and there 
were no requirements for  financial statements to be prepared or audited for ACN 120 875 498 Pty Limited (previously Australian Membrane 
Technolgies Pty Limited) as it is a dormant company.
7E. Investment in joint venture
denwO %noitaroprocnI fo ecalPemaN
Element 42 LLC Delaware U.S.A. 50%
Element 42 LLC. was incorporated in Delaware, USA on 1 June 2010.  At 30 June 2011 ANSTO's investment was carrying value of investment:
US$200 (2010: US$200). Element 42 LLC has not traded.
7F. Investment - other
denwO %noitaroprocnI fo ecalPemaN
2011 2010
 $  $
%5ailartsuAdtL ytP slacituecamrahP ytiralC -                -              
%4ailartsuAkirtemyloP ecnavdA -                -              
-                -
Clarity Pharmaceuticals Pty Ltd. was incorporated in New South Wales, Australia on 17 Sept 2010.
Advance Polymetrik Pty Ltd. was incorporated in Victoria, Australia on 20 Dec 2001. 
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2011 2010                
$'000 $'000
8 Non-financial assets  
8A. Land and buildings  
Land - at independent valuation - 30 June 2007 (fair value) 78,700 78,700             
78,700 78,700             
Buildings - at cost 58,499 47,351             
Less accumulated depreciation 16,214 17,145             
42,285 30,206             
Buildings - at independent valuation - 30 June 2007 (fair value) 83,540 83,316             
Less accumulated depreciation 21,181 15,685             
62,359 67,631             
Building under construction 25,820 19,973             
Total buildings 130,464 117,810           
Total land and buildings 209,164 196,510           
8B. Infrastructure, plant, equipment and major facilities   
8B(i). Plant and equipment
Plant and equipment - at cost 277,065 228,074           
Less accumulated depreciation 92,649 60,971             
184,416 167,103           
Plant and equipment - at independent valuation - 30 June 2007 (fair value) 59,167 60,274             
Less accumulated depreciation 37,831 30,379             
21,336 29,895             
Plant and equipment under construction 52,826 27,863             
875,852   tnempiuqe dna tnalp latoT 224,861           
8B(ii). Infrastructure
Electrical/site services facilities - at cost 1,723 1,699               
Less accumulated depreciation 564 195                  
1,159 1,504               
Electrical/site services facilities 
at independent valuation - 30 June 2007 (fair value) 28,005 28,006             
Less accumulated depreciation 9,725 7,279               
18,280 20,727             
Total infrastructure 19,439 22,231             
FINANCIAL YEAR
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8 Non-financial assets (continued)   
8 Non-financial assets (continued)   
2011 2009
$'000 $'000
8B(iii). Major national and major research facilities
Major national research facilities - at cost 4,926 4,988
Less accumulated depreciation 422 127
4,504 4,861
Major national research facilities 
at independent valuation - 30 June 2007 (fair value) 2,869 2,825
Less accumulated depreciation 648 457
2,221 2,368
Major research facilities at cost 338 143
Less accumulated depreciation 82 8
256 135
Major research facilities 
at independent valuation - 30 June 2007 (fair value) 6,259 6,239
Less accumulated depreciation 2,805 2,101
3,454 4,138
OPAL nuclear research reactor at cost 7,455 4,816
Less accumulated depreciation 420 113
7,035 4,703
OPAL nuclear research reactor 
at independent valuation - 30 June 2009 (fair value) 450,482 450,084
Less accumulated depreciation 49,456 24,726
401,026 425,358
694,814seitilicafhcraeserrojamdnalanoitanrojamlatoT 441,563
315,696seitilicafrojamdnatnempiuqe,tnalp,erutcurtsarfnilatoT 688,655
776,509seitilicafrojamdnatnempiuqe,tnalp,erutcurtsarfni,sgnidliub,dnallatoT 885,165
Movement summary 2010-2011 for all consolidated assets irrespective of valuation basis (excluding intangibles)
Land Buildings Total Land Infrastructure, Total
and Buildings plant, equipment
national and 
major facilities
$'000 $'000 $'000 $'000 $'000
007,870102yluJ1tasaeulavssorG     150,640      229,340        815,011                1,044,351
Additions - new assets -              16,757        16,757          54,558                  71,315
Decommissioning Cost -              1,553          1,553            25,942                  27,495
Transfers/reclassifications -              (1,091)        (1,091)           1,556                    465
Disposals -              -                 -                    (5,952)                   (5,952)
007,871102enuJ03tasaeulavssorG     167,859      246,559        891,115                1,137,674
Accumulated depreciation/
-0102yluJ1noitasitroma               32,830        32,830          126,356                159,186
Depreciation/amortisation -              4,565          4,565            66,171                  70,736
Impairment -              -                 -                    3,711                    3,711
Adjustment for disposals -              -                 -                    (1,636)                   (1,636)
Accumulated depreciation/
-1102enuJ03noitasitroma               37,395        37,395          194,602                231,997
007,871102enuJ03tasaeulavkoobteN     130,464      209,164        696,513                905,677
Movement summary 2009-2010 for all consolidated assets irrespective of valuation basis (excluding intangibles)
Land Buildings Total Land Infrastructure, Total
and Buildings plant, equipment
national and 
major facilities
$'000 $'000 $'000 $'000 $'000
007,879002yluJ1tasaeulavssorG     104,370      183,070          751,108                  934,178
Additions - new assets -              18,266        18,266          42,185                  60,451
Net revaluation decrement -              -                 -                    (51,109)                 (51,109)
Decommissioning Cost -              10,869        10,869          104,213                115,082
Transfers/reclassifications -              17,135        17,135          (20,417)                 (3,282)
Disposals -              -                 -                    (10,969)                 (10,969)
007,870102enuJ03tasaeulavssorG     150,640      229,340        815,011                1,044,351
Accumulated depreciation/
-9002yluJ1noitasitroma               25,425        25,425          138,810                164,235
Depreciation/amortisation -              7,405          7,405            43,982                  51,387
Net revaluation decrement -              -                 -                    (51,109)                 (51,109)
Adjustment for disposals -              -                 -                    (5,327)                   (5,327)
Accumulated depreciation/
-0102enuJ03noitasitroma               32,830        32,830          126,356                159,186
007,870102enuJ03tasaeulavkoobteN     117,810      196,510        688,655                885,165
Note:
Impairment of $3,711 thousand for property, plant and equipment were booked for 2011 (Nil, 2010).
No Property, plant or equipment are expected to be sold or disposed of within the next 12 months.
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8 Non-financial assets (continued)   
8 Non-financial assets (continued)   
2011 2009
$'000 $'000
8B(iii). Major national and major research facilities
Major national research facilities - at cost 4,926 4,988
Less accumulated depreciation 422 127
4,504 4,861
Major national research facilities 
at independent valuation - 30 June 2007 (fair value) 2,869 2,825
Less accumulated depreciation 648 457
2,221 2,368
Major research facilities at cost 338 143
Less accumulated depreciation 82 8
256 135
Major research facilities 
at independent valuation - 30 June 2007 (fair value) 6,259 6,239
Less accumulated depreciation 2,805 2,101
3,454 4,138
OPAL nuclear research reactor at cost 7,455 4,816
Less accumulated depreciation 420 113
7,035 4,703
OPAL nuclear research reactor 
at independent valuation - 30 June 2009 (fair value) 450,482 450,084
Less accumulated depreciation 49,456 24,726
401,026 425,358
694,814seitilicafhcraeserrojamdnalanoitanrojamlatoT 441,563
315,696seitilicafrojamdnatnempiuqe,tnalp,erutcurtsarfnilatoT 688,655
776,509seitilicafrojamdnatnempiuqe,tnalp,erutcurtsarfni,sgnidliub,dnallatoT 885,165
Movement summary 2010-2011 for all consolidated assets irrespective of valuation basis (excluding intangibles)
Land Buildings Total Land Infrastructure, Total
and Buildings plant, equipment
national and 
major facilities
$'000 $'000 $'000 $'000 $'000
007,870102yluJ1tasaeulavssorG     150,640      229,340        815,011                1,044,351
Additions - new assets -              16,757        16,757          54,558                  71,315
Decommissioning Cost -              1,553          1,553            25,942                  27,495
Transfers/reclassifications -              (1,091)        (1,091)           1,556                    465
Disposals -              -                 -                    (5,952)                   (5,952)
007,871102enuJ03tasaeulavssorG     167,859      246,559        891,115                1,137,674
Accumulated depreciation/
-0102yluJ1noitasitroma               32,830        32,830          126,356                159,186
Depreciation/amortisation -              4,565          4,565            66,171                  70,736
Impairment -              -                 -                    3,711                    3,711
Adjustment for disposals -              -                 -                    (1,636)                   (1,636)
Accumulated depreciation/
-1102enuJ03noitasitroma               37,395        37,395          194,602                231,997
007,871102enuJ03tasaeulavkoobteN     130,464      209,164        696,513                905,677
Movement summary 2009-2010 for all consolidated assets irrespective of valuation basis (excluding intangibles)
Land Buildings Total Land Infrastructure, Total
and Buildings plant, equipment
national and 
major facilities
$'000 $'000 $'000 $'000 $'000
007,879002yluJ1tasaeulavssorG     104,370      183,070          751,108                  934,178
Additions - new assets -              18,266        18,266          42,185                  60,451
Net revaluation decrement -              -                 -                    (51,109)                 (51,109)
Decommissioning Cost -              10,869        10,869          104,213                115,082
Transfers/reclassifications -              17,135        17,135          (20,417)                 (3,282)
Disposals -              -                 -                    (10,969)                 (10,969)
007,870102enuJ03tasaeulavssorG     150,640      229,340        815,011                1,044,351
Accumulated depreciation/
-9002yluJ1noitasitroma               25,425        25,425          138,810                164,235
Depreciation/amortisation -              7,405          7,405            43,982                  51,387
Net revaluation decrement -              -                 -                    (51,109)                 (51,109)
Adjustment for disposals -              -                 -                    (5,327)                   (5,327)
Accumulated depreciation/
-0102enuJ03noitasitroma               32,830        32,830          126,356                159,186
007,870102enuJ03tasaeulavkoobteN     117,810      196,510        688,655                885,165
Note:
Impairment of $3,711 thousand for property, plant and equipment were booked for 2011 (Nil, 2010).
No Property, plant or equipment are expected to be sold or disposed of within the next 12 months.
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2011 2010
$'000 $'000
8C.  Inventories  
Raw materials and stores-not held for resale 
Stores - at cost 1,778 2,240
Cobalt-60 sources - at net realisable value 215 245
Reactor fuel and heavy water - at average purchase price 13,215 10,593
Nuclear materials - at net realisable value - 134
Provision for stock diminution (95) (309)
15,113 12,903
Work in progress - at cost 237 584
Finished goods - at cost 279 297
Total inventories 15,629 13,784
8D.  Intangibles   
8D.  Intangibles (continued)  
Licences at cost 1,224 1,009
Less accumulated amortisation 1,039 1,009
185 -
Design fees at cost 1,882 466
Less accumulated amortisation 398 104
1,484 362
Software at cost 32,603 18,466
Less accumulated amortisation 19,659 14,256
12,944 4,210
Software under construction 4,335 10,845
Total intangibles 18,948 15,417
Movement summary 2010-2011 for all consolidated intangibles irrespective of valuation basis
Licenses Software Total
$'000 $'000 $'000
900,10102enuJ03tasaeulavssorG       29,777        30,786
512stessawen-snoitiddA          9,981          10,196
-noitacifissalceR/refsnarT               (465)           (465)
-slasopsiD               (473)           (473)
422,11102enuJ03tasaeulavssorG       38,820        40,044
Accumulated depreciation/
900,10102enuJ03noitasitroma       14,360        15,369
03noitasitroma/noitaicerpeD            5,697          5,727
Accumulated depreciation/
930,11102enuJ03noitasitroma       20,057        21,096
5811102enuJ03tasaeulavkoobteN          18,763        18,948
Movement summary 2009-2010 for all consolidated intangibles irrespective of valuation basis
Licenses Software Total
$'000 $'000 $'000
Gross value as at 1 July 2009 1,009      16,834        17,843
-stessawen-snoitiddA               10,286        10,286
-noitacifissalceR/refsnarT               3,282          3,282
-slasopsiD               (625)           (625)
900,10102enuJ03tasaeulavssorG       29,777        30,786
Accumulated depreciation/
900,18002yluJ1noitasitroma       11,593        12,602
-noitasitroma/noitaicerpeD               3,035          3,035
-slasopsidroftnemtsujdA               (268)           (268)
Accumulated depreciation/
900,10102enuJ03noitasitroma       14,360        15,369
-0102enuJ03tasaeulavkoobteN               15,417        15,417
Note:
No indicators of impairment were found for intangible assets.
No Intangibles are expected to be sold or disposed of within the next 12 months.
8E. Other  
Deferred tax asset - 433
Prepayments 7,255 6,226
7,255 6,659
Total non-financial assets 947,509 921,025
No indicators of impairment were found for other non-financial assets
The Deferred Tax Asset of USD 369,000 or AUD 433,000 recognised as an asset at 30 June 2010 has been derecognised 
at 30 June 2011 as the directors do not believe it is probable that sufficient profits will be generated to utilise the tax losses.
Consolidated
FINANCIAL YEAR
Consolidated
FINANCIAL YEAR
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2011 2010
$'000 $'000
8C.  Inventories  
Raw materials and stores-not held for resale 
Stores - at cost 1,778 2,240
Cobalt-60 sources - at net realisable value 215 245
Reactor fuel and heavy water - at average purchase price 13,215 10,593
Nuclear materials - at net realisable value - 134
Provision for stock diminution (95) (309)
15,113 12,903
Work in progress - at cost 237 584
Finished goods - at cost 279 297
Total inventories 15,629 13,784
8D.  Intangibles   
8D.  Intangibles (continued)  
Licences at cost 1,224 1,009
Less accumulated amortisation 1,039 1,009
185 -
Design fees at cost 1,882 466
Less accumulated amortisation 398 104
1,484 362
Software at cost 32,603 18,466
Less accumulated amortisation 19,659 14,256
12,944 4,210
Software under construction 4,335 10,845
Total intangibles 18,948 15,417
Movement summary 2010-2011 for all consolidated intangibles irrespective of valuation basis
Licenses Software Total
$'000 $'000 $'000
900,10102enuJ03tasaeulavssorG       29,777        30,786
512stessawen-snoitiddA          9,981          10,196
-noitacifissalceR/refsnarT               (465)           (465)
-slasopsiD               (473)           (473)
422,11102enuJ03tasaeulavssorG       38,820        40,044
Accumulated depreciation/
900,10102enuJ03noitasitroma       14,360        15,369
03noitasitroma/noitaicerpeD            5,697          5,727
Accumulated depreciation/
930,11102enuJ03noitasitroma       20,057        21,096
5811102enuJ03tasaeulavkoobteN          18,763        18,948
Movement summary 2009-2010 for all consolidated intangibles irrespective of valuation basis
Licenses Software Total
$'000 $'000 $'000
Gross value as at 1 July 2009 1,009      16,834        17,843
-stessawen-snoitiddA               10,286        10,286
-noitacifissalceR/refsnarT               3,282          3,282
-slasopsiD               (625)           (625)
900,10102enuJ03tasaeulavssorG       29,777        30,786
Accumulated depreciation/
900,18002yluJ1noitasitroma       11,593        12,602
-noitasitroma/noitaicerpeD               3,035          3,035
-slasopsidroftnemtsujdA               (268)           (268)
Accumulated depreciation/
900,10102enuJ03noitasitroma       14,360        15,369
-0102enuJ03tasaeulavkoobteN               15,417        15,417
Note:
No indicators of impairment were found for intangible assets.
No Intangibles are expected to be sold or disposed of within the next 12 months.
8E. Other  
Deferred tax asset - 433
Prepayments 7,255 6,226
7,255 6,659
Total non-financial assets 947,509 921,025
No indicators of impairment were found for other non-financial assets
The Deferred Tax Asset of USD 369,000 or AUD 433,000 recognised as an asset at 30 June 2010 has been derecognised 
at 30 June 2011 as the directors do not believe it is probable that sufficient profits will be generated to utilise the tax losses.
Consolidated
FINANCIAL YEAR
Consolidated
FINANCIAL YEAR
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Consolidated
1102seitilibaiL9 2010                  2009
$'000 $'000 $'000
9A. Interest bearing liabilities
Other (a) 2,484 3,497                 3,308
484,2seitilibailgniraebtseretnilatoT 3,497                 3,308
Provision
9B. Employee provisions
Annual leave 10,267 9,174                 8,666
Long service leave 18,261 16,313               14,547
28,528 25,487               23,213
Employee provisions are expected to be settled in:
No more than 12 months 3,836 2,815                 1,609
More than 12 months 24,692 22,672               21,604
825,82snoisivorpeeyolpmelatoT 25,487               23,213
9C Decommissioning provisions
Decommissioning cost (c) 291,465 269,517             181,762
291,465 269,517             181,762
9D Other 
Other claims (b) 286 270                    2,007
286 270                    2,007
972,023noisivorplatoT 295,274             206,982
Payables
9E Suppliers
Trade creditors 11,383 12,578               8,263
11,383 12,578               8,263
Supplier payables expected to be settled 
within 12 months
Related entities - 76                     -
External parties 11,383 12,502               8,263
383,11latoT 12,578               8,263
9F Employees
Accrued salaries and wages 2,819 2,347                 1,168
Incentives 1,017 468                    441
3,836 2,815                 1,609
9G Grants 
Non-profit entities 687 562                    575
687 562                    575
9H Other 
Revenue received in advance 1,433 1,557                 1,171
1,433 1,557                 1,171
933,71selbayaplatoT 17,512               11,618
201,043seitilibaillatoT 316,283             221,908
Notes:
(a) Relates to prepaid revenue under a lease of property.
(b)  This provision includes redundancy.
(c)  This provision includes decommisioning cost relating to property, plant & equipment and infrastructure, 
local and overseas legacy waste and current OPAL waste.
9I Provision movement reconciliation 
Provision for Provision for Total 
Decommissioning Other Claims Provisions
Costs
$'000 $'000 $'000
757,1818002yluJ1tnuomagniyrraC 175,4                     186,328
Amounts used (4,536)                             (2,564)                    (7,100)
Change in accounting estimate (14,865) -                             (14,865)
Unwinding discount 19,406 -                             19,406
Closing balance 30 June 2009 181,762 700,2                     183,769
267,1819002yluJ1tnuomagniyrraC 700,2                     183,769
Provisions not required -                                      (1,605)                    (1,605)
Additional provisions made -                                      -                             -
Amounts used (5,525)                             (132)                       (5,657)
Change in accounting estimate 79,418 -                             79,418
Unwinding discount 13,862 -                             13,862
Closing balance 30 June 2010 269,517 072                        269,787
715,9620102yluJ1tnuomagniyrraC 072                        269,787
Provisions not required (3,909) -                             (3,909)
Additional provisions made 27,498 61                          27,514
Amounts used (8,964) -                             (8,964)
Change in accounting estimate (7,764) -                             (7,764)
Unwinding discount 15,087 -                             15,087
Closing balance 30 June 2011 291,465 682                        291,751
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Consolidated
1102seitilibaiL9 2010                  2009
$'000 $'000 $'000
9A. Interest bearing liabilities
Other (a) 2,484 3,497                 3,308
484,2seitilibailgniraebtseretnilatoT 3,497                 3,308
Provision
9B. Employee provisions
Annual leave 10,267 9,174                 8,666
Long service leave 18,261 16,313               14,547
28,528 25,487               23,213
Employee provisions are expected to be settled in:
No more than 12 months 3,836 2,815                 1,609
More than 12 months 24,692 22,672               21,604
825,82snoisivorpeeyolpmelatoT 25,487               23,213
9C Decommissioning provisions
Decommissioning cost (c) 291,465 269,517             181,762
291,465 269,517             181,762
9D Other 
Other claims (b) 286 270                    2,007
286 270                    2,007
972,023noisivorplatoT 295,274             206,982
Payables
9E Suppliers
Trade creditors 11,383 12,578               8,263
11,383 12,578               8,263
Supplier payables expected to be settled 
within 12 months
Related entities - 76                     -
External parties 11,383 12,502               8,263
383,11latoT 12,578               8,263
9F Employees
Accrued salaries and wages 2,819 2,347                 1,168
Incentives 1,017 468                    441
3,836 2,815                 1,609
9G Grants 
Non-profit entities 687 562                    575
687 562                    575
9H Other 
Revenue received in advance 1,433 1,557                 1,171
1,433 1,557                 1,171
933,71selbayaplatoT 17,512               11,618
201,043seitilibaillatoT 316,283             221,908
Notes:
(a) Relates to prepaid revenue under a lease of property.
(b)  This provision includes redundancy.
(c) T is provision inclu es decommisioning cost relating to property, plant & equipment and infrastructure, 
local and overseas legacy waste and current OPAL waste.
9I Provision movement reconciliation 
Provision for Provision for Total 
Decommissioning Other Claims Provisions
Costs
$'000 $'000 $'000
757,1818002yluJ1tnuomagniyrraC 175,4                     186,328
Amounts used (4,536)                             (2,564)                    (7,100)
Change in accounting estimate (14,865) -                             (14,865)
Unwinding discount 19,406 -                             19,406
Closing balance 30 June 2009 181,762 700,2                     183,769
267,1819002yluJ1tnuomagniyrraC 700,2                     183,769
Provisions not required -                                      (1,605)                    (1,605)
Additional provisions made -                                      -                             -
Amounts used (5,525)                             (132)                       (5,657)
Change in accounting estimate 79,418 -                             79,418
Unwinding discount 13,862 -                             13,862
Closing balance 30 June 2010 269,517 072                        269,787
715,9620102yluJ1tnuomagniyrraC 072                        269,787
Provisions not required (3,909) -                             (3,909)
Additional provisions made 27,498 61                          27,514
Amounts used (8,964) -                             (8,964)
Change in accounting estimate (7,764) -                             (7,764)
Unwinding discount 15,087 -                             15,087
Closing balance 30 June 2011 291,465 682                        291,751
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Consolidated
2011             2010               2009                
$'000 $'000 $'000
10 Equity
Contributed equity
Replacement research reactor equity injections
Balance 1 July 385,836        385,836          385,836           
Balance 30 June 385,836        385,836          385,836           
Other equity injections
Balance 1 July 82,020          62,020            60,420             
Equity injections from Government - Other (f) 14,100          20,000            1,600               
Balance 30 June 96,120          82,020            62,020             
659,184ytiuqe detubirtnoc latoT         467,856          447,856           
Reserves, including movements
Asset revaluation reserve
Balance 1 July 328,456        294,271          229,248           
Revaluation adjustment 10,652          34,185            65,023             
Balance 30 June 339,108        328,456          294,271           
OPAL depreciation reserve
Balance 1 July 9,061            9,061              35,258             
Transferred to retained surpluses (a) -                    -                      (26,197)            
Balance 30 June 9,061            9,061              9,061               
Reactor licensing reserve
Balance 1 July -                    -                      1,500               
Transferred to retained surpluses -                    -                      (1,500)              
Balance 30 June -                    -                      -                       
Regional security of radioactive reserve
Balance 1 July 939               629                 757                  
Transferred (to)/from retained surpluses (b) (372)              310                 (128)                 
Balance 30 June 567               939                 629                  
Nuclear & radiological security reserve
Balance 1 July 539               539                 360                  
Transferred to retained surpluses (c) (539)              -                      179                  
Balance 30 June -                    539                 539                  
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Consolidated
2011 2010               2009
$'000 $'000 $'000
Low Dose Nuclear Waste Repository
Balance 1 July 4,211 3,032              3,032
Transferred to retained surpluses (d) (3,137) 1,179 -
Balance 30 June 1,074 4,211              3,032
Intermediate low level waste (ILLW) return
Balance 1 July - -                      -
Transferred from retained surpluses (e) 785 -                      -
Balance 30 June 785 -                      -
Foreign currency reserve
Balance 1 July 13 (3)                    (22)
Movement (g) 201 16                   19
Balance 30 June 214 13                   (3)
Other reserve
Balance 1 July 139 150                 -
Movement (h) (139) (11)                  150
Balance 30 June - 139                 150
908,053sevreserlatoT 343,358          307,679
Retained surpluses(deficit)
Retained surpluses 1 July (58,404) (33,173) (59,508)
Adjustment to opening Balance 
Transfer from OPAL depreciation reserve  (a) - -                      26,197
Transfer from regional security of radioactive reserve (b) 372 (310)                128
Transfer from nuclear & radiological security reserve (c) 539 -                      (179)
Transfer from Low Dose Nuclear Waste Repository (d) 3,137 (1,179) -
Transfer to Intermediate low level waste (ILLW) return (e) (785) -                      -
Transfer from reactor licensing reserve - -                      1,500
Transfer to other reserve 139 -                      (150)
Transfer to foreign currency reserve (9) -                      -
(Deficit) (40,074) (23,742) (1,161)
)580,59(enuJ03sesulprusdeniateR (58,404)           (33,173)
086,737ytiuqelatoT 752,810          722,362
(a) OPAL depreciation reserve
This reserve represents unused funding for OPAL depreciation.  This was due to a delay in final commissioning of
OPAL.
(b) Regional security of radioactive materials reserve
This represents unused funding from prior years. This is due to delays in participation by some regional countries.
(c) Nuclear and radiological security reserve
This reserve relates to funding which started in 2009-10 and will run through up to 2010-11. 
d) Low Dose Nuclear Waste Repository
This reserve relates to funding for low level waste facility at ANSTO for its own use and used by other Commonwealth agencies. 
(e) Intermediate low level waste (ILLW) return
This reserve relates to unspent appropriation for ILLW return.
(f) Equity Injection from Government 
Comparatives for 2009/10 has been changed to reflect the current year accounting treatment of EIF contributions from Department
of Finance and Deregulation (DOFD) from Revenue to Equity Injection.
(g) Foreign currency reserve
This reserve relates to foreign currency translation at balance date.
(h) Other reserves
This reserve relates to ANSTO Inc. deferred tax assets.During 2010/11 the balance of this reserve was 
transferred to retained surplus.
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11 Cash flow reconciliation
2011 2010                 
Notes $'000 $'000
Reconciliation of Operating Surplus (Deficit) to Net Cash from Operating Activities: 
Operating (deficit) (a) (40,074) (23,742)            
Non-cash items 
Depreciation/amortisation 80,174 54,422              
Net write-down of Investment 5,000 -                       
Net loss on disposal of non-financial assets 3,264 243                   
Unrealised foreign exchange (gain) loss 349 (98)                   
Unwinding of Discount - decommissioning costs 15,087 13,862              
Loss on sale of subsidiary - 870                   
Changes in assets and liabilities 
(Increase) in trade goods and services receivables (3,128) (259)                 
(Increase)/Decrease in other receivables (297) 1,191                
(Increase)/Decrease in GST receivables (277) 431                   
(Increase)/Decrease in accrued interest 1,020 (284)                 
(Increase) in prepayments (1,029) (2,140)              
(Increase) in inventories (1,845) (5,073)              
Increase/(Decrease) in payables (1,545) 4,413                
Increase in employee entitlements 4,062 3,480                
Increase in revenue received in advance 1 373                   
Increase/(Decrease) in deferred income tax 433 (138)                 
Increase/(Decrease) in reserves 16,560 (1,018)              
Increase/(Decrease) in other provision 16 (1,737)              
Increase/(Decrease) in decommissioning cost provision (26,350) (2,663)              
Increase/(Decrease) in interest bearing liabilities (1,013) 189                   
804,05 seitivitca gnitarepo morf hsac teN 42,322              
12 Government funding
Revenue from Government 165,592 155,240            
Government equity injection 4,100 -                   
Education Investment Fund equity injection (a) 10,000 20,000              
179,692 175,240            
(a) Changes to 2010 comparatives refer note 26
Appropriations are made to the Department of Innovation, Industry, Science and Research (DIISR) 
which are then paid to ANSTO.
Consolidated
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13 Board membership  
The members of the Board during the financial year and to the date of the report on the statements were:
mreTmreT
Member Appointed Concluded Concludes
Z Switkowski 1 January 2006 31 December 2010
4102 yluJ 42 0102 yluJ 52dleifneerG P
3102 hcraM 219002 hcraM 31nilhguoLcM C
1102 rebmetpeS 527002 rebmetpeS 62ttocS A
2102 lirpA 038002 yaM 1volopoC D
2102 lirpA 038002 yaM 1nraeH J
2102 rebmeceD 118002 rebmeceD 21 htymS E
4102 enuJ 030102 yluJ 1dnoP S
6102 yraurbeF 321102 yraurbeF 42nayR J
4102 yraurbeF 829002 hcraM 1nosretaP A
For the 2010-2011 financial year the aggregate remuneration paid to members of the Board
is disclosed in Note 14.
14 Remuneration of members of the Board  
Members' remuneration is determined by the Remuneration
Tribunal and payment is made in accordance with Section 12
of the ANSTO Act 1987 (as amended).
Included in operating expenses (Note 6) are:
2011 2010
The number of non-executive directors of ANSTO included in Number Number
these figures are shown below in the relevant remuneration bands:
Remuneration between
less than $150,000 9 8
9latoT 8
309,912 304,145
Remuneration of executive directors is included in Note 15: Remuneration of senior executives. 
Total remuneration received or due and receivable by 
directors
Consolidated
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15 Remuneration of senior executives   
2011 2010
$ $
Short-term employee benefits:
Salary 3,455,858 2,972,514 
Annual leave accrued 243,168 141,348 
Performance bonuses 534,100 242,323 
Other allowance 37,280 32,780 
Total short-term employee benefits 4,270,406 3,388,965 
Post-employment benefits:
Superannuation 566,152 477,850 
Total post-employment benefits 566,152 477,850 
Other long-term benefits:
Long-service leave 85,224 74,553 
Total other long-term benefits 85,224 74,553 
Termination benefits  -  -
Total 4,921,782 3,941,368 
Notes:
Fixed Elements and Bonus Paid1
Senior
Executives Salary Allowances Total
Total remuneration (including part-time arrangements):
less than $150,000 3 122,859  - 122,859 5,767 
$150,000 to $179,999 3 154,477 6,000 160,477 24,373 
$180,000 to $209,999 4 191,549 2,547 194,096 15,094 
$210,000 to $239,999 3 215,486 4,453 219,939 10,208 
$240,000 to $269,999 4 259,789  - 259,789 7,500 
$270,000 to $299,999 1 280,000  - 280,000 5,950 
$360,000 to $389,999
$390,000 to $419,999 1 346,698 44,884 391,582 67,540 
Total
Total remuneration (including part-time arrangements):
less than $150,000
$150,000 to $179,999
$180,000 to $209,999
$210,000 to $239,999
$240,000 to $269,999
$270,000 to $299,999
$360,000 to $389,999
$390,000 to $419,999
Total
19
Note 15A: Senior Executive Remuneration Expense for the Reporting Period
1. Note 15A was prepared on an accrual basis (so the performance bonus expenses 
disclosed above differ from the cash 'Bonus paid' in Note 15B).
2. Note 15A excludes acting arrangements and part-year service where remuneration 
expensed for a senior executive was less than $150,000.
as at 30 June 2011
Note 15B: Average Annual Remuneration Packages and Bonus Paid for Substantive Senior Executives as at the end of the Reporting Period
Fixed elements
Bonus paid2
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Notes:
     • CSS rate at 15.4% (2010 15.4%) of salary.
     • PSS rate at 17.0% (2010 19.1%) of salary.
     • PSSap rate at 15.4% (2010 15.4%).
     • Other at rate 9%
(e) Others: 
Note 15C: Other Highly Paid Staff
(d) Variable allowances: 
During the reporting period, there were 26 (2010: 13) employees whose salary plus 
performance bonus were $150,000 or more. These employees did not have a role as senior 
executive or director and were therefore not disclosed as senior executives in Note 15A 
and Note 15B.
1. This table reports substantive senior executives who were employed by the entity at the end of the reporting period. Fixed 
elements were based on the employment agreement of each individual. Each row represents an average annualised figure 
(based on headcount) for the individuals in that remuneration package band (i.e. the 'Total' column).
2. This represents average actual bonuses paid during the reporting period in that remuneration package band. The 'Bonus paid' 
was excluded from the 'Total' calculation, (for the purpose of determining remuneration package bands). The 'Bonus paid' within
a particular band may vary between financial years due to various factors such as individuals commencing with or leaving the 
entity during the financial year.
Variable Elements:
With the exception of bonuses, variable elements were not included in the 'Fixed Elements and Bonus Paid' table above. The 
following variable elements were available as part of senior executives' remuneration package:
• Bonuses were based on the performance rating of each individual. The maximum bonus that an individual can receive were 
10 per cent of his/her base salary.
(a) Bonuses: 
• This represents Living away home allowance (LAFHA) and rentals as per individual package.
Various salary sacrifice arrangements were available to senior executives including super, motor vehicle and expense payment 
fringe benefits.
(b) On average senior executives were entitled to the following leave entitlements:
• Annual Leave (AL): entitled to 20 days (2010: 20 days) each full year worked (pro-rata for part-time SES);
• Personal Leave (PL): entitled to 18 days (2010: 20 days) or part-time equivalent; and
• Long Service Leave (LSL): in accordance with Long Service Leave Act.
(c) Senior executives were members of one of the following superannuation funds:
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16 OPAL Nuclear Research Reactor 
The OPAL nuclear research reactor operated for 276 days in the financial year, which translates into a planned availability of 90%
for the financial year. 
Irradiations for research, industry and radiopharmaceutical supply all increased throughout the year, and reliability of supply of these
irradiated products was good.
The Cold Neutron Source, which is a major component of the OPAL reactor important for neutron beam research, was unavailable for about 
half the year, due to failures in the Helium gas part of the refrigerant system connected to the Cold Neutron Source. Similar failures occurred 
in 2009-10.  Due to the importance of this system to neutron beam research programs, the ANSTO Executive has directly intervened with the major 
suppliers of the system regarding the need to establish a definitive root cause for the failures and to provide mitigation to protect against subsequent 
failures prior to the root cause being established. The Cold Neutron Source was functioning at the end of the financial year.
The Heavy Water Isotopic Purification System has been constructed, and pre-testing has been completed prior to the plant being commissioned.
The plant will be used to continually upgrade the purity of the heavy water inventory in the reactor. This will assist with optimising reactor 
performance.
ANSTO continues to work with INVAP on the resolution of a small number of other engineering defects. Progress on achieving acceptable
disposition of these defects continues to be monitored.
17 Insurances   
Insurance risks, including professional indemnity, general liability, industrial special
risk for property used substantially for commercial purposes, directors and officers, and travel, are placed through
Comcover, the Government's insurable risk managed fund.
Workers compensation is insured through Comcare Australia and by virtue of statute under the 
Safety Rehabilitation and Compensation Act 1988.
A Deed of Indemnity between the Commonwealth Government and ANSTO, under which the government has
formally agreed to indemnify ANSTO and ANSTO Officers from any loss or liability arising from claims
caused by ionising radiation, remains in place until August 2018. 
2011 2010
18 Remuneration of auditors
Audit fees in relation to the financial statements for the reporting period 167,500 177,500
Grant audits 11,000 -
178,500 177,500
No other services were provided by the Auditor-General during the reporting period.
19 Related party disclosures  
Several ANSTO Board Members were associated with entities with which ANSTO had commercial transactions
during the year as part of their role in hospitals or universities. All such transactions were in accordance with ANSTO's normal
commercial terms and conditions. None of those transactions led to any conflict of interest.
20 Trust money
2011 2010
ANSTO receives monies from trade creditors as security deposits for $ $
$ $
contracts to be performed. These monies are held in a Trust Account and 
refunded to the respective trade creditors on satisfactory completion of 
the contract.
Balance 1 July 7 20
Add: receipts 1 -
Deduct: payments - (13)
Balance 30 June 8 7
Consolidated
Consolidated
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AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2011
21  Financial instruments 
(a)  Fair value of financial instruments
Financial Notes
Instruments
Carrying Amount Fair Value
Carrying
Amount Fair Value
2011 2011 2010 2010
$’000 $’000 $’000 $’000
Financial assets 
A7 knab ta hsaC 3,278                     3,278 5,023               5,023              
C7ytirutam ot dleh tnemtsevnI 115,268                 115,268 129,000           129,000          
C7 tnemtsevnI -                         - 5,000               5,000              
Receivables for goods and services 7B 9,125                     9,125 6,296               6,296              
B7snaoL -                         - -                   -                 
B7deurcca tseretnI 628                        628 1,648               1,648              
B7 rehtO 768                        768 471                  471                 
Total financial assets 
760,921)desingocer(                  129,067 147,438           147,438          
Total financial liabilities
E9srotiderc edarT 11,383                   11,383 12,578             12,578            
F9seeyolpmE 3,836                     3,836 2,815               2,815              
G9ecnavda ni deviecer tnarG 687                        687 562                  562                 
A9seitilibail gniraeb tseretnI 2,484                     2,484 3,497               3,497              
H9rehtO 1,433                     1,433 1,557               1,557              
Total financial liabilities
328,91)desingocer(                    19,823 21,009             21,009            
(b)  Net income from financial assets
Financial Notes
Instruments
2011 2010
$’000 $’000
Financial assets 
A7 knab ta hsaC 124 124                  
C7ytirutam ot dleh tnemtsevnI 7,233 6,144               
B7snaoL - -                   
753,7 stessa laicnanif morf emocnI teN 6,268               
(c)  Net expenses from financial liabilities
Financial liabilities
A9seitilibail gniraeb tseretnI 105 198                  
Net expenses from financial liabilities 105 198                  
Financial assets
The net fair values of cash, deposits on call and non-interest-bearing monetary financial assets are in accord 
with their carrying amounts.
Loans receivable are carried at cost, which is above their net fair value, because it is intended to hold them 
to maturity.
Financial liabilities
The net fair values for trade creditors and revenue received in advance, all of which are short-term in nature, are 
in accord with their carrying amounts.
(d)  Credit risk exposures
The maximum exposure to credit risk is the risk that arises from potential default of a debtor. This is equal to the total amount
of trade and other receivables as per note 7B. ANSTO has assessed the risk of the default on payment and 
has provided for doubtful debts account as per note 7B(b).
ANSTO manages its credit risk by undertaking background and credit checks prior to allowing a debtor relationship. In addition,
the Organisation has policies and procedures that guide employees to apply debt recovery techniques. The Organisation holds 
no collateral to mitigate against credit risk.
Consolidated
Consolidated
33
Financial Statements 2010-2011
Notes to and forming part of the Financial Statements 
for the year ended 30 June 2011
ANSTO Annual Report 2010-2011  l  80
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NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2011
21  Financial instruments 
(a)  Fair value of financial instruments
Financial Notes
Instruments
Carrying Amount Fair Value
Carrying
Amount Fair Value
2011 2011 2010 2010
$’000 $’000 $’000 $’000
Financial assets 
A7 knab ta hsaC 3,278                     3,278 5,023               5,023              
C7ytirutam ot dleh tnemtsevnI 115,268                 115,268 129,000           129,000          
C7 tnemtsevnI -                         - 5,000               5,000              
Receivables for goods and services 7B 9,125                     9,125 6,296               6,296              
B7snaoL -                         - -                   -                 
B7deurcca tseretnI 628                        628 1,648               1,648              
B7 rehtO 768                        768 471                  471                 
Total financial assets 
760,921)desingocer(                  129,067 147,438           147,438          
Total financial liabilities
E9srotiderc edarT 11,383                   11,383 12,578             12,578            
F9seeyolpmE 3,836                     3,836 2,815               2,815              
G9ecnavda ni deviecer tnarG 687                        687 562                  562                 
A9seitilibail gniraeb tseretnI 2,484                     2,484 3,497               3,497              
H9rehtO 1,433                     1,433 1,557               1,557              
Total financial liabilities
328,91)desingocer(                    19,823 21,009             21,009            
(b)  Net income from financial assets
Financial Notes
Instruments
2011 2010
$’000 $’000
Financial assets 
A7 knab ta hsaC 124 124                  
C7ytirutam ot dleh tnemtsevnI 7,233 6,144               
B7snaoL - -                   
753,7 stessa laicnanif morf emocnI teN 6,268               
(c)  Net expenses from financial liabilities
Financial liabilities
A9seitilibail gniraeb tseretnI 105 198                  
Net expenses from financial liabilities 105 198                  
Financial assets
The net fair values of cash, deposits on call and non-interest-bearing monetary financial assets are in accord 
with their carrying amounts.
Loans receivable are carried at cost, which is above their net fair value, because it is intended to hold them 
to maturity.
Financial liabilities
The net fair values for trade creditors and revenue received in advance, all of which are short-term in nature, are 
in accord with their carrying amounts.
(d)  Credit risk exposures
The maximum exposure to credit risk is the risk that arises from potential default of a debtor. This is equal to the total amount
of trade and other receivables as per note 7B. ANSTO has assessed the risk of the default on payment and 
has provided for doubtful debts account as per note 7B(b).
ANSTO manages its credit risk by undertaking background and credit checks prior to allowing a debtor relationship. In addition,
the Organisation has policies and procedures that guide employees to apply debt recovery techniques. The Organisation holds 
no collateral to mitigate against credit risk.
Consolidated
Consolidated
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AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION 
NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2011
21  Financial instruments (cont.)
(e)  Liquidity risk
ANSTO financial liabilities are payables and other interest bearing liabilities. The exposure to liquidity risk is based on the notion that the Organisation 
will encounter difficulty in meeting its obligations associated with financial liabilities. This is highly unlikely due to Australian Government Appropriation funding and 
mechanism available to the Organisation and internal policies and procedures put in place to ensure there are appropriate resources  to meet its financial obligations.
Consolidated
Financial Notes
Instruments
nuomAgniyrraC1102 t On Demand 1 Year or Less 1 to 2 Years More than 2 years Total Contractual
Cash Flows
$’000 $’000 $’000 $’000 $’000 $’000
Financial liabilities
E9srotidercedarT 11,383 -                     11,383                  -                    -                           11,383
F9seeyolpmE 3,836                        -                     3,836                    -                    -                           3,836
G9ecnavdanideviecertnarG 687                           -                     687                       -                    -                           687
A9seitilibailgniraebtseretnI 2,484                        -                     2,484                    -                    -                           2,484
H9rehtO 1,433                        -                     1,433                    -                    -                           1,433
Total financial liabilities
328,91)desingocer( -                     19,823                  -                    -                           19,823
lautcartnoClatoTsraey2nahteroMsraeY2ot1sseLroraeY1dnameDnOtnuomAgniyrraC0102
Cash Flows
$’000 $’000 $’000 $’000 $’000 $’000
Financial liabilities
875,21E9srotidercedarT - 12,578 -                    - 12,578
518,2F9seeyolpmE - 2,815 -                    - 2,815
265G9ecnavdanideviecertnarG - 562 -                    - 562
794,3A9seitilibailgniraebtseretnI - 3,497 -                    - 3,497
755,1H9rehtO - 1,557 -                    - 1,557
Total financial liabilities
(recognised) 21,009 - 21,009 -                    - 21,009
Consolidated
Consolidated
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AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION 
NOTES TO AND FORMING PART OF THE FINANCIAL STATEMENTS
for the year ended 30 June 2011
21  Financial instruments (cont.)
(f)  Market risk - consolidated
(i) Interest rate risk 
This refers to the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. 
ANSTO is exposed to interest rate risk primarily from Investment held to maturity. The impact as shown below.
Risk variable
2011 2010 1.75% -1.75% 1.50% -1.50%
Profit or Equity Profit or Equity
loss loss
2011 2011 2010 2010
000’$000’$000’$ $’000 $’000
Investment held to maturity 115,268 137,661
Interest 1.75% 1.50% 2,017            2,017 1,935            1,935
Interest -1.75% -1.50% (2,017)          (2,017) (1,935)          (1,935)
Interest rate sensitivity analysis has been calculated on a ‘reasonably possible’ change basis. A ‘reasonably possible’ change has been estimated 
using both statistical and non-statistical analyses. The statistical analysis has been based on the cash rate for the past five years issued by the Reserve Bank 
of Australia (RBA) as the underlying dataset. This information is then revised and adjusted for reasonableness under the current economic circumstances.
As a result of the analyses above, a standard rate of 175 basis points (2010: 150 basis points) shock level was selected as a ‘reasonably possible’ 
change in market interest rate.
175 basis points is managements best estimate of future volatility.
(ii) Foreign currency rate
This refers to the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign currency rates. 
ANSTO is exposed to foreign currency rate risk primarily from trade creditors. The impact only relates to assets and not profit and loss or equity.
Risk variable
2011 2010 15.00% -15.00% 14.00% -14.00%
Profit or Equity Profit or Equity
loss loss
2011 2011 2010 2010
000’$000’$000’$ $’000 $’000
USD Currency 139 145
Foreign currency 15.00% 14.00% 21                 21 20                 20
Foreign currency -15.00% -14.00% (21)               (21) (20)               (20)
The method used to arrive at the possible risk of 15% (2010, 14%) was based on both statistical and non-statistical analyses. The statistical analysis has 
been based on main currencies movement for the last five years. The two main currencies ANSTO has exposure to are USD and EURO currencies.
This information is then revised and adjusted for reasonableness under the current economic circumstances.
15% (2010, 14%) is managements best estimate of future USD foreign exchange volatility. 
(g)  Reconciliation of level 3 fair value hierarchy
2011 2010
$’000 $’000
Opening balance 5,000            5,000
)000,5(ssoldnatiforpnidesingocerdoirepehtrofsessolrosniaglatoT           -
Closing Balance -                   5,000
The investment in Australian Synchrotron Holding Company (ASHCo) of $5 million was assessed as requiring impairment testing. On the basis, ANSTO
secured confirmation from the CEO of ASHCo that it only had secured funding to 30 June 2012 with a letter of comfort from the Victorian Government to 
30 September 2012. On that basis ANSTO has determined that the investment of $5,000 thousand is fully impaired.
Investments
Consolidated
Effect on Effect onChange in variable
Consolidated
Change in variable Effect on Effect on
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            FINANCIAL YEAR
2011 2010
$ $
22 Operating lease arrangements
Payment recognised as expense
Minimum lease payments 203 9
203 9
Operating lease commitments
One year or less 137 137
From one to five years 685 685
Over five years 1,040 1,177
1,862 1,999
ANSTO has a twenty five year lease contract with Central Sydney Area Health Services that will expire on 29 Jan 2025 with 
an annual rental payable  of $137,000 (2010: $137,000).The annual rental is subject to review every three years.
23 Income tax expense (benefit)
Income tax benefit - (138)
Reversal of Deferred Tax Asset 345 -
543)tifeneb(esnepxexatemocnilatoT (138)
ANSTO's subsidiaries are subject to normal taxation but are in tax loss positions.
Unbooked deferred tax assets in relation to unrecouped tax losses in the subsidiaries is $1,047 thousand (2010: $320 thousand).
24 Other comprehensive income
256,01sevresernoitaulavertessanisegnahC 581,43
256,01emocnievisneherpmocrehtonistnemtsujdanoitaulaverlatoT 34,185
25 Information relating to ANSTO ('the parent entity')
ANSTO only presents the financial statements on a Consolidated basis. A summary of ANSTO (parent company only)
financial information is as follows:
            FINANCIAL YEAR
2011 2010
$ $
Current assets 141,891 163,551
Total assets 1,078,019 1,071,966
Current liabilities 21,318 21,850
Total liabilities 339,854 316,397
659,184ytiuqedetubirtnoC 467,856
Retained surplus (94,387) (55,494)
901,933evresernoitaulavertessA 328,457
Other reserve 11,487 14,750
Total equity 738,165 755,569
)651,24(ytitnetnerapehtfossolrotiforP (21,049)
)405,13(ytitnetnerapehtfoemocnievisneherpmoclatoT 13,281
The parent has issued the following guarantees in relation to the debts of its subsidiaries:
The ANSTO's Board has passed resolutions that in the event that its subsidiaries, PETNET Aust Pty Ltd and ANSTO Inc., 
do not meet their obligations under the terms of the overdrafts, loans, leases or other liabilities, ANSTO will guarantee its payments. 
The parent has no contingent liability for 2011 (2010: nil).
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26 Prior year adjustments
26 Prior year adjustments (continued)
Correction of calculations in estimating the decommissioning cost in the previous financial years as follows:
`
Balance Sheet items: $’000
$’000
Decommissioning provisions
Reported 30 June 2009 119,374
329,53lasopsidetsawlacolrofnoisivorpgninoissimmoceD)1(
006,63OTSNAotgninruteretsawleveLwoLetaidemretnIotgnitalernoisivorpgninoissimmoceD)2(
460,6leuFtnepSLAPOotgnitalernoisivorpgninoissimmoceD)3(
)991,61(tsoCgninoissimmoceDtnempiuqe&tnalp,ytreporPLAPOotgnitalernoisivorpgninoissimmoceD)4(
Restated 30 June 2009 181,762
1 July 2009 181,762
730,9lasopsidetsawlacolrofnoisivorpgninoissimmoceD)1(
436OTSNAotgninruteretsawleveLwoLetaidemretnIotgnitalernoisivorpgninoissimmoceD)2(
102,2leuFtnepSLAPOotgnitalernoisivorpgninoissimmoceD)3(
517,43tsoCgninoissimmoceDtnempiuqe&tnalp,ytreporPLAPOotgnitalernoisivorpgninoissimmoceD)4(
      (5) Amounts used (5,525)
      (6) Change in accounting estimate 41,950
      (7) Unwinding discount 4,743
Restated 30 June 2010 269,517
Contributed Equity
1 July 2009 447,856
      (1) EIF Funds reclassified from Revenue to Equity as approved by Department 
            of Finance and Deregulation. 20,000
30 June 2010 467,856
Retained Earnings
30 June 2009 45,775
      (1) Decommissioning provision for local waste disposal (35,923)
      (2) Decommissioning provision relating to Intermediate Low Level waste returning to ANSTO (36,600)
      (3) Decommissioning provision relating to OPAL Spent Fuel (6,064)
      (4) Decommissioning provision relating to OPAL Property, plant & equipment Decommissioning Cost (361)
Restated 30 June 2009 (33,173)
Opening Retained Earnings - 1 July 2009 (33,173)
      Reported 2010 Profit 8,239
      Less: Prior year adjustments
730,9lasopsidetsawlacolrofnoisivorpgninoissimmoceD)1(
436OTSNAotgninruteretsawleveLwoLetaidemretnIotgnitalernoisivorpgninoissimmoceD)2(
102,2leuFtnepSLAPOotgnitalernoisivorpgninoissimmoceD)3(
901tsoCgninoissimmoceDtnempiuqe&tnalp,ytreporPLAPOotgnitalernoisivorpgninoissimmoceD)4(
      (5) EIF Funds reclassified from Revenue to Equity as approved by Department 
            of Finance and Deregulation. 20,000
       Total prior year adjustments 31,981
      Restated 2010 Loss (23,742)
      Transfer between equity components (1,489)
Closing Retained Earnings - 30 June 2010 (58,404)
Total Reserves
Reported 30 June 2009 291,119
065,61tsoCgninoissimmoceDEPPLAPOotgnitalernoisivorpgninoissimmoceD)1(
Restated 30 June 2009 307,679
1 July 2009 307,679
      (1) Revaluation Adjustment in 2010 68,791
      (2) Transfer (to)/from retained earnings 1,494
)606,43(tsoCgninoissimmoceDEPPLAPOotgnitalernoisivorpgninoissimmoceD)3(
Restated 30 June 2010 343,358
Profit or Loss
       The adjustment also had the effect of overstating consolidated profit after income tax by $31,981 thousand 
       for the year ended 30 June 2010 as follows: 
      (1) Suppliers expenses 2,862
      (2) Finance costs 9,119
      (3) Grant expenses 20,000
       Total prior year adjustments 31,981
Supplier expenses - Adjustment related to the costs associated with the revision of decommissioning estimates. 
Finance costs - This relates to unwinding costs for local and overseas waste, OPAL spent fuel and OPAL decommissioning provisions.
Grant expenses - The $20,000 thousand has been reclassified to reflect the current year accounting treatment of EIF contributions from the DOFD.
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26 Prior year adjustments
26 Prior year adjustments (continued)
Correction of calculations in estimating the decommissioning cost in the previous financial years as follows:
`
Balance Sheet items: $’000
$’000
Decommissioning provisions
Reported 30 June 2009 119,374
329,53lasopsidetsawlacolrofnoisivorpgninoissimmoceD)1(
006,63OTSNAotgninruteretsawleveLwoLetaidemretnIotgnitalernoisivorpgninoissimmoceD)2(
460,6leuFtnepSLAPOotgnitalernoisivorpgninoissimmoceD)3(
)991,61(tsoCgninoissimmoceDtnempiuqe&tnalp,ytreporPLAPOotgnitalernoisivorpgninoissimmoceD)4(
Restated 30 June 2009 181,762
1 July 2009 181,762
730,9lasopsidetsawlacolrofnoisivorpgninoissimmoceD)1(
436OTSNAotgninruteretsawleveLwoLetaidemretnIotgnitalernoisivorpgninoissimmoceD)2(
102,2leuFtnepSLAPOotgnitalernoisivorpgninoissimmoceD)3(
517,43tsoCgninoissimmoceDtnempiuqe&tnalp,ytreporPLAPOotgnitalernoisivorpgninoissimmoceD)4(
      (5) Amounts used (5,525)
      (6) Change in accounting estimate 41,950
      (7) Unwinding discount 4,743
Restated 30 June 2010 269,517
Contributed Equity
1 July 2009 447,856
      (1) EIF Funds reclassified from Revenue to Equity as approved by Department 
            of Finance and Deregulation. 20,000
30 June 2010 467,856
Retained Earnings
30 June 2009 45,775
      (1) Decommissioning provision for local waste disposal (35,923)
      (2) Decommissioning provision relating to Intermediate Low Level waste returning to ANSTO (36,600)
      (3) Decommissioning provision relating to OPAL Spent Fuel (6,064)
      (4) Decommissioning provision relating to OPAL Property, plant & equipment Decommissioning Cost (361)
Restated 30 June 2009 (33,173)
Opening Retained Earnings - 1 July 2009 (33,173)
      Reported 2010 Profit 8,239
      Less: Prior year adjustments
730,9lasopsidetsawlacolrofnoisivorpgninoissimmoceD)1(
436OTSNAotgninruteretsawleveLwoLetaidemretnIotgnitalernoisivorpgninoissimmoceD)2(
102,2leuFtnepSLAPOotgnitalernoisivorpgninoissimmoceD)3(
901tsoCgninoissimmoceDtnempiuqe&tnalp,ytreporPLAPOotgnitalernoisivorpgninoissimmoceD)4(
      (5) EIF Funds reclassified from Revenue to Equity as approved by Department 
            of Finance and Deregulation. 20,000
       Total prior year adjustments 31,981
      Restated 2010 Loss (23,742)
      Transfer between equity components (1,489)
Closing Retained Earnings - 30 June 2010 (58,404)
Total Reserves
Reported 30 June 2009 291,119
065,61tsoCgninoissimmoceDEPPLAPOotgnitalernoisivorpgninoissimmoceD)1(
Restated 30 June 2009 307,679
1 July 2009 307,679
      (1) Revaluation Adjustment in 2010 68,791
      (2) Transfer (to)/from retained earnings 1,494
)606,43(tsoCgninoissimmoceDEPPLAPOotgnitalernoisivorpgninoissimmoceD)3(
Restated 30 June 2010 343,358
Profit or Loss
       The adjustment also had the effect of overstating consolidated profit after income tax by $31,981 thousand 
       for the year ended 30 June 2010 as follows: 
      (1) Suppliers expenses 2,862
      (2) Finance costs 9,119
      (3) Grant expenses 20,000
       Total prior year adjustments 31,981
Supplier expenses - Adjustment related to the costs associated with the revision of decommissioning estimates. 
Finance costs - This relates to unwinding costs for local and overseas waste, OPAL spent fuel and OPAL decommissioning provisions.
Grant expenses - The $20,000 thousand has been reclassified to reflect the current year accounting treatment of EIF contributions from the DOFD.
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Governance and performance
Compliance 
ANSTO is subject to the provisions 
of various Commonwealth Acts and 
Regulations made under these various 
Acts and Commonwealth Awards. 
The principal Act is the Australian Nuclear 
Science and Technology Organisation  
Act 1987. 
The principal Award is the Australian 
Nuclear Science and Technology 
Organisation (General) Award 1990. 
Amendments to governance parts of 
the ANSTO Act 
There were no changes to the governance 
part of the ANSTO Act during 2010-2011 
reporting period. 
Nuclear liability
The Minister executed a new Deed of 
Indemnity on 27 August 2008 for a period 
of ten-years. The Indemnity commits the 
Government to meeting any damages 
awarded against ANSTO, its employees 
and its contractors for damage caused by 
ionising radiation whilst providing comfort 
to the local community and to ANSTO’s 
suppliers, who cannot be covered by 
ANSTO’s normal insurance arrangements 
and are not accustomed to being exposed 
to risks of this nature. Any claim would 
first attach to the general $50 million 
cover that ANSTO has with Comcover to 
the extent that it was insured under that 
policy, with the remainder covered by this 
indemnity agreement.
The functions of the Board 
A Board established under Section 8  
of the Australian Nuclear Science and 
Technology Organisation Act 1987  
governs ANSTO. The general functions  
of the Board, as set out in Section 10 of 
the ANSTO Act, are to ensure the proper 
and efficient performance of the  
functions of the organisation and to 
determine the policy of the organisation 
with respect to any matter, having  
regard to the current policies of the 
Commonwealth Government. 
In particular, it has responsibility for: 
•  approval of organisational strategy and 
the annual business plan and budget 
•  monitoring financial performance 
•  monitoring managerial performance 
•  ensuring that the significant risks facing 
the organisation have been identified, 
and that appropriate control, monitoring 
and reporting mechanisms are in place. 
The Commonwealth Authorities and 
Companies Act (CAC Act) requires the 
Board to comply with certain accountability 
and corporate governance principles, 
including: 
•  the maintenance of an Audit Committee 
•  specific financial and reporting provisions 
•  disclosure of all Board members’ 
personal interests 
•  provision of indemnities and indemnity 
insurance in certain circumstances. 
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All CAC Act requirements are currently 
being met. 
Processes are in place for performance 
assessment of both the Board as a whole 
and of the individual members. 
The Board has established an Audit & 
Risk Committee and a Remuneration 
Committee. All matters considered by 
those Committees are submitted to 
the Board for information and, where 
appropriate, for ratification.
Board Charter 
ANSTO has an established Board Charter, 
setting out the respective rights and 
responsibilities, functions and powers of 
Board members and ANSTO executives. 
It is made available internally on ANSTO’s 
intranet and it is proposed to publish the 
Board Charters on ANSTO’s website in line 
with current best practice.
Board membership 
During the 2010-2011 financial year, the 
Board comprised eight non-executive 
members, drawn from the broader 
community, who are not involved in the 
day-to-day running of the organisation, and 
the Chief Executive Officer.
The ANSTO Act provides that the Chief 
Executive Officer shall manage the 
affairs of the organisation, subject to the 
directions of, and in accordance with, 
policies determined by the Board. Senior 
management attend Board meetings as 
required to report on matters relevant to 
their individual areas of responsibility. 
Each Board member brings 
complementary skills and experience to 
the Board. Its members during the  
2010-2011 financial year had experience 
in areas that included industry, information 
and communication technology, mining, 
scientific research, medicine and the 
commercialisation of research. 
The Board meets regularly in accordance 
with a formally approved timetable  
and agenda.
Seven Board meetings were held during 
the 2010-2011 financial year. Details of 
the number of Board meetings attended 
by each member during the period in 
which each member held office during the 
financial year are shown on page 89. 
Board remuneration and allowances 
The remuneration and allowances of 
members of the Board, including the Chief 
Executive Officer, are determined by the 
Remuneration Tribunal. Remuneration of 
members of the Board is disclosed in the 
Financial Statements. 
Disclosure of interests of Board 
Members 
Sections 27F-27K of the CAC Act 
provides for the disclosure of material 
personal interests in a matter that is being 
considered by the Board, and prohibits 
participation, deliberation and decision 
making by any member on such matters. 
All these requirements were met during 
the year. 
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Board member access to 
independent professional advice 
The Board has established procedures by 
which members, in the interests of their 
duties, may seek independent professional 
advice at ANSTO’s expense. In brief, 
members must first seek permission from 
the ANSTO Chairman. 
Report of operations 
Section 9 and Schedule 1 of the CAC Act 
requires that the Organisation’s Annual 
Report include a report of operations, 
financial statements and the Auditor 
General’s report on those financial 
statements. The Commonwealth 
Authorities and Companies (Report of 
Operations) Orders 2005 set out the 
requirements for such a report.
The Board reports that: 
•  ANSTO’s mission and strategic directions 
are being actioned 
•  Actual performance is reported against 
approved performance indicators 
•  There have been no significant changes 
in ANSTO’s state of affairs or principal 
activities during the year 
•  ANSTO has continued to manage both 
the risks and opportunities it faces.
Meetings – Board 
Member Eligible to attend Attended
Professor Paul Greenfield AO  
(Chair from 24 February 2011)
7 7
Dr Zygmunt Switkowski  
(Chair to 31 December 2010)
4 4
Professor David Copolov, OAM 7 6
Professor John Hearn 7 5
Ms Christine McLoughlin 7 7
Dr Susan Pond, AM 7 7
Mr John Ryan, PSM 2 2
Ms Erica Smyth 7 7
Professor Andrew M Scott 7 6
Dr Adrian Paterson  
(Chief Executive Officer) 
7 7
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The Board also reports that, in the opinion 
of senior management and the Board, at 
the time of making this report, adequate 
cash resources are, and will continue  
to be, available to cover ANSTO’s 
requirement for working capital, to pay 
existing debts, and meet obligations  
during the next financial year. 
The Board states that a risk oversight 
and management policy and supporting 
processes are in place to ensure both 
compliance with this policy and ongoing 
continuous improvement. 
Health, safety and environmental 
protection 
The Board places primary importance 
on the safe performance of all ANSTO 
activities. The monitoring of health, 
safety and environmental protection in 
general and compliance with relevant 
legislation in particular, is designated as a 
responsibility of the whole Board. During 
2010-2011, ANSTO continued to focus 
on improving the organisational safety 
culture and on initiatives relating to key 
elements underpinning a good safety 
culture. Improvements were made to the 
event reporting system which has seen 
a significant improvement in the data, 
particularly from the “near-hit” events. 
This, coupled with a CEO directed focus 
on appropriate and timely investigation of 
all reported events has driven continuous 
improvement in safety performance, 
as evidenced in a significant reduction 
in worker injuries. Contractor safety 
management has also remained a key area 
of focus for the organisation, with the aim 
of integrating ANSTO’s contract partners 
into its safety culture and encouraging 
contractors to support ANSTO as a learning 
organisation by sharing elements of best 
safety practice. Increased compliance 
and governance was also initiated with 
the introduction of the Building Owner 
and Building Manager roles, whereby 
responsibility for safety management 
within a building, and including ancillary 
services and surrounding areas, was given 
to appointed Building Managers. 
Audit & Risk Committee 
The Audit & Risk Committee, a formal sub-
committee of the Board, was comprised 
during the year of Ms C McLoughlin 
(Chair), Professor P Greenfield AO, (1 July 
2010 - 23 February 2011), Professor AM 
Scott, Professor D Copolov, Professor 
J Hearn, Ms E Smyth, Dr S Pond AM, 
Mr J Ryan PSM and a member external 
to ANSTO, Mr W Wilton. Mr Wilton is a 
Chartered Accountant. The Chair of the 
ANSTO Board, the Chief Executive Officer, 
the Chief Financial Officer, representatives 
of the Australian National Audit Office, 
Deloitte representatives who are under 
contract by the Australian National Audit 
Office and the Chief Internal Auditor 
attended all meetings or relevant parts of 
all meetings by invitation. Others attend 
meetings, as appropriate, at the invitation 
of the Committee.
In accordance with good practice, all Board 
members receive copies of Audit & Risk 
Committee papers and meeting minutes, 
and can attend Committee meetings as 
a right. This Committee was established 
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by the Board under a formal written 
Charter to oversee the organisation’s 
risk management policies, practices 
and controls in relation to financial and 
commercial activities, including the 
financial reporting process, legislative 
and regulatory conformance, corporate 
governance and asset protection. 
Its Charter extends to the review of 
safety and environmental systems and 
performance. Additionally in accordance 
with the provisions of the CAC Act, the 
Committee is responsible for assisting 
Board members to fulfil their specific 
responsibilities under that Act. The 
Committee has unlimited access to both 
the internal and external auditors and to 
senior management. 
The Committee scrutinises the annual 
financial statements of ANSTO and 
considers the appropriateness of 
accounting practices reflected therein. It 
receives a signed recommendation from 
the Chief Executive Officer, and the Chief 
Financial Officer, as to the veracity of the 
financial statements signed by the Board. 
Five Audit & Risk Committee meetings 
were held during the financial year. Details 
of the number of Committee meetings 
held and attended during the period in 
which each member held office during the 
financial year are provided in the  
table above. 
The Committee generally meets quarterly. 
The remuneration and allowances of Board 
members who are members of the Audit 
& Risk Committee are determined by the 
Remuneration Tribunal. The remuneration 
of the External Representative is 
determined by the Board on appointment. 
Meetings – Audit & Risk Committee 
Member Eligible to attend Attended
Ms Christine McLoughlin 5 5
Professor David Copolov OAM 5 4
Professor John Hearn 5 3
Dr Susan Pond AM 5 5
Mr John Ryan PSM 1 1
Professor Andrew M Scott 5 5
Ms Erica Smyth 5 5
Mr Warren Wilton  
(External Representative)
5 5
Professor Paul Greenfield AO 4 4
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Remuneration Committee 
The Remuneration Committee, a formal 
subcommittee of the Board, comprised 
during the year Ziggy Switkowski (Chair 
to 31 December 2010), Professor Paul 
Greenfield (Chair from 1 January 2011 and 
John Ryan. The Chief Executive Officer 
attends all meetings or relevant parts of 
all meetings by invitation. Others attend 
meetings, as appropriate, at the invitation 
of the Committee. 
This Committee was established by the 
Board under a formal written Charter to 
oversee: 
•  The overall remuneration policy and 
strategy for the organisation 
•  The performance and remuneration 
policies for the Chief Executive Officer 
•  The compliance of remuneration 
policies and practices with statutory and 
regulatory requirements. 
Induction and continuing 
professional development of  
ANSTO executives
Processes are in place for induction and 
ongoing education to inform executives 
of their responsibilities and rights. New 
executives have access to appropriate 
induction documents and processes 
(including those relating to safety and 
security) and to ANSTO officers. 
Risk management 
The Board is responsible for the 
governance of risk through formal 
processes, which include the development 
and implementation of a policy and plan 
for a systematic and disciplined approach 
to evaluate and improve the effectiveness 
of risk management, as well as the 
related internal control, compliance and 
governance processes. Management is 
accountable to the Board for designing, 
implementing and monitoring the system 
and process of risk management and 
integrating it into the day-to-day activities 
of the organisation. During the financial 
year, the CEO appointed a suitably skilled 
and experienced Senior Manager to assist 
management with the execution of their 
risk management responsibility.
The Board recognises that developing 
and implementing ANSTO’s strategies 
requires careful consideration and 
balancing of both risk and opportunity. 
 Meetings – Remuneration Committee 
Member Eligible to attend Attended
Professor Paul Greenfield AO  
(Chair from 1 January 2011)
1 1
Dr Zygmunt Switkowski  
(Chair to 31 December 2010)
1 1
Mr John Ryan PSM  
(Member from 9 June 2011)
0 0
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In this regard, the Board ensures that 
it understands the implications of risks 
taken by management, as well as the 
potential impact of risk-taking on ANSTO’s 
stakeholders.
The Board regularly receives and reviews a 
register of ANSTO’s key risks and ensures 
that particular attention is focussed 
on those risks that may negatively 
impact the sustainability and reputation 
of the organisation. The Board also 
receives regular assurance regarding the 
implementation of the risk management 
plan and the risk management maturity  
of ANSTO.
Ethical standards 
ANSTO’s ethics policy is set out in a 
document entitled Code of Ethics. The 
Code provides a reference point for ethical 
behaviour and applies to members of the 
Board, management and all staff. The 
Code sets out the standards for ethical 
behaviour and conduct and provides 
guidance by defining the expected values 
and standards of workplace behaviour and 
performance. 
Fraud control 
The organisation has an established fraud 
control policy and plan, in line with the 
Fraud Control Policy of the Commonwealth 
and guidelines set out by the Attorney 
General’s Department, Criminal Justice 
Division. 
External audit 
Under Section 8 of the CAC Act the 
Commonwealth Auditor-General, through 
the Australian National Audit Office 
(ANAO), is the external auditor for ANSTO. 
The ANAO, as a matter of policy, provides 
only audit services to ANSTO. 
The Audit & Risk Committee reviews 
the ANAO audit plan and reports and 
meets with ANAO representatives prior 
to recommending to the Board that the 
annual financial statements be accepted 
and the Statement by Directors signed. 
Internal audit 
The ANSTO Internal Audit function has 
a dual reporting line to the Audit & Risk 
Committee and the Chief Executive 
Officer. Its responsibility is to provide an 
independent, risk-based review function, 
as set out in a formal Charter periodically 
reviewed by the Audit & Risk Committee 
and endorsed by the Board. The Audit 
& Risk Committee approves the annual 
Internal Audit plan and receives regular 
reports on progress against that plan. 
Internal control 
The Board is responsible for ensuring that 
appropriate policies and internal controls 
are in place and operating. 
Compliance and review are monitored 
through the Audit & Risk Committee and 
the Internal Audit function. 
Service Charter 
ANSTO’s Service Charter sets out a 
statement of what ANSTO does and  
the standards of product and service  
that customers, stakeholders and the 
community can expect from the 
organisation. 
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Judicial decisions and reviews by 
outside bodies 
There were no judicial decisions or 
decisions of administrative tribunals that 
had a significant impact on the operations 
of ANSTO during the reporting year. 
There were no specific reports issued  
by the Commonwealth Auditor-General, 
other than that issued in relation to the 
2010-2011 financial statements. 
There were no reports on the operations 
of ANSTO by a Parliamentary Committee 
or the Commonwealth Ombudsman during 
the reporting year.
The Minister for Innovation, Industry, 
Science & Research established a 
review into the current health and safety 
arrangements at ANSTO Health on 9 
February 2011. The review panel reported 
back to the Minister on 26 May 2011. 
The review made 14 recommendations 
relating to ANSTO Health (ANSTO’s 
radiopharmaceutical production division) 
and three recommendations to the 
external regulator, ARPANSA, and the 
remaining recommendation to the 
ANSTO Board. The Board has initiated 
a review of the recommendations and 
responded to the Minister. The Board will 
continue to monitor compliance with the 
recommendations.
During the year, Comcare also completed 
an investigation into a safety incident 
at ANSTO Health and alleged adverse 
action against a staff member for raising 
a safety complaint. Comcare provided its 
report in December 2010, without firstly 
seeking ANSTO’s input as to its accuracy. 
ANSTO challenged the findings of that 
investigation mainly on the grounds of 
denial of procedural fairness and wrong 
factual findings. Comcare subsequently 
undertook a review to assist its decision 
maker in determining whether a fresh 
investigation should occur. While Comcare 
did not agree that procedural fairness 
had been denied to ANSTO, the review 
panel accepted that the staff member 
had not been detrimentally affected 
for raising a safety allegation and that 
the initial investigation did have some 
flaws. ANSTO is currently working 
through and or responding to Comcare’s 
recommendations. 
The ANSTO Board initiated a review of 
the operations at ANSTO Health to be 
undertaken by a consultancy group with 
specific expertise in the nuclear and 
medical devices industry. In addition to a 
desk top review of processes, a site visit 
was completed in May. The output and 
recommendations from the review will be 
used to inform and direct the continuous 
improvement approach within the 
organisation.
Ministerial directions 
There were no ministerial directions to 
ANSTO made under either the ANSTO Act 
or the CAC Act during the reporting year.
Indemnities and insurance 
premiums for officers 
ANSTO’s insurance coverage includes 
professional indemnity and directors’ 
and officers’ liability. Certain sections of 
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the CAC Act contain prohibitions against 
ANSTO giving indemnities and paying 
insurance premiums relating to liabilities 
arising from conduct involving a lack of 
good faith by officers. There have been 
no exceptions to these provisions and 
no claims were made against ANSTO in 
respect of such liability that required a 
claim on ANSTO’s insurer, Comcover. 
Business continuity planning 
Continuity of ANSTO business is a 
critical issue that has been considered 
and planned for by the Board, the Chief 
Executive Officer and senior management. 
Many services delivered by ANSTO are 
critical to the economic and social well-
being of our society. A failure to deliver 
these could have significant consequences 
for those concerned. As a consequence, 
ANSTO regularly reviews all aspects of its 
business continuity management plans 
to ensure a constant state of readiness, 
including ANSTO’s response to any 
incident that may eventuate at the OPAL 
research reactor. A test schedule is in 
place and is being monitored, additionally 
plans are scheduled to be reviewed and 
updated annually. 
Following the Fukushima Daiichi accident, 
the Board requested a detailed review of 
the OPAL research reactor’s safety case 
to ensure that health and safety risks 
are contained to a level that is as low 
as reasonably practical and that ANSTO 
will be able to respond effectively to any 
incident that may eventuate at the reactor. 
This review confirmed the robustness of 
the OPAL reactor’s safety case. 
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 2009-2010 2010-2011 2009-2010 2010-2011 2009-2010 2010-2011
Female 291 358 28% 30% $69,499 $71,976
Male 757 868 72% 70% $84,486 $88,163
 2009-2010 2010-2011 2009-2010 2010-2011 2009-2010 2010-2011
People with disabilities 11 14 1.05% 1% $88,264 $77,496
Aboriginal & Torres  9 11 0.9% 1% $74,404 $74,495 
Straight Islander
Non-English speaking  273 329 26.05% 27% $83,690 $88,076 
background
Objectives
1. To ensure that Equal Employment 
Opportunity (EEO) principles and 
practices are actively incorporated into 
all people management practices.
2. To ensure that the structures and 
processes used to implement EEO 
adjust to changing employment needs.
3. To confirm and communicate the vision 
that ANSTO’s employment activities 
reflect ANSTO’s values. ANSTO actively 
seeks to implement EEO and diversity 
principles in its management practices. 
Human resource processes operate 
within the ISO 9001 framework.
Family services and Childcare Centre
The Corporate Family Program is a 
partnership between ANSTO and Expect A 
Star Education Services to provide a range 
of family services, including parenting 
seminars; a range of qualified, background 
checked, and First Aid-trained nannies, 
babysitters and emergency care workers; 
and the purchase of educational resources.
ANSTO has entered into a partnership with 
Sutherland Shire Council for Vacation Care 
for ANSTO employees and contractors at 
their Lucas Heights venue during school 
holidays. 
Tendering is underway for the design of 
the ANSTO Childcare Centre, and to select 
a not-for-profit operator. Construction is 
expected to start in December 2011 with 
completion scheduled for August 2012.
Equality of employment opportunity
 Number employed % of total staff  Average salary
 Number employed % of total staff  Average salary
Equality of Employment
Opportunity
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This appendix describes the functions and powers of the organisation under the 
Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act), which  
is ANSTO’s enabling legislation. In the text below, ‘Organisation’ means the Australian 
Nuclear Science and Technology Organisation.
Section 5: Functions of the Organisation
(1) The functions of the Organisation are:
 (a) to undertake research and development in relation to:
  (i)  nuclear science and nuclear technology; and
   (ia) the application and use of nuclear science and nuclear technology; and
  (ii)  the production and use of radioisotopes, and the use of isotopic  
   techniques and nuclear radiation, for medicine, science, industry, 
   commerce and agriculture; and
  (iii) such other matters as the Minister directs; and
 (b)  to encourage and facilitate the application and use of the results of such 
  research and development; and
 (ba) to condition, manage and store radioactive materials and radioactive waste, 
  arising from:
  (i) the Organisation’s activities (including the production of radioactive 
   materials for other persons); or
  (ii)  the activities of companies in which the Organisation holds a controlling  
   interest (including the production of radioactive materials for other  
   persons); or
  (iii)  the use by other persons of radioactive materials produced by the 
   Organisation or such companies; or
  (iv)  the activities of other persons who are specified in the regulations; and
 (bb) to condition, manage and store radioactive materials and radioactive waste  
  generated, possessed or controlled by the Commonwealth or a Commonwealth  
  entity; and
 (bc) to condition, manage and store radioactive materials and radioactive waste at  
  the request of:
  (i) a law enforcement agency; or
  
Functions and powers
of the Organisation 
under the ANSTO Act
99  l  Australian Nuclear Science and Technology Organisation
  (ii)  a Commonwealth, State or Territory agency responsible for the 
   management of emergencies or disasters; including, but not limited to,   
   radioactive materials or radioactive waste involved in, or arising out of, a   
   radiological incident or a radiological emergency; and
 (bd) to condition, manage and store radioactive waste that has been, or is to be, 
  sent to Australia under contractual arrangements relating to the conditioning or   
  reprocessing of ANSTO spent nuclear fuel; and
 (c)  to produce, acquire, provide and sell goods, and to provide services, that are:
  (i)  in connection with the production and use of radioisotopes, and the use of  
   isotopic techniques and nuclear radiation, for medicine, science, industry,  
   commerce and agriculture; or
   (ia)  in connection with the conditioning, management and storage of  
    radioactive materials or radioactive waste; or
   (ib)  in connection with nuclear science and nuclear technology; or
   (ic)  in connection with the application and use of nuclear science and  
    nuclear technology; or
  (ii)  otherwise in connection with matters related to its activities; and
 (d)  to act as a means of liaison between Australia and other countries in matters  
  related to its activities; and
 (e)  to provide advice on aspects of:
  (i)  nuclear science and nuclear technology; and
  (ii)  the application and use of nuclear science and nuclear technology; and
  (iii)  other matters related to its activities; and
 (ea)  to make available to other persons, on a commercial basis, the knowledge,  
  expertise, equipment, facilities, resources and property of the Organisation by:
  (i)  providing training and management expertise; or
  (ii)  selling or leasing equipment; or
  (iii)  leasing land, buildings and facilities; or
  (iv)  taking any other action that the Organisation thinks appropriate; and
 (f)  to cooperate with appropriate authorities of the Commonwealth, the States and  
  the Territories, and with other organisations and institutions in Australia or   
  elsewhere, in matters related to its activities; and
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 (g)  to publish scientific and technical reports, periodicals and papers on matters  
  related to its activities; and
 (h)  to collect and sell or distribute, as appropriate, information and advice on   
  matters related to its activities; and
 (j)  to arrange for training, and the establishment and award of scientific research  
  studentships and fellowships, in matters related to its activities; and
 (k)  to make grants in aid of research into matters related to its activities; and
 (m)  to make arrangements with universities and other educational research  
  institutions, professional bodies and other persons for the conduct of  
  research or of other activities in matters related to its activities.
(1A) A regulation made for the purposes of subparagraph (1)(ba)(iv) must not have the  
 effect of authorising the premises on which the Lucas Heights Research    
 Laboratories are situated to become a national nuclear waste repository.
(1B) In subsection (1A):
 national nuclear waste repository means a site chosen by the Commonwealth,  
 after the commencement of this subsection, for the storage of nuclear waste with  
 a view to it never being moved to another site.
(1C) Without limiting paragraph 5(1)(bb):
 (a)  radioactive materials and radioactive waste generated by a Commonwealth  
  contractor under a contract between the Commonwealth contractor and the  
  Commonwealth or a Commonwealth entity are taken to be generated by the  
  Commonwealth or the Commonwealth entity, as the case requires; and
 (b)  radioactive materials and radioactive waste possessed or controlled by a  
  Commonwealth contractor under a contract between the Commonwealth  
  contractor and the Commonwealth or a Commonwealth entity are taken to be  
  possessed or controlled by the Commonwealth or the Commonwealth entity,  
  as the case requires.
(2) The Organisation shall not undertake research or development into the design or  
 production of nuclear weapons or other nuclear explosive devices.
(3)  In undertaking its functions, the Organisation is to have regard to:
 (a)  the Commonwealth Government’s national science, technology and energy  
  policy objectives; and
 (b)  the Commonwealth Government’s commercialisation objectives for public  
  research institutions.
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(4)  The Minister shall not give a direction under subparagraph (1)(a)(iii) to the  
 Organisation to undertake research or development in relation to a matter unless  
 the Minister is satisfied that research or development by the Organisation in relation  
 to that matter would be an effective use of the staff of the Organisation, and would  
 not duplicate unnecessarily any activity being carried on, or proposed to be carried  
 on, by any other agency or authority of the Commonwealth.
(5)  The Organisation may perform its functions to the extent only that they are not in  
 excess of the functions that may be conferred on it by virtue of any of the legislative  
 powers of the Parliament, and, in particular, may perform its functions:
 (a)  in so far as it is appropriate for those functions to be performed by the  
  Organisation on behalf of the Government of the Commonwealth as the  
  national Government of Australia; and
 (b)  for purposes for which it is appropriate for the Parliament as the national  
  Parliament of Australia to authorise the Organisation to perform functions; and
 (c)  by way of expenditure of money that is available for the purposes of the  
  Organisation in accordance with an appropriation made by the Parliament; and
 (d)  in the course of, or in relation to, trade and commerce with other countries,   
  among the States, between Territories or between a Territory and a State; and
 (e)  for purposes related to external affairs; and
 (f)  for purposes in or in relation to a Territory; and
 (g) for purposes related to the defence of the Commonwealth.
Section 6: General powers of Organisation
(1)  Subject to this Act, the Organisation has power to do all things necessary or  
 convenient to be done for or in connection with the performance of its functions  
 and, in particular, has power:
 (a)  to enter into contracts;
 (b)  to acquire, hold and dispose of real or personal property;
 (c)  to occupy, use and control any land or building owned or held under lease by the 
  Commonwealth and made available for the purposes of the Organisation;
 (d)  to erect buildings and structures and carry out works;
 (e)  to form, or participate in the formation of, a company or partnership;
 (f)  to appoint agents and attorneys, and to act as an agent for other persons;
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 (g)  to engage persons to perform services for the Organisation;
 (h)  to design, produce, construct and operate equipment and facilities; and
 (j)  to do anything incidental to any of its powers.
(2)  The powers of the Organisation may be exercised within or outside Australia.
(3)  To avoid doubt, the Organisation has the power to construct buildings and facilities  
 for the sole purpose of performing the function referred to in paragraph 5(1)(ea).
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Environmental Protection
ANSTO is committed to operating in a 
manner that protects the environment and 
is consistent with Australian and 
international standards. Environmental 
awareness is promoted throughout the 
organisation which strives for continual 
improvement in environmental performance. 
Environmental management system
To provide assurance that ANSTO 
is maintaining sound environmental 
protection practices, we maintain an 
environmental management system 
(EMS) that is certified to the International 
Standard ISO 14001. This standard 
requires that environmental risks and 
legal requirements are understood and 
managed, an appropriate measurement 
and review system is in operation, and that 
there is an organisational commitment to 
continual improvement. 
In addition all parts of our environmental 
monitoring program operate within 
a quality system certified to the 
ISO 9001:2000 standard for Quality 
Management Systems. 
Environmental performance
Accurate measurements with 
independent verification
ANSTO conducts an extensive 
environmental monitoring program that 
measures radioactivity in authorised 
airborne emissions and liquid effluent 
discharges to the sewer, and in samples of 
air, surface water, ground water, sediment 
and biota from the local environment.
General environmental radiation and local 
weather conditions are measured and 
reported online via the ANSTO webpage. 
Many of the monitoring results are 
independently verified. Environmental 
monitoring in 2010-2011 confirmed 
that ANSTO’s authorised releases of 
radioactive material to the air and sewer 
had minimal impact on the environment, 
and that the modern OPAL reactor has 
significantly reduced the contribution 
made by ANSTO’s research reactor to the 
already tiny potential public dose from 
liquid and airborne emissions. 
Emissions to air
Computer modelling is used to estimate 
the potential radiation doses to people at 
various distances from the Lucas Heights 
site. The measured stack discharges and 
concurrent weather data are inputs to the 
model, which incorporates conservative 
assumptions about environmental 
pathways and food consumption. The 
maximum public dose estimated for 
ANSTO’s airborne emissions in 2010-
2011 was 0.0022 mSv. This is 0.2 per 
cent of the annual public dose limit of 
1.0 mSv established by ARPANSA, and 
continues the low dose pattern for the 
previous decade. Doses from ANSTO’s 
airborne emissions in 2010-2011 remain at 
historical levels despite increased medical 
isotope production (see graph on following 
page). Note that 2007-2008 saw the shut 
down of major facilities including the 
medical isotope production facility and the 
HIFAR research reactor. 
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Annual dose to the general public from 
various sources compared to maximum 
potential dose due to ANSTO airborne 
emissions in 2010-11. 
Liquid effluent discharges  
within limits
Effluent discharged from ANSTO into 
the sewer complied with all limits for 
radioactive discharges, in accordance with 
the Trade Waste Agreement with Sydney 
Water. Compliance with these limits 
ensures that water at the Cronulla sewage 
treatment plant meets World Health 
Organization drinking water standards 
for radioactivity. Concentration limits for 
nonradioactive materials such as ammonia, 
zinc and total dissolved solids were also 
met. Sydney Water conducts independent 
testing of liquid effluent discharges to 
sewer and the Trade Waste Agreement is 
periodically reviewed to provide assurance 
that ANSTO’s discharges remain within 
authorised limits and pose no threat to the 
environment. Effluent from the Sutherland 
Shire undergoes tertiary treatment at the 
2008-2009 2009-2010 2010-20112007-20082006-2007
2008-2009 2009-2010 2010-2011
0.0022
2007-20082006-20072005-20062004-20052003-20042002-2003
~0.8 mSv from 
medical diagnostics
ANSTO 0.0022 mSv 
~1.5 mSv from 
natural background
2008-2009 2009-2010 2010-20112007-20082006-2007
2008-2009 2009-2010 2010-2011
0.0022
2007-20082006-20072005-20062004-20052003-20042002-2003
~0.8 mSv from 
medical diagnostics
ANSTO 0.0022 mSv 
~1.5 mSv from 
natural background
Maximum annual effective dose from LHSTC airborne discharges at the 1.6 km boundary 
of ANSTO’s buffer zone, 1999 to 2011
For our closest neighbours, ANSTO’s 
activities added less than 0.2 per cent to 
the 1.5 mSv dose that every Australian 
receives from natural background radiation 
each year, as shown in the chart below.
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Cronulla sewage treatment plant and 
is ultimately discharged to the ocean 
at Potter Point. Studies carried out for 
marine biota in the receiving environment 
at Potter Point have confirmed that the 
radiological risk to humans and marine  
life from ANSTO’s liquid effluent 
discharges is negligible. 
Good water quality
Stormwater runoff does not contribute 
to any public water supply, however 
ANSTO regularly monitors stormwater 
leaving the site, as well as sampling the 
nearby Woronora River. Results show 
that concentrations of tritiated water in 
the environment have decreased since 
the HIFAR reactor closed in January 2007, 
and are well below the level considered 
safe for Australian drinking water. Gross 
alpha and beta measurements were also 
below the levels required for surface 
waters under the NSW Protection of the 
Environment Operations Act 1997. In fact, 
most measurements were below the 
stricter levels of the Australian Drinking 
Water Guidelines. Groundwater from the 
Lucas Heights site contained only low 
levels of tritium and naturally-occurring 
radionuclides.
Detailed reporting
The results and findings from our 
environmental monitoring program are 
available to the public in the annual 
report series Environmental and Effluent 
Monitoring at ANSTO Sites, available on 
the ANSTO website.
ANSTO also reports annually to the 
Department of Environment and Heritage 
about any of its activities that fall under 
the National Environmental Protection 
Measures. Overall, ANSTO commits 
significant resources to effectively monitor, 
manage and report on its environmental 
impacts and responsibilities. 
Ecologically sustainable 
development (ESD)
ANSTO’s commitment to environmental 
protection and sustainability principles is 
defined in strategic plans which inform 
its social, economic and environmental 
core values. These priorities are integral 
to ANSTO’s Business Management 
System – the framework that defines how 
business is conducted to deliver outcomes 
to our customers and stakeholders in 
a safe, consistent and environmentally 
responsible manner. Targets and objectives 
for protecting human health, safeguarding 
our operations and minimising our 
environmental footprint flow down from 
these overarching documents.
ANSTO activities that contribute to ESD 
include our research into significant 
environmental issues such as dry land 
salinity, groundwater movement, human 
impacts on climate and purification of 
waste water. This research enhances 
scientific knowledge and improves 
environmental outcomes.
ANSTO’s active support of nuclear non-
proliferation ideals and the development 
of nuclear safeguards through its 
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collaborative research with bodies such  
as the International Atomic Energy  
Agency and the Comprehensive Test  
Ban Treaty Organisation, also accords  
with ESD principles.
Finally, ANSTO’s commitment to 
sound environmental management and 
ecologically sustainable development 
means that special emphasis is placed 
on reducing the environmental footprint 
by minimising waste production and the 
consumption of resources such as paper, 
electricity and water, and by recycling 
consumables. It also ensures that we 
manage our past and current waste in a 
manner that protects human health and 
the environment, now and in the future.
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Safety arrangements
ANSTO is committed to ensuring 
a safe and healthy environment for 
employees, visitors, contractors and the 
external community. ANSTO strives, 
through a process of continuous 
improvement, to fully integrate health, 
safety and environment into all aspects 
of its activities. All ANSTO activities are 
governed by a ‘safety first’ philosophy that 
means work is planned and will only be 
performed if it is judged to be safe.
Safety and environmental principles, 
values and commitments are set out in the 
ANSTO Health, Safety and Environment 
Policy which is supported by a framework 
of documents that constitutes our safety 
management system. Key elements of the 
safety system are:
• documented requirements and guidance
•  formal review and approval of potentially 
hazardous work
•  auditing and evaluation of safety 
performance
•  communication of safety issues and 
performance to employees, contractors 
and the community.
ANSTO fosters a cooperative, consultative 
relationship with employees and 
contractors regarding health, safety and 
welfare by having established:
• Occupational, health, safety and 
environmental management 
arrangements (OHSEMA)
•  designated work groups (DWGs)
•  health and safety representatives (HSRs)
•  health and safety committees (HSCs).
Accidents and incidents
An important part of ANSTO’s safety 
management system is the capturing of 
information on all safety-related events 
including accidents and ‘near hits’. This 
ensures the proper investigation of all 
such events and the implementation of 
safety improvements. It also gives us data 
to drive improvements in ANSTO’s safety 
performance.
One key indicator of safety performance is 
the number of near hit events reported. An 
emphasis on the reporting of near hits is 
an essential component of a robust safety 
culture and key driver for continuous 
safety improvement. 2010-2011 saw 
a focus on increased event reporting, 
focussed investigation and completion of 
arising actions; resulting in a 63 per cent 
increase in the number of near hit events 
reported with a consequential reduction in 
Lost Shift injuries of 65 per cent.  
ANSTO also works with its regulators to 
improve Occupational Health & Safety 
(OHS) across site. In 2010-2011 ANSTO 
informed Comcare of 26 notifiable 
incidents. One of these was a Serious 
Personal Injury, 23 were Dangerous 
Occurrences and two were Incapacities 
resulting in more than 30 days off work.
Safety Initiatives
The following initiatives contributed to 
ANSTO’s commitment to the health 
and safety of employees, visitors and 
contractors.
• Contractor Management Monitor and 
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Review – ongoing improvements to the 
management of contractors on site.
• Event Management – Introduction of an 
online notification system; introduction 
of an event rating process; introduction 
of an action management application. 
• Legacy Issue Management – review of 
the Asbestos Management Plan and 
register
• Rollout of the role of Building Manager 
- local delegates of the relevant Building 
Owner who are responsible for a 
specified building and are authorised 
to address any health, safety and 
environment concerns relating to 
personnel, equipment, processes and 
ancillary services associated with that 
building. 
• Emergency Management - a tabletop 
exercise of the ANSTO Pandemic 
Business Continuity Plan was 
conducted. The exercise identified 
that the plan was in line with current 
practices and advice given by health 
authorities and it considered all levels of 
a pandemic emergency. 
The following initiatives targeted the 
health and welfare of employees. 
• Men’s Health Program – onsite medical 
appointments targeting men’s health 
issues
• Women’s Health Program – onsite 
medical appointments targeting 
women’s health issues
• Bowel Screening – in line with the 
annual Rotary initiative, free screening 
kits were made available for all staff
• Flu Vaccination Program – free 
vaccinations available for employees and 
contractors.
Australian Radiation Protection and 
Nuclear Safety Regulations 1999, 
Statutory Rules 1999 No. 37 as 
amended.
Occupational Radiation Exposure
Everyone in the world is exposed to 
ionising radiation from natural sources. 
People may also be exposed to radiation 
from non-natural sources, including 
nuclear medical procedures for diagnosis 
and treatment of certain illnesses. 
Personal radiation exposure (‘dose’) is 
measured in sieverts (Sv), however, 
typical annual exposures are so small that 
they are usually expressed in units of 
one thousandth of a sievert, known as a 
millisievert (mSv).
According to the most recent data from 
ARPANSA, the average dose an Australian 
receives from natural background radiation 
(excluding medical sources) is 1.5 mSv 
per year. Federal and State regulations 
require that a member of the public should 
receive no more than 1 mSv per year from 
radiation sources other than background 
radiation and medical procedures. The 
regulatory limit for radiation workers is 20 
mSv per year, averaged over five years, 
with no more than 50 mSv in any one year. 
In 2010-2011 the average effective dose 
across all ANSTO workers was 0.4mSv.
This is derived from recommendations 
made by the International Commission 
on Radiation Protection (ICRP), who 
have specified three basic principles for 
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radiation protection, which are applied  
at ANSTO:
1  All exposures to ionising radiation  
shall have a positive net benefit
2  All exposures shall be maintained  
as low as reasonably achievable  
(ALARA), accounting for social and 
economic factors
3  All exposures shall be less than the 
relevant statutory limit.
The application of these principles, 
requires us to ensure that our occupational 
exposures are not just less than the 
statutory dose limit(s), but are as far below 
them as we can reasonably achieve. To 
this end ANSTO has imposed its own 
annual dose constraint of 15 mSv to any 
member of staff.
The radiation exposure of ANSTO’s 
workers who are routinely engaged 
in working with ionising radiation, is 
monitored by our specialist dosimetry 
service, with records of all exposures 
maintained. Monitoring results for 2010-
2011 show that the radiation doses 
received by ANSTO workers remain 
significantly below regulatory limits.
Table 1 shows the maximum, average and 
collective effective doses for the past five 
years. Collective effective dose is the total 
cumulative dose to an exposed group, in 
this case all ANSTO personnel registered 
with our radiation dosimetry service.
Table 2 shows the distribution of individual 
effective doses over the same period. The 
graph in Figure 1 compares maximum and 
average effective doses. Regulations give 
annual dose limits for radiation workers 
for the whole body (effective dose), for 
the skin (shallow dose) and for extremities 
such as hands or feet. 
 Maximum effective dose mSv  9.4  8.9  8.6  7.0 6.2
 Average effective dose mSv  0.6  0.6  0.6  0.4 0.4
 Collective effective dose person-mSv  545  531  542  399 425
  0 to < 2  926  914  907  890 989
  2 to < 5  41  36  37  28 23
  5 to < 10  13  13  12  8 7
  10 to < 15  0  0  0  0 0
  > 15  0  0  0  0 0
Table 1: Effective dose
Table 2: Distribution of individual effective dose
 2006-2007 2007-2008 2008-2009 2009-2010 2010-2011
  mSv 2006-2007 2007-2008 2008-2009 2009-2010 2010-2011
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The dose limits are:
•  whole body 20 mSv, averaged over  
five years
•  shallow (skin) 500 mSv 
•  extremities 500 mSv.
Emergency preparedness and 
responses
ANSTO and emergency services 
organisations jointly maintain a 24-hour 
emergency response capability to deal 
with incidents at ANSTO’s Southern 
Sydney campus. The Response Plan for 
Accidents and Incidents describes how an 
emergency response will be coordinated 
and identifies who is responsible for which 
actions. Each organisation has standing 
procedures detailing each individual 
response. NSW emergency services 
manage responses to emergencies with 
potential significant offsite radiological 
consequences at state level according 
to the Lucas Heights Emergency Sub 
Plan. There is also a district-level Lucas 
Heights Emergency Evacuation Sub Plan 
supporting these arrangements. In the 
event of an emergency, ANSTO staff 
would give technical assistance and 
practical support to emergency service 
organisations.
ANSTO maintains a close working 
relationship with emergency service 
organisations through the Local Liaison 
Working Party. The Working Party includes 
ANSTO specialists and representatives 
of emergency service organisations, local 
government, and support organisations, 
including NSW Health. ARPANSA is an 
observer.
An ongoing program of emergency training 
and evacuation drills is in place for all 
of site. Staff in each work area undergo 
training in the local emergency response 
protocols and are familiarised with the 
appropriate muster points. This training 
is supplemented with evacuation drills 
that are run with the respective Building 
Wardens. Specific radiological training is 
also provided to Fire and Rescue NSW 
members as part of their hazardous 
materials (HAZMAT) training.
2008-2009 2009-2010 2010-20112007-20082006-2007
2008-2009 2009-2010 2010-2011
0.0022
2007-20082006-20072005-20062004-20052003-20042002-2003
~0.8 mSv from 
medical diagnostics
ANSTO 0.0022 mSv 
~1.5 mSv from 
natural background
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Appendix 5
Freedom of information Act 1982, 
subsection 8(1)
The Freedom of Information Act 1982 (FOI 
Act) provides the public with a general right 
of access to documents held by Australian 
Government agencies, including ANSTO. 
This general right is limited by exceptions 
to protect essential public interests, 
including the privacy of individuals and 
the business affairs of those who give 
information to the agency.
The following information is provided in 
compliance with the previous section 8 
of the FOI Act (which ceased to be in 
effect as of 30 April 2011). Details of the 
functions of the organisation, membership 
of the Board and decision making powers 
of the Board and the Executive are 
provided on page 87, 88 and 98.
ANSTO has been preparing to implement 
the new proactive publication provisions 
under the current section 8 of the FOI Act, 
which came into force on 1 May 2011. 
ANSTO will comply with, and report on, 
the new requirements of section 8 in the 
next Annual Report.
Arrangements for external 
participation
Liaison groups
The Local Liaison Working Party 
(LLWP), established in 1967, comprises 
representatives from the NSW Police, 
Ambulance, Fire Brigades, Rural Fire 
Service, the NSW Department of 
Environment and Conservation, the NSW 
Department of Health, the Australian 
Federal Police, the Georges River District 
Emergency Management Officer, the State 
Emergency Management Committee, 
the State Emergency Service, Sutherland 
Shire Council and ANSTO, as well as an 
observer from ARPANSA. The LLWP is a 
communication forum for all parties which 
play a role in emergency preparedness and 
response at ANSTO’s Southern Sydney 
campus.
ANSTO state government 
arrangements
Given that ANSTO is located in New South 
Wales, it liaises with a range of NSW 
departments and authorities responsible 
for safety, environmental planning and 
related matters.
Associated organisations and other 
arrangements
AINSE  arranges access by staff and 
students of Australasian universities to the 
major facilities at ANSTO.
Less formal arrangements exist for 
promoting discussions, the exchange 
of views and/or collaboration with 
organisations outside the Commonwealth 
Government. These organisations include 
local government, standards bodies, 
professional societies, unions and staff 
associations, industrial groups and 
international nuclear agencies.
Categories of documents held
Computer software packages, computer 
printouts, technical books and reports, and 
International Nuclear Information System 
documents are available for purchase. 
Single copies of the annual report, Nuclear 
Matters (staff newsletter), strategic plans, 
ANSTO emergency plans, environmental 
monitoring reports, general information 
literature, videos and DVDs (under loan 
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arrangements) are appropriately available 
on request.
Documents relating to decision-making 
processes include Cabinet documents 
about matters in which ANSTO has an 
interest; ministerial correspondence 
and directions; ANSTO Board agenda, 
memoranda and decisions; deeds, 
legal contracts and formal agreements; 
minutes and submissions; employment, 
delegations, security, finance and 
accounting handbooks and manuals.
General correspondence includes: 
ministerial briefs; speeches; conference 
papers for national and international 
meetings; parliamentary questions and 
answers; cables, telexes and facsimiles; 
and general records files.
Technical documents held include: 
scientific and technical reports and 
laboratory notes comprising patents 
and inventions; computer media; plant 
and equipment operating manuals; 
maintenance, quality assurance and safety 
manuals; reactor operating authorisations, 
records and log books; radioisotope quality 
control procedures manuals; radioisotope 
catalogues and price lists; engineering 
service general records; nuclear material 
movement vouchers and accounting 
records; photographs; and radiographs.
Health and safety documents include: 
staff medical records; safety-related 
survey records; film badge and radiological 
records; accident reports; and emergency 
response procedures.
Administration documents held include: 
personnel records such as staff promotion 
files; ANSTO awards; organisation and 
establishment reports; compensation files; 
computer media with administrative
instructions and information storage; 
staff lists and classifications; mailing lists; 
visitor and contractor records; Freedom of 
Information requests; accounting records; 
pay-roll, flexitime and overtime records; 
tender and contract documents; building 
plans, specifications and instructions; 
directives; orders; memoranda; bulletins; 
notices; and information.
Other documents held include drawing 
office records such as plans, microfilm, 
drawings, maps and photographs.
Facilities for access
By arrangement, FOI inquirers can peruse 
information in the Visitors Centre at the 
entrance to ANSTO.
Information about ANSTO is also available 
on the internet through the organisation’s 
website at www.ansto.gov.au. ANSTO 
also has a free enquiry service for 
members of the public, which is outlined 
in the Community Right to Know Charter 
available at www.ansto.gov.au. Interested 
parties are encouraged to contact 
enquiries@ansto.gov.au for any further 
information.
Members of the public may also obtain 
access to scientific publications from 
ANSTO Publications Online at  
apo.ansto.gov.au
Contact
Direct enquiries to ANSTO, Locked Bag 
2001 Kirrawee DC NSW 2232, Australia or 
via email to foi@ansto.gov.au
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Appendix 6
Index of compliance with reporting guidelines under various Acts, Regulations and Orders 
applicable to ANSTO as a Commonwealth authority
ANSTO Act 1987 (As amended)
Functions and Powers  98-102
Commonwealth Authorities and Companies Orders (Financial statements for  
reporting periods ending on or after 30 June 2005) under the Commonwealth  
Authorities and Companies Act 1997 (As amended)
Financial statements and reports  40-85
Commonwealth Authorities and Companies (Report of Operations) Orders 2005 
under the Commonwealth Authorities and Companies Act 1997 (As amended)
Certification of report of operations  ii
Enabling legislation  87
Responsible minister  2
Board members 
  Names, qualifications, experience and special responsibilities, meeting attendance  3, 
 87-95
Organisational structure and location of major activities and facilities  1, 5-6
Review of operations for year and future prospects  16-39, 89-90
Judicial decisions and reviews by outside bodies  94
Statement on governance  87-95
Effects of ministerial directions  94
Indemnities and insurance premiums for officers  94-95
Requirements under other guidelines and legislation
Service charter  93
Ecologically sustainable development and environmental performance  103-106
Freedom of information  111-112
Occupational health and safety  107-110
Fraud control  93
Equality of employment opportunity  97
Index of compliance with
reporting guidelines
ANSTO Annual Report 2010-2011  l  114
Acronyms
ACAS  Australian Collaboration for Accelerator Science
AINSE Australian Institute of Nuclear Science and Engineering
ALARA  as low as reasonably achievable
AMS  Accelerator mass spectrometry
ANA  Australian Nuclear Association
ANAO Australian National Audit Office
ANSTO  Australian Nuclear Science and Technology Organisation
ANTARES  Australian National Tandem Accelerator for Applied Research
ARPANSA  Australian Radiation Protection and Nuclear Safety Agency
BATAN National Nuclear Energy Agency of Indonesia
CAC Act  Commonwealth Authorities and Companies Act
CAS Centre for Accelerator Science
CEA  French Atomic Energy Commission
CERN European Organisation for Nuclear Research
CRCBID  Cooperative Research Centre for Biomedical Imaging Development
DIISR  Department of Innovation, Industry, Science and Research
DOFD   Department of Finance and Deregulation
DWGs Designated Work Groups
EIF Education Investment Fund
EMS Environmental management system
EPR Emergency preparedness and response
ESD Ecologically sustainable development
FOI Freedom of Information
GATRI Gamma Technology Research Irradiator
HAZMAT Hazardous materials
HEU Highly enriched uranium
HIFAR High Flux Australian Reactor
HSRs Health and safety representatives
IAEA International Atomic Energy Commission
ICRP International Commission on Radiation Protection
IER    Institute of Environmental Research
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Acronyms
IME Institute of Materials Engineering
IMSS Institute of Materials Structure Science
J-PARC Japan Proton Accelerator Research Complex
KAERI Korean Atomic Energy Research Institute
KEK  High Energy Accelerator Research Organisation
LEU Low enriched uranium
LLWP Local Liaison Working Party
LHC  Large Hadron Collider
LHSTC Lucas Heights Science and Technology Centre
MOU  Memorandum of understanding
MOX Mixed oxide
NEA  Nuclear Energy Agency
NMC   National Medical Cyclotron
NYSF National Youth Science Forum
OAM   Order of Australia Medal
OECD  Organisation for Economic Co-operation and Development
OPAL Open Pool Australian Lightwater reactor
PET Positron emission tomography
SANS Small-angle neutron scattering
SAXS Small-angle X-ray scattering
SERA  Safety, Environmental and Radiological Assurance
SINAP  Shanghai Institute of Applied Physics
STAR     Small Tandem for Applied Research
UMPNER  Uranium Mining, Processing and Nuclear Energy Review
US United States
WTIA       Welding Technology Institute of Australia
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Index
A
accelerator mass spectrometry (AMS), 37
 dating techniques, 22–3
Accelerator Mass Spectrometry 
Conference (AMS 12), 30
accelerators, 27–8
access to documents, 111–12
Access to Major Research Facilities 
Program (AMRFP), 36
accidents and incidents, 107
acronyms, 114–15
ANSTO see Australian Nuclear Science and 
Technology Organisation (ANSTO)
ANSTO/AINSIE Neutron School on 
Dynamics and Kinetics, 36
ANSTO BATAN Memorandum of 
Cooperation, 17
ANSTO Childcare Centre, 37, 97
ANSTO Eureka Prize for Innovative Use of 
Technology, 10, 29
ANSTO Health, 7–8, 32, 94
 Current Health and Safety 
Arrangements, 9
 earnings, 12
ANSTO Minerals, 8, 33
 earnings, 12, 33
ANSTO Minerals Precinct Facilities, 37
Arambatzis, Peter, 5, 6
Askew, Geoff, 5, 6
audit
 external, 93
 internal, 93
Audit & Risk Committee, 88, 90–1, 93
 establishment, 90
 meetings, 91
 members, 90
Austin Health, 35–6
 Centre for Positron Emission 
Tomography (PET), 35–6
Australian Collaboration for Accelerator 
Science (ACAS), 10
Australian Drinking Water Guidelines, 105
Australian Institute of Nuclear Science and 
Engineering (AINSE), 1, 34, 36
Australian Institute of Physics Congress, 
30
Australian Institute of Project 
Management, 12
Australian Museum’s Science in the Bush/
Suburbs/City program, 30
Australian National Audit Office (ANA)), 90
Australian National Tandem Accelerator for 
Applied Research (ANTARES) accelerator, 
22, 27
Australian Nuclear Association (ANA), 32
Australian Nuclear Science and Technology 
Organisation (ANSTO)
 about, 1–2
 activities, 17–37
 annual report requirements, 89
 Audit & Risk Committee, 88, 90–1
 awards, 11–12
 Board, 3–4, 10, 11 see also Board
 Building Manager role, 90
 Building Owner role, 90
 business continuity planning, 95
 Business Management System, 105
 businesses, 32–3
 capital investment, 36–7
 Code of Ethics, 93
 community and education, 28–30
 compliance, 87, 94, 113
 Corporate Plan 2010-2015, 2, 8, 9
 Distinguished Lecture Series, 30–1
Index
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 environmental protection, 103–6
 Equality of Employment Opportunity, 97
 ethics policy, 93
 Executive Team, 5–6
 executives, induction and continuing   
 professional development, 92
 external audit, 93
 external revenue outcomes, 12
 fraud control, 93
 freedom of information, 111–12
 functions under ANSTO Act, 98–101
 governance and performance, 87–95
 health, safety and environmental   
 protection, 90, 107
 highlights, 11–15
 indemnities and insurance premiums,  
 94–5
 innovation, 1
 internal audit, 93
 internal control, 93
 international collaborations, 1–2, 9–10
 judicial decisions and reviews by   
 outside bodies, 94
 key outcomes, 1
 key performance indicators, 39
 ministerial directions, 94
 mission 7
 networks, 1–2
 neutron beam facilities, 2, 7, 14
 outstanding staff achievements, 31–2
 partnerships and associated    
 organisations, 33–6
 performance against strategic   
 objectives, 39
 policy advice, 1
 powers, general, under ANSTO Act,   
 101–2
 public support, 10
 Remuneration Committee, 88, 91–2
 reporting guidelines, index of   
 compliance, 113
 research, 1, 9–10
 responsible Minister, 2
 risk management, 92–3
 role, 1, 10
 Service Charter, 93
 staff, 1, 31–2, 97
 Statement of Compliance, 2
 strategic directions 2010-2015, 2
 vision, 2
 visitors, 28–9
 website, 88, 105
 workshops, 36
Australian Nuclear Science and Technology 
Organisation Act 1987 (ANSTO Act), 87
 amendments to governance parts, 87
 functions and powers of ANSTO under,  
 98–102
Australian Radiation Protection and Nuclear 
Safety Agency (ARPANSA), 14, 94, 103, 
108
Australian Standards committees, 15
Australian Synchrotron, 33–4
Australian wetlands research, 22
B
Banati, Professor Richard, 5, 6, 30
Beckett, Michael, 5, 6
Best Small Project Award, 12
Bilby - time-of-flight SANS instrument, 26
Biomacromolecules, 19
Blazek, Jaroslav, 19
Blisset, Mr Robert (Rob), 5, 6
Board, 94
 ANSTO Corporate Plan 2010-2015, 2
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 Audit & Risk Committee, 88, 90–1
 Charter, 88, 91
 Chief Executive Officer, 88–9
 disclosure of interests, 89
 functions, 87–8
 health, safety and environmental   
 protection, 90
 independent professional advice, 89
 meetings, 88, 89
 members, 3–4, 88–9
 new leadership, 11
 remuneration and allowances, 89
 Remuneration Committee, 88, 91–2
 report of operations, 89–90
 risk management, 92–3
bowel cancer, 19
Bragg Institute, 1, 10, 27, 34, 36
business continuity planning, 95
businesses, 32–3
C
capital investment, 36–7
carbon dioxide monitoring ,JB.24–5
Carlson, Mr John, 31
Carr, Senator Hon. Kim, 2, 9, 32
CEA see French Atomic Energy 
Commission (CEA)
Centre for Accelerator Science (CAS), 28, 
37
CERN see European Organisation for 
Nuclear Research (CERN)
Chairman’s Report, 7–8
Changing Climates, Earth Systems and 
Society, 14, 31
Charles Darwin University, 23
chemeca chemistry conference, 30
Chief Executive Officer’s Report, 9–10
China, ancient
 farming and metallurgy in, 20
Chinese Academy of Sciences, 9
Chisari, Robert, 23
climate change, 1, 20–3
 Changing Climates, Earth Systems and 
Society, 14, 31
Code of Ethics, 93
Cohen, Dr David, 31–2
Cold Neutron Source, 26
cold triple-axis spectrometer (SIKA), 26
Cole, Stephanie, 5, 6
Comcare, 94, 107
Comcover, 87, 95
Commonwealth Auditor-General, 93, 94
Commonwealth Authorities and 
Companies Act (CAC Act), 87, 88, 89, 91, 
93, 95
Commonwealth Authorities and 
Companies (Report of Operations) Orders 
2005, 2, 89
Commonwealth Ombudsman, 94
community and education
 school tours, 29
 sponsorships, 29–30
 visitors, 28–9
compliance, 87, 94, 113
Comprehensive Test Ban Treaty, 106
Cooperative Research Centre for 
Biomedical Imaging Development’s 
(CRCBID) research program, 18, 19–20
Copolov, Professor David, OAM,, 3, 4, 11, 
88, 90, 91
cosmogenic radionuclide surface exposure 
dating, 21
Craufurd-Hill, Jasmin, 30
Cubbin, Douglas (Doug), 5, 6
Cyclotek (Aust) Pty Ltd, 18, 20
Index
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D
Danilkin, Sergey, 14
Darling River, effect of drought, 20
Darwin Harbour, 23
Darwish, Tamim, 24
Davies, Justin, 30
decommissioning
 HIFAR, 28, 103, 105
 Moata research reactor, 11–12, 28
 National Medical Cyclotron (NMC), 28
Deed of Indemnity, 87
Department of Environment and Heritage, 
105
Department of Foreign Affairs and Trade, 
17
Department of Resources, Energy and 
Tourism, 11
Dingo - neutron radiography, tomography 
and imaging station, 26
Distinguished Lecture Series, 30–1
Dodson, Professor Lyndon, 5, 6, 31, 35
 book release, 14, 31
Doser, Dr Michael, 31
drought, effect on Darling River, 20
E
East Antarctic Ice Sheet, 21
Echidna - high-resolution powder 
diffractometer, 24, 26
ecologically sustainable development 
(ESD), 105–6
education see community and education
Education Investment Fund, 26
Edwards, Professor Lyndon, 5, 6
electricity supplies, 13–14
Embassy of Italy, 36
emergency preparedness and responses, 
110
Emu - high-resolution backscattering 
spectrometer, 26
Engineering Summit and Science meets 
Parliament events, 30
engineering/technology
 accelerators, 27–8
 irradiation facility, 28
 nuclear safety, 25
 operation of OPAL and other facilities,  
 25–8
environment and climate change, 20–3 see 
also climate change
Environmental and Effluent Monitoring, 
105
environmental management system, 103
environmental performance, 103
 accurate measurements with   
 independent verification, 103
environmental protection, 103
 ecologically sustainable development  
 (ESD), 105–6
 emissions to air, 103–4
 environmental management system,  
 103
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freedom of information, 111–12
 associated organisations, 111
 categories of documents, 111–12
 facilities for access, 112
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indemnities and insurance premiums, 94–5
Indemnity, Deed of, 87
Indonesian Counter Terrorism Cooperation, 
17
Indonesian emergency preparedness and 
response (EPR) project, 17
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radiocarbon dating in China, 20
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Public information
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our database, call +61 2 9717 3111 or email 
enquiries@ansto.gov.au
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